Sentence	entity_1	entity_2	entity_3	entity_4	entity_5	entity_6	entity_7	json	split
There were significant differences in s - VEGF between the RCC patients and the controls ( 207. 3 + / - 32. 9 vs. 71. 5 + / - 9. 1 pg / ml, mean + / - SE) ( P less than 0. 005), between the tumor - bearing renal veins and the contralateral ones ( P less than 0. 01), between the pre - and post - nephrectomy situations ( P less than 0. 01) and among the various parameters of tumor status such as tumor extent ( P less than 0. 001) and existence of metastasis ( P less than 0. 001).	VEGF,42,46,Gene_or_gene_product	RCC,59,62,Cancer	patients,63,71,Organism	tumor,190,195,Cancer	renal veins,206,217,Multi	tumor,376,381,Cancer	tumor,397,402,Cancer	"[{""token"": ""VEGF"", ""start_span"": 42, ""end_span"": 46, ""type"": ""Gene_or_gene_product""}, {""token"": ""RCC"", ""start_span"": 59, ""end_span"": 62, ""type"": ""Cancer""}, {""token"": ""patients"", ""start_span"": 63, ""end_span"": 71, ""type"": ""Organism""}, {""token"": ""tumor"", ""start_span"": 190, ""end_span"": 195, ""type"": ""Cancer""}, {""token"": ""renal veins"", ""start_span"": 206, ""end_span"": 217, ""type"": ""Multi""}, {""token"": ""tumor"", ""start_span"": 376, ""end_span"": 381, ""type"": ""Cancer""}, {""token"": ""tumor"", ""start_span"": 397, ""end_span"": 402, ""type"": ""Cancer""}]"	train
LMP1 of Epstein - Barr virus induces proliferation of primary mouse embryonic fibroblasts and cooperatively transforms the cells with a p16 - insensitive CDK4 oncogene.	LMP1,0,4,Gene_or_gene_product	Epstein - Barr virus,8,28,Organism	mouse,62,67,Organism	embryonic fibroblasts,68,89,Cell	cells,123,128,Cell	p16,136,139,Gene_or_gene_product	CDK4,154,158,Gene_or_gene_product	"[{""token"": ""LMP1"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene_or_gene_product""}, {""token"": ""Epstein - Barr virus"", ""start_span"": 8, ""end_span"": 28, ""type"": ""Organism""}, {""token"": ""mouse"", ""start_span"": 62, ""end_span"": 67, ""type"": ""Organism""}, {""token"": ""embryonic fibroblasts"", ""start_span"": 68, ""end_span"": 89, ""type"": ""Cell""}, {""token"": ""cells"", ""start_span"": 123, ""end_span"": 128, ""type"": ""Cell""}, {""token"": ""p16"", ""start_span"": 136, ""end_span"": 139, ""type"": ""Gene_or_gene_product""}, {""token"": ""CDK4"", ""start_span"": 154, ""end_span"": 158, ""type"": ""Gene_or_gene_product""}]"	train
The latent membrane protein LMP1 of Epstein - Barr virus ( EBV) is often present in EBV - associated malignancies including nasopharyngeal carcinoma and Hodgkin ' s lymphoma.	LMP1,28,32,Gene_or_gene_product	Epstein - Barr virus,36,56,Organism	EBV,59,62,Organism	EBV,84,87,Organism	malignancies,101,113,Cancer	nasopharyngeal carcinoma,124,148,Cancer	Hodgkin ' s lymphoma,153,173,Cancer	"[{""token"": ""LMP1"", ""start_span"": 28, ""end_span"": 32, ""type"": ""Gene_or_gene_product""}, {""token"": ""Epstein - Barr virus"", ""start_span"": 36, ""end_span"": 56, ""type"": ""Organism""}, {""token"": ""EBV"", ""start_span"": 59, ""end_span"": 62, ""type"": ""Organism""}, {""token"": ""EBV"", ""start_span"": 84, ""end_span"": 87, ""type"": ""Organism""}, {""token"": ""malignancies"", ""start_span"": 101, ""end_span"": 113, ""type"": ""Cancer""}, {""token"": ""nasopharyngeal carcinoma"", ""start_span"": 124, ""end_span"": 148, ""type"": ""Cancer""}, {""token"": ""Hodgkin ' s lymphoma"", ""start_span"": 153, ""end_span"": 173, ""type"": ""Cancer""}]"	train
This is primarily based on limited in vitro studies on tumor cells derived from transitional cell carcinoma of the bladder that revealed a dose - and time - dependent inhibition of cell growth by ciprofloxacin at concentrations that are easily attainable in the urine of patients.	tumor cells,55,66,Cell	transitional cell carcinoma,80,107,Cancer	bladder,115,122,Organ	cell,181,185,Cell	ciprofloxacin,196,209,Chemical	urine,262,267,Organism_substance	patients,271,279,Organism	"[{""token"": ""tumor cells"", ""start_span"": 55, ""end_span"": 66, ""type"": ""Cell""}, {""token"": ""transitional cell carcinoma"", ""start_span"": 80, ""end_span"": 107, ""type"": ""Cancer""}, {""token"": ""bladder"", ""start_span"": 115, ""end_span"": 122, ""type"": ""Organ""}, {""token"": ""cell"", ""start_span"": 181, ""end_span"": 185, ""type"": ""Cell""}, {""token"": ""ciprofloxacin"", ""start_span"": 196, ""end_span"": 209, ""type"": ""Chemical""}, {""token"": ""urine"", ""start_span"": 262, ""end_span"": 267, ""type"": ""Organism_substance""}, {""token"": ""patients"", ""start_span"": 271, ""end_span"": 279, ""type"": ""Organism""}]"	train
This study uses quantitative histomorphometry and double - immunohistologic detection techniques for the demarcation of proliferating endothelial cells, to show that synchronized hair follicle cycling in adolescent C57BL / 6 mice is associated with substantial angiogenesis, and that inhibiting angiogenesis in vivo by the intraperitoneal application of a fumagillin derivative retards experimentally induced anagen development in these mice.	endothelial cells,134,151,Cell	hair follicle,179,192,Multi	C57BL / 6 mice,215,229,Organism	intraperitoneal,323,338,Immaterial_anatomical_entity	fumagillin derivative,356,377,Chemical	anagen,409,415,Multi	mice,437,441,Organism	"[{""token"": ""endothelial cells"", ""start_span"": 134, ""end_span"": 151, ""type"": ""Cell""}, {""token"": ""hair follicle"", ""start_span"": 179, ""end_span"": 192, ""type"": ""Multi""}, {""token"": ""C57BL / 6 mice"", ""start_span"": 215, ""end_span"": 229, ""type"": ""Organism""}, {""token"": ""intraperitoneal"", ""start_span"": 323, ""end_span"": 338, ""type"": ""Immaterial_anatomical_entity""}, {""token"": ""fumagillin derivative"", ""start_span"": 356, ""end_span"": 377, ""type"": ""Chemical""}, {""token"": ""anagen"", ""start_span"": 409, ""end_span"": 415, ""type"": ""Multi""}, {""token"": ""mice"", ""start_span"": 437, ""end_span"": 441, ""type"": ""Organism""}]"	train
In order to study their relation to the metastatic profile and survival, we evaluated the association between pretreatment serum levels of S - 100beta, IL - 6, IL - 10 and IL - 12 and metastatic site and survival in 50 patients with advanced melanoma who were to receive chemoimmunotherapy.	serum,123,128,Organism_substance	S - 100beta,139,150,Gene_or_gene_product	IL - 6,152,158,Gene_or_gene_product	IL - 10,160,167,Gene_or_gene_product	IL - 12,172,179,Gene_or_gene_product	patients,219,227,Organism	melanoma,242,250,Cancer	"[{""token"": ""serum"", ""start_span"": 123, ""end_span"": 128, ""type"": ""Organism_substance""}, {""token"": ""S - 100beta"", ""start_span"": 139, ""end_span"": 150, ""type"": ""Gene_or_gene_product""}, {""token"": ""IL - 6"", ""start_span"": 152, ""end_span"": 158, ""type"": ""Gene_or_gene_product""}, {""token"": ""IL - 10"", ""start_span"": 160, ""end_span"": 167, ""type"": ""Gene_or_gene_product""}, {""token"": ""IL - 12"", ""start_span"": 172, ""end_span"": 179, ""type"": ""Gene_or_gene_product""}, {""token"": ""patients"", ""start_span"": 219, ""end_span"": 227, ""type"": ""Organism""}, {""token"": ""melanoma"", ""start_span"": 242, ""end_span"": 250, ""type"": ""Cancer""}]"	train
The findings suggest that elevated serum levels of S - 100beta, IL - 6 and IL - 10 reflect concurrent liver or bone metastases in melanoma.	serum,35,40,Organism_substance	S - 100beta,51,62,Gene_or_gene_product	IL - 6,64,70,Gene_or_gene_product	IL - 10,75,82,Gene_or_gene_product	liver,102,107,Organ	bone,111,115,Organ	melanoma,130,138,Cancer	"[{""token"": ""serum"", ""start_span"": 35, ""end_span"": 40, ""type"": ""Organism_substance""}, {""token"": ""S - 100beta"", ""start_span"": 51, ""end_span"": 62, ""type"": ""Gene_or_gene_product""}, {""token"": ""IL - 6"", ""start_span"": 64, ""end_span"": 70, ""type"": ""Gene_or_gene_product""}, {""token"": ""IL - 10"", ""start_span"": 75, ""end_span"": 82, ""type"": ""Gene_or_gene_product""}, {""token"": ""liver"", ""start_span"": 102, ""end_span"": 107, ""type"": ""Organ""}, {""token"": ""bone"", ""start_span"": 111, ""end_span"": 115, ""type"": ""Organ""}, {""token"": ""melanoma"", ""start_span"": 130, ""end_span"": 138, ""type"": ""Cancer""}]"	train
TEL, a putative tumor suppressor, modulates cell growth and cell morphology of ras - transformed cells while repressing the transcription of stromelysin - 1.	TEL,0,3,Gene_or_gene_product	tumor,16,21,Cancer	cell,44,48,Cell	cell,60,64,Cell	ras,79,82,Gene_or_gene_product	cells,97,102,Cell	stromelysin - 1,141,156,Gene_or_gene_product	"[{""token"": ""TEL"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 16, ""end_span"": 21, ""type"": ""Cancer""}, {""token"": ""cell"", ""start_span"": 44, ""end_span"": 48, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 60, ""end_span"": 64, ""type"": ""Cell""}, {""token"": ""ras"", ""start_span"": 79, ""end_span"": 82, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 97, ""end_span"": 102, ""type"": ""Cell""}, {""token"": ""stromelysin - 1"", ""start_span"": 141, ""end_span"": 156, ""type"": ""Gene_or_gene_product""}]"	train
We present evidence that apoptosis of caspase - 3 - deficient MCF - 7 breast cancer cells is defective in response to cisplatin treatment, as determined by chromatin condensation, nuclear fragmentation, DNA fragmentation, and release of cytochrome c from the mitochondria.	caspase - 3,38,49,Gene_or_gene_product	cisplatin,118,127,Chemical	chromatin,156,165,Cellular_component	nuclear,180,187,Cellular_component	DNA,203,206,Cellular_component	cytochrome c,237,249,Gene_or_gene_product	mitochondria,259,271,Cellular_component	"[{""token"": ""caspase - 3"", ""start_span"": 38, ""end_span"": 49, ""type"": ""Gene_or_gene_product""}, {""token"": ""cisplatin"", ""start_span"": 118, ""end_span"": 127, ""type"": ""Chemical""}, {""token"": ""chromatin"", ""start_span"": 156, ""end_span"": 165, ""type"": ""Cellular_component""}, {""token"": ""nuclear"", ""start_span"": 180, ""end_span"": 187, ""type"": ""Cellular_component""}, {""token"": ""DNA"", ""start_span"": 203, ""end_span"": 206, ""type"": ""Cellular_component""}, {""token"": ""cytochrome c"", ""start_span"": 237, ""end_span"": 249, ""type"": ""Gene_or_gene_product""}, {""token"": ""mitochondria"", ""start_span"": 259, ""end_span"": 271, ""type"": ""Cellular_component""}]"	train
PROCEDURE: To investigate the effect of p75 expression in NB, we transfected the p75 cDNA into SH - SY5Y cells, an NB cell line lacking expression of both p75 and TrkA.	p75,40,43,Gene_or_gene_product	NB,58,60,Cancer	p75,81,84,Gene_or_gene_product	SH - SY5Y cells,95,110,Cell	NB cell line,115,127,Cell	p75,155,158,Gene_or_gene_product	TrkA,163,167,Gene_or_gene_product	"[{""token"": ""p75"", ""start_span"": 40, ""end_span"": 43, ""type"": ""Gene_or_gene_product""}, {""token"": ""NB"", ""start_span"": 58, ""end_span"": 60, ""type"": ""Cancer""}, {""token"": ""p75"", ""start_span"": 81, ""end_span"": 84, ""type"": ""Gene_or_gene_product""}, {""token"": ""SH - SY5Y cells"", ""start_span"": 95, ""end_span"": 110, ""type"": ""Cell""}, {""token"": ""NB cell line"", ""start_span"": 115, ""end_span"": 127, ""type"": ""Cell""}, {""token"": ""p75"", ""start_span"": 155, ""end_span"": 158, ""type"": ""Gene_or_gene_product""}, {""token"": ""TrkA"", ""start_span"": 163, ""end_span"": 167, ""type"": ""Gene_or_gene_product""}]"	train
The soluble factors they release in its presence arrest the cycle of endothelial cells ( EC), inhibit in vitro angiogenesis, negatively modulate the production of matrix metalloproteinase - 9, and the ability of EC to adhere to vitronectin and up - regulate ICAM - 1 and VCAM - 1 expression.	endothelial cells,69,86,Cell	EC,89,91,Cell	matrix metalloproteinase - 9,163,191,Gene_or_gene_product	EC,212,214,Cell	vitronectin,228,239,Gene_or_gene_product	ICAM - 1,258,266,Gene_or_gene_product	VCAM - 1,271,279,Gene_or_gene_product	"[{""token"": ""endothelial cells"", ""start_span"": 69, ""end_span"": 86, ""type"": ""Cell""}, {""token"": ""EC"", ""start_span"": 89, ""end_span"": 91, ""type"": ""Cell""}, {""token"": ""matrix metalloproteinase - 9"", ""start_span"": 163, ""end_span"": 191, ""type"": ""Gene_or_gene_product""}, {""token"": ""EC"", ""start_span"": 212, ""end_span"": 214, ""type"": ""Cell""}, {""token"": ""vitronectin"", ""start_span"": 228, ""end_span"": 239, ""type"": ""Gene_or_gene_product""}, {""token"": ""ICAM - 1"", ""start_span"": 258, ""end_span"": 266, ""type"": ""Gene_or_gene_product""}, {""token"": ""VCAM - 1"", ""start_span"": 271, ""end_span"": 279, ""type"": ""Gene_or_gene_product""}]"	train
Inhibition of PDGF - stimulated and matrix - mediated proliferation of human vascular smooth muscle cells by SPARC is independent of changes in cell shape or cyclin - dependent kinase inhibitors.	PDGF,14,18,Gene_or_gene_product	matrix,36,42,Cellular_component	human,71,76,Organism	vascular smooth muscle cells,77,105,Cell	SPARC,109,114,Gene_or_gene_product	cell,144,148,Cell	cyclin - dependent kinase inhibitors,158,194,Chemical	"[{""token"": ""PDGF"", ""start_span"": 14, ""end_span"": 18, ""type"": ""Gene_or_gene_product""}, {""token"": ""matrix"", ""start_span"": 36, ""end_span"": 42, ""type"": ""Cellular_component""}, {""token"": ""human"", ""start_span"": 71, ""end_span"": 76, ""type"": ""Organism""}, {""token"": ""vascular smooth muscle cells"", ""start_span"": 77, ""end_span"": 105, ""type"": ""Cell""}, {""token"": ""SPARC"", ""start_span"": 109, ""end_span"": 114, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 144, ""end_span"": 148, ""type"": ""Cell""}, {""token"": ""cyclin - dependent kinase inhibitors"", ""start_span"": 158, ""end_span"": 194, ""type"": ""Chemical""}]"	train
METHODS: Tumor biopsy specimens and serum were obtained from 37 neuroblastoma patients; adrenal biopsy sections and sera of 7 normal children served as controls.	Tumor biopsy specimens,9,31,Cancer	serum,36,41,Organism_substance	neuroblastoma,64,77,Cancer	patients,78,86,Organism	adrenal biopsy sections,88,111,Multi	sera,116,120,Organism_substance	children,133,141,Organism	"[{""token"": ""Tumor biopsy specimens"", ""start_span"": 9, ""end_span"": 31, ""type"": ""Cancer""}, {""token"": ""serum"", ""start_span"": 36, ""end_span"": 41, ""type"": ""Organism_substance""}, {""token"": ""neuroblastoma"", ""start_span"": 64, ""end_span"": 77, ""type"": ""Cancer""}, {""token"": ""patients"", ""start_span"": 78, ""end_span"": 86, ""type"": ""Organism""}, {""token"": ""adrenal biopsy sections"", ""start_span"": 88, ""end_span"": 111, ""type"": ""Multi""}, {""token"": ""sera"", ""start_span"": 116, ""end_span"": 120, ""type"": ""Organism_substance""}, {""token"": ""children"", ""start_span"": 133, ""end_span"": 141, ""type"": ""Organism""}]"	train
Dietary CLA decreased serum levels of vascular endothelial growth factor ( VEGF) and whole mammary gland levels of VEGF and its receptor Flk - 1.	CLA,8,11,Chemical	serum,22,27,Organism_substance	vascular endothelial growth factor,38,72,Gene_or_gene_product	VEGF,75,79,Gene_or_gene_product	mammary gland,91,104,Organ	VEGF,115,119,Gene_or_gene_product	Flk - 1,137,144,Gene_or_gene_product	"[{""token"": ""CLA"", ""start_span"": 8, ""end_span"": 11, ""type"": ""Chemical""}, {""token"": ""serum"", ""start_span"": 22, ""end_span"": 27, ""type"": ""Organism_substance""}, {""token"": ""vascular endothelial growth factor"", ""start_span"": 38, ""end_span"": 72, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 75, ""end_span"": 79, ""type"": ""Gene_or_gene_product""}, {""token"": ""mammary gland"", ""start_span"": 91, ""end_span"": 104, ""type"": ""Organ""}, {""token"": ""VEGF"", ""start_span"": 115, ""end_span"": 119, ""type"": ""Gene_or_gene_product""}, {""token"": ""Flk - 1"", ""start_span"": 137, ""end_span"": 144, ""type"": ""Gene_or_gene_product""}]"	train
Histologic evaluation revealed that although tumors overexpressing TIMP - 3 had an increased number of CD31 ( +) endothelial cells, these endothelial cells had not formed functional tubules, as evidenced by decreased vessel continuity and minimal pericyte recruitment.	tumors,45,51,Cancer	TIMP - 3,67,75,Gene_or_gene_product	CD31,103,107,Gene_or_gene_product	endothelial cells,113,130,Cell	tubules,182,189,Tissue	vessel,217,223,Multi	pericyte,247,255,Cell	"[{""token"": ""tumors"", ""start_span"": 45, ""end_span"": 51, ""type"": ""Cancer""}, {""token"": ""TIMP - 3"", ""start_span"": 67, ""end_span"": 75, ""type"": ""Gene_or_gene_product""}, {""token"": ""CD31"", ""start_span"": 103, ""end_span"": 107, ""type"": ""Gene_or_gene_product""}, {""token"": ""endothelial cells"", ""start_span"": 113, ""end_span"": 130, ""type"": ""Cell""}, {""token"": ""tubules"", ""start_span"": 182, ""end_span"": 189, ""type"": ""Tissue""}, {""token"": ""vessel"", ""start_span"": 217, ""end_span"": 223, ""type"": ""Multi""}, {""token"": ""pericyte"", ""start_span"": 247, ""end_span"": 255, ""type"": ""Cell""}]"	train
Looking for mechanisms linking Brn - 3a to carcinogenesis, we discuss the role of this transcription factor in influencing Bcl - 2 / p53 antagonism and Bcl - 2 / VEGF induction of tumor angiogenesis, concluding this review with a proposal for the oncogenic nature of Brn - 3a.	Brn - 3a,31,39,Gene_or_gene_product	Bcl - 2,123,130,Gene_or_gene_product	p53,133,136,Gene_or_gene_product	Bcl - 2,152,159,Gene_or_gene_product	VEGF,162,166,Gene_or_gene_product	tumor,180,185,Cancer	Brn - 3a,267,275,Gene_or_gene_product	"[{""token"": ""Brn - 3a"", ""start_span"": 31, ""end_span"": 39, ""type"": ""Gene_or_gene_product""}, {""token"": ""Bcl - 2"", ""start_span"": 123, ""end_span"": 130, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 133, ""end_span"": 136, ""type"": ""Gene_or_gene_product""}, {""token"": ""Bcl - 2"", ""start_span"": 152, ""end_span"": 159, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 162, ""end_span"": 166, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 180, ""end_span"": 185, ""type"": ""Cancer""}, {""token"": ""Brn - 3a"", ""start_span"": 267, ""end_span"": 275, ""type"": ""Gene_or_gene_product""}]"	train
F - 2 cells cultured on Matrigel showed evident tube formation, and coculture of F - 2 cells with A431 cells led to the formation of A431 cell nests constantly surrounded by tube - like networks consisting of F - 2 cells.	F - 2 cells,0,11,Cell	tube,48,52,Tissue	F - 2 cells,81,92,Cell	A431 cells,98,108,Cell	A431 cell,133,142,Cell	tube,174,178,Tissue	F - 2 cells,209,220,Cell	"[{""token"": ""F - 2 cells"", ""start_span"": 0, ""end_span"": 11, ""type"": ""Cell""}, {""token"": ""tube"", ""start_span"": 48, ""end_span"": 52, ""type"": ""Tissue""}, {""token"": ""F - 2 cells"", ""start_span"": 81, ""end_span"": 92, ""type"": ""Cell""}, {""token"": ""A431 cells"", ""start_span"": 98, ""end_span"": 108, ""type"": ""Cell""}, {""token"": ""A431 cell"", ""start_span"": 133, ""end_span"": 142, ""type"": ""Cell""}, {""token"": ""tube"", ""start_span"": 174, ""end_span"": 178, ""type"": ""Tissue""}, {""token"": ""F - 2 cells"", ""start_span"": 209, ""end_span"": 220, ""type"": ""Cell""}]"	train
These results indicate that the interaction of tumor cells and endothelial cells in orderly tumor angiomorphogenesis is highly dependent on the action of cell adhesion molecules mediating the adhesion of cancer cells to endothelial cells, inhibition of which remarkably retards tumor growth and angiogenesis.	tumor cells,47,58,Cell	endothelial cells,63,80,Cell	tumor,92,97,Cancer	cell,154,158,Cell	cancer cells,204,216,Cell	endothelial cells,220,237,Cell	tumor,278,283,Cancer	"[{""token"": ""tumor cells"", ""start_span"": 47, ""end_span"": 58, ""type"": ""Cell""}, {""token"": ""endothelial cells"", ""start_span"": 63, ""end_span"": 80, ""type"": ""Cell""}, {""token"": ""tumor"", ""start_span"": 92, ""end_span"": 97, ""type"": ""Cancer""}, {""token"": ""cell"", ""start_span"": 154, ""end_span"": 158, ""type"": ""Cell""}, {""token"": ""cancer cells"", ""start_span"": 204, ""end_span"": 216, ""type"": ""Cell""}, {""token"": ""endothelial cells"", ""start_span"": 220, ""end_span"": 237, ""type"": ""Cell""}, {""token"": ""tumor"", ""start_span"": 278, ""end_span"": 283, ""type"": ""Cancer""}]"	train
We investigated the roles of the prostaglandin synthases cyclooxygenase ( COX) I and COX - II in angiogenesis and progesterone production in the newly formed CL, using inhibitors of the COX enzymes and the gonadotropin - induced pseudopregnant rat as a model.	prostaglandin,33,46,Chemical	COX - II,85,93,Gene_or_gene_product	progesterone,114,126,Chemical	CL,158,160,Multi	COX enzymes,186,197,Gene_or_gene_product	gonadotropin,206,218,Gene_or_gene_product	rat,244,247,Organism	"[{""token"": ""prostaglandin"", ""start_span"": 33, ""end_span"": 46, ""type"": ""Chemical""}, {""token"": ""COX - II"", ""start_span"": 85, ""end_span"": 93, ""type"": ""Gene_or_gene_product""}, {""token"": ""progesterone"", ""start_span"": 114, ""end_span"": 126, ""type"": ""Chemical""}, {""token"": ""CL"", ""start_span"": 158, ""end_span"": 160, ""type"": ""Multi""}, {""token"": ""COX enzymes"", ""start_span"": 186, ""end_span"": 197, ""type"": ""Gene_or_gene_product""}, {""token"": ""gonadotropin"", ""start_span"": 206, ""end_span"": 218, ""type"": ""Gene_or_gene_product""}, {""token"": ""rat"", ""start_span"": 244, ""end_span"": 247, ""type"": ""Organism""}]"	train
BACKGROUND & # 38; OBJECTIVE: It has been proved that Epstein - Barr virus ( EBV) latent membrane protein 1 ( EBV - LMP1) can induce the expression of matrix metalloproteinase - 9 ( MMP - 9).	Epstein - Barr virus,54,74,Organism	EBV,77,80,Organism	latent membrane protein 1,82,107,Gene_or_gene_product	EBV,110,113,Organism	LMP1,116,120,Gene_or_gene_product	matrix metalloproteinase - 9,151,179,Gene_or_gene_product	MMP - 9,182,189,Gene_or_gene_product	"[{""token"": ""Epstein - Barr virus"", ""start_span"": 54, ""end_span"": 74, ""type"": ""Organism""}, {""token"": ""EBV"", ""start_span"": 77, ""end_span"": 80, ""type"": ""Organism""}, {""token"": ""latent membrane protein 1"", ""start_span"": 82, ""end_span"": 107, ""type"": ""Gene_or_gene_product""}, {""token"": ""EBV"", ""start_span"": 110, ""end_span"": 113, ""type"": ""Organism""}, {""token"": ""LMP1"", ""start_span"": 116, ""end_span"": 120, ""type"": ""Gene_or_gene_product""}, {""token"": ""matrix metalloproteinase - 9"", ""start_span"": 151, ""end_span"": 179, ""type"": ""Gene_or_gene_product""}, {""token"": ""MMP - 9"", ""start_span"": 182, ""end_span"": 189, ""type"": ""Gene_or_gene_product""}]"	train
RESULTS: Adenoviral transduction of endothelial cells with pAd - Survivin inhibited growth factor deprivation - or ceramide - induced apoptosis, reduced caspase - 3 and - 7 generation, and stabilized three - dimensional capillary networks in vitro.	Adenoviral,9,19,Organism	endothelial cells,36,53,Cell	pAd - Survivin,59,73,Gene_or_gene_product	ceramide,115,123,Chemical	caspase - 3,153,164,Gene_or_gene_product	- 7,169,172,Gene_or_gene_product	capillary networks,220,238,Multi	"[{""token"": ""Adenoviral"", ""start_span"": 9, ""end_span"": 19, ""type"": ""Organism""}, {""token"": ""endothelial cells"", ""start_span"": 36, ""end_span"": 53, ""type"": ""Cell""}, {""token"": ""pAd - Survivin"", ""start_span"": 59, ""end_span"": 73, ""type"": ""Gene_or_gene_product""}, {""token"": ""ceramide"", ""start_span"": 115, ""end_span"": 123, ""type"": ""Chemical""}, {""token"": ""caspase - 3"", ""start_span"": 153, ""end_span"": 164, ""type"": ""Gene_or_gene_product""}, {""token"": ""- 7"", ""start_span"": 169, ""end_span"": 172, ""type"": ""Gene_or_gene_product""}, {""token"": ""capillary networks"", ""start_span"": 220, ""end_span"": 238, ""type"": ""Multi""}]"	train
Cytotoxic concentrations of cisplatin, etoposide, doxorubicin or peplomycin ( tentatively termed as Group I compounds), but not methotrexate and 5 - FU ( tentatively termed as Group II compounds), enhanced the cytotoxic activity of NaF.	cisplatin,28,37,Chemical	etoposide,39,48,Chemical	doxorubicin,50,61,Chemical	peplomycin,65,75,Chemical	methotrexate,128,140,Chemical	5 - FU,145,151,Chemical	NaF,232,235,Chemical	"[{""token"": ""cisplatin"", ""start_span"": 28, ""end_span"": 37, ""type"": ""Chemical""}, {""token"": ""etoposide"", ""start_span"": 39, ""end_span"": 48, ""type"": ""Chemical""}, {""token"": ""doxorubicin"", ""start_span"": 50, ""end_span"": 61, ""type"": ""Chemical""}, {""token"": ""peplomycin"", ""start_span"": 65, ""end_span"": 75, ""type"": ""Chemical""}, {""token"": ""methotrexate"", ""start_span"": 128, ""end_span"": 140, ""type"": ""Chemical""}, {""token"": ""5 - FU"", ""start_span"": 145, ""end_span"": 151, ""type"": ""Chemical""}, {""token"": ""NaF"", ""start_span"": 232, ""end_span"": 235, ""type"": ""Chemical""}]"	train
NaF reduced the glucose consumption at early stage, possibly by inhibition of glycolysis, whereas cisplatin and etoposide reduced the glucose consumption at later stage, suggesting that early decline of glucose consumption is rather specific to NaF.	NaF,0,3,Chemical	glucose,16,23,Chemical	cisplatin,98,107,Chemical	etoposide,112,121,Chemical	glucose,134,141,Chemical	glucose,203,210,Chemical	NaF,245,248,Chemical	"[{""token"": ""NaF"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Chemical""}, {""token"": ""glucose"", ""start_span"": 16, ""end_span"": 23, ""type"": ""Chemical""}, {""token"": ""cisplatin"", ""start_span"": 98, ""end_span"": 107, ""type"": ""Chemical""}, {""token"": ""etoposide"", ""start_span"": 112, ""end_span"": 121, ""type"": ""Chemical""}, {""token"": ""glucose"", ""start_span"": 134, ""end_span"": 141, ""type"": ""Chemical""}, {""token"": ""glucose"", ""start_span"": 203, ""end_span"": 210, ""type"": ""Chemical""}, {""token"": ""NaF"", ""start_span"": 245, ""end_span"": 248, ""type"": ""Chemical""}]"	train
This chapter focuses on the morphology of blood vessel formation in and around the early central nervous system ( CNS, i. e., brain and spinal cord) of avian embryos.	blood vessel,42,54,Multi	central nervous system,89,111,Anatomical_system	CNS,114,117,Anatomical_system	brain,126,131,Organ	spinal cord,136,147,Organ	avian,152,157,Organism	embryos,158,165,Developing_anatomical_structure	"[{""token"": ""blood vessel"", ""start_span"": 42, ""end_span"": 54, ""type"": ""Multi""}, {""token"": ""central nervous system"", ""start_span"": 89, ""end_span"": 111, ""type"": ""Anatomical_system""}, {""token"": ""CNS"", ""start_span"": 114, ""end_span"": 117, ""type"": ""Anatomical_system""}, {""token"": ""brain"", ""start_span"": 126, ""end_span"": 131, ""type"": ""Organ""}, {""token"": ""spinal cord"", ""start_span"": 136, ""end_span"": 147, ""type"": ""Organ""}, {""token"": ""avian"", ""start_span"": 152, ""end_span"": 157, ""type"": ""Organism""}, {""token"": ""embryos"", ""start_span"": 158, ""end_span"": 165, ""type"": ""Developing_anatomical_structure""}]"	train
In mice, xenografts of human glioblastoma U87MG, which has decreased expression of ING4, grow significantly faster and have higher vascular volume fractions than control tumours.	mice,3,7,Organism	xenografts,9,19,Cancer	human,23,28,Organism	glioblastoma U87MG,29,47,Cancer	ING4,83,87,Gene_or_gene_product	vascular,131,139,Multi	tumours,170,177,Cancer	"[{""token"": ""mice"", ""start_span"": 3, ""end_span"": 7, ""type"": ""Organism""}, {""token"": ""xenografts"", ""start_span"": 9, ""end_span"": 19, ""type"": ""Cancer""}, {""token"": ""human"", ""start_span"": 23, ""end_span"": 28, ""type"": ""Organism""}, {""token"": ""glioblastoma U87MG"", ""start_span"": 29, ""end_span"": 47, ""type"": ""Cancer""}, {""token"": ""ING4"", ""start_span"": 83, ""end_span"": 87, ""type"": ""Gene_or_gene_product""}, {""token"": ""vascular"", ""start_span"": 131, ""end_span"": 139, ""type"": ""Multi""}, {""token"": ""tumours"", ""start_span"": 170, ""end_span"": 177, ""type"": ""Cancer""}]"	train
We show that ING4 physically interacts with p65 ( RelA) subunit of nuclear factor NF - kappaB, and that ING4 regulates brain tumour angiogenesis through transcriptional repression of NF - kappaB - responsive genes.	ING4,13,17,Gene_or_gene_product	p65,44,47,Gene_or_gene_product	RelA,50,54,Gene_or_gene_product	NF - kappaB,82,93,Gene_or_gene_product	ING4,104,108,Gene_or_gene_product	brain tumour,119,131,Cancer	NF - kappaB,183,194,Gene_or_gene_product	"[{""token"": ""ING4"", ""start_span"": 13, ""end_span"": 17, ""type"": ""Gene_or_gene_product""}, {""token"": ""p65"", ""start_span"": 44, ""end_span"": 47, ""type"": ""Gene_or_gene_product""}, {""token"": ""RelA"", ""start_span"": 50, ""end_span"": 54, ""type"": ""Gene_or_gene_product""}, {""token"": ""NF - kappaB"", ""start_span"": 82, ""end_span"": 93, ""type"": ""Gene_or_gene_product""}, {""token"": ""ING4"", ""start_span"": 104, ""end_span"": 108, ""type"": ""Gene_or_gene_product""}, {""token"": ""brain tumour"", ""start_span"": 119, ""end_span"": 131, ""type"": ""Cancer""}, {""token"": ""NF - kappaB"", ""start_span"": 183, ""end_span"": 194, ""type"": ""Gene_or_gene_product""}]"	train
With the discovery that TGFbeta1 was a potent growth inhibitor of epithelial cells, and the identification of inactivating mutations within the TGFbeta1 signaling pathway in cancers it became clear that TGFbeta1 signaling is a tumor suppressor pathway for early stages of cancer.	TGFbeta1,24,32,Gene_or_gene_product	epithelial cells,66,82,Cell	TGFbeta1,144,152,Gene_or_gene_product	cancers,174,181,Cancer	TGFbeta1,203,211,Gene_or_gene_product	tumor,227,232,Cancer	cancer,272,278,Cancer	"[{""token"": ""TGFbeta1"", ""start_span"": 24, ""end_span"": 32, ""type"": ""Gene_or_gene_product""}, {""token"": ""epithelial cells"", ""start_span"": 66, ""end_span"": 82, ""type"": ""Cell""}, {""token"": ""TGFbeta1"", ""start_span"": 144, ""end_span"": 152, ""type"": ""Gene_or_gene_product""}, {""token"": ""cancers"", ""start_span"": 174, ""end_span"": 181, ""type"": ""Cancer""}, {""token"": ""TGFbeta1"", ""start_span"": 203, ""end_span"": 211, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 227, ""end_span"": 232, ""type"": ""Cancer""}, {""token"": ""cancer"", ""start_span"": 272, ""end_span"": 278, ""type"": ""Cancer""}]"	train
In this study, to examine hypoxia - specific production of anti - angiogenic therapeutic gene, we constructed 5 copies of HRE ( 5xHRE) of human VEGF linked to soluble Tie2 ( sTie2) driven by minimal SV40 promoter ( 5xHRE / SV40 / sTie2).	human,138,143,Organism	VEGF,144,148,Gene_or_gene_product	Tie2,167,171,Gene_or_gene_product	sTie2,174,179,Gene_or_gene_product	SV40,199,203,Gene_or_gene_product	SV40,223,227,Gene_or_gene_product	sTie2,230,235,Gene_or_gene_product	"[{""token"": ""human"", ""start_span"": 138, ""end_span"": 143, ""type"": ""Organism""}, {""token"": ""VEGF"", ""start_span"": 144, ""end_span"": 148, ""type"": ""Gene_or_gene_product""}, {""token"": ""Tie2"", ""start_span"": 167, ""end_span"": 171, ""type"": ""Gene_or_gene_product""}, {""token"": ""sTie2"", ""start_span"": 174, ""end_span"": 179, ""type"": ""Gene_or_gene_product""}, {""token"": ""SV40"", ""start_span"": 199, ""end_span"": 203, ""type"": ""Gene_or_gene_product""}, {""token"": ""SV40"", ""start_span"": 223, ""end_span"": 227, ""type"": ""Gene_or_gene_product""}, {""token"": ""sTie2"", ""start_span"": 230, ""end_span"": 235, ""type"": ""Gene_or_gene_product""}]"	train
Thalidomide and angiostatin inhibit tumor growth in a murine xenograft model of human cervical cancer.	Thalidomide,0,11,Chemical	angiostatin,16,27,Gene_or_gene_product	tumor,36,41,Cancer	murine,54,60,Organism	xenograft,61,70,Cancer	human,80,85,Organism	cervical cancer,86,101,Cancer	"[{""token"": ""Thalidomide"", ""start_span"": 0, ""end_span"": 11, ""type"": ""Chemical""}, {""token"": ""angiostatin"", ""start_span"": 16, ""end_span"": 27, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 36, ""end_span"": 41, ""type"": ""Cancer""}, {""token"": ""murine"", ""start_span"": 54, ""end_span"": 60, ""type"": ""Organism""}, {""token"": ""xenograft"", ""start_span"": 61, ""end_span"": 70, ""type"": ""Cancer""}, {""token"": ""human"", ""start_span"": 80, ""end_span"": 85, ""type"": ""Organism""}, {""token"": ""cervical cancer"", ""start_span"": 86, ""end_span"": 101, ""type"": ""Cancer""}]"	train
HKa and D5 inhibit bovine pulmonary artery endothelial cell ( BPAE) or human umbilical vein endothelial cell chemotaxis in the modified - Boyden chamber in response toVEGF or S1P.	HKa,0,3,Gene_or_gene_product	bovine,19,25,Organism	pulmonary artery endothelial cell,26,59,Cell	BPAE,62,66,Cell	human umbilical vein endothelial cell,71,108,Cell	toVEGF,165,171,Gene_or_gene_product	S1P,175,178,Gene_or_gene_product	"[{""token"": ""HKa"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene_or_gene_product""}, {""token"": ""bovine"", ""start_span"": 19, ""end_span"": 25, ""type"": ""Organism""}, {""token"": ""pulmonary artery endothelial cell"", ""start_span"": 26, ""end_span"": 59, ""type"": ""Cell""}, {""token"": ""BPAE"", ""start_span"": 62, ""end_span"": 66, ""type"": ""Cell""}, {""token"": ""human umbilical vein endothelial cell"", ""start_span"": 71, ""end_span"": 108, ""type"": ""Cell""}, {""token"": ""toVEGF"", ""start_span"": 165, ""end_span"": 171, ""type"": ""Gene_or_gene_product""}, {""token"": ""S1P"", ""start_span"": 175, ""end_span"": 178, ""type"": ""Gene_or_gene_product""}]"	train
Inhibition of c - Jun amino - terminal kinase ( JNK) blocked type III collagen expression in LRP - 1 - deficient MEFs, suggesting regulation of JNK activity as a mechanism by which LRP - 1 controls mRNA expression.	c - Jun amino - terminal kinase,14,45,Gene_or_gene_product	JNK,48,51,Gene_or_gene_product	type III collagen,61,78,Gene_or_gene_product	LRP - 1,93,100,Gene_or_gene_product	MEFs,113,117,Cell	JNK,144,147,Gene_or_gene_product	LRP - 1,181,188,Gene_or_gene_product	"[{""token"": ""c - Jun amino - terminal kinase"", ""start_span"": 14, ""end_span"": 45, ""type"": ""Gene_or_gene_product""}, {""token"": ""JNK"", ""start_span"": 48, ""end_span"": 51, ""type"": ""Gene_or_gene_product""}, {""token"": ""type III collagen"", ""start_span"": 61, ""end_span"": 78, ""type"": ""Gene_or_gene_product""}, {""token"": ""LRP - 1"", ""start_span"": 93, ""end_span"": 100, ""type"": ""Gene_or_gene_product""}, {""token"": ""MEFs"", ""start_span"": 113, ""end_span"": 117, ""type"": ""Cell""}, {""token"": ""JNK"", ""start_span"": 144, ""end_span"": 147, ""type"": ""Gene_or_gene_product""}, {""token"": ""LRP - 1"", ""start_span"": 181, ""end_span"": 188, ""type"": ""Gene_or_gene_product""}]"	train
Our results showed that MTX administration increased the MDA and MPO activities and collagen content and decreased GSH levels in all tissues, while these alterations were reversed in L - Car - treated group.	MTX,24,27,Chemical	MDA,57,60,Chemical	MPO,65,68,Chemical	collagen,84,92,Gene_or_gene_product	GSH,115,118,Chemical	tissues,133,140,Tissue	L - Car,183,190,Chemical	"[{""token"": ""MTX"", ""start_span"": 24, ""end_span"": 27, ""type"": ""Chemical""}, {""token"": ""MDA"", ""start_span"": 57, ""end_span"": 60, ""type"": ""Chemical""}, {""token"": ""MPO"", ""start_span"": 65, ""end_span"": 68, ""type"": ""Chemical""}, {""token"": ""collagen"", ""start_span"": 84, ""end_span"": 92, ""type"": ""Gene_or_gene_product""}, {""token"": ""GSH"", ""start_span"": 115, ""end_span"": 118, ""type"": ""Chemical""}, {""token"": ""tissues"", ""start_span"": 133, ""end_span"": 140, ""type"": ""Tissue""}, {""token"": ""L - Car"", ""start_span"": 183, ""end_span"": 190, ""type"": ""Chemical""}]"	train
Severe degeneration of the intestinal mucosa, liver parenchyma, and glomerular and tubular epithelium observed in the saline - treated MTX group was improved by L - Car treatment.	intestinal mucosa,27,44,Multi	liver parenchyma,46,62,Multi	glomerular,68,78,Tissue	tubular epithelium,83,101,Tissue	saline,118,124,Chemical	MTX,135,138,Chemical	L - Car,161,168,Chemical	"[{""token"": ""intestinal mucosa"", ""start_span"": 27, ""end_span"": 44, ""type"": ""Multi""}, {""token"": ""liver parenchyma"", ""start_span"": 46, ""end_span"": 62, ""type"": ""Multi""}, {""token"": ""glomerular"", ""start_span"": 68, ""end_span"": 78, ""type"": ""Tissue""}, {""token"": ""tubular epithelium"", ""start_span"": 83, ""end_span"": 101, ""type"": ""Tissue""}, {""token"": ""saline"", ""start_span"": 118, ""end_span"": 124, ""type"": ""Chemical""}, {""token"": ""MTX"", ""start_span"": 135, ""end_span"": 138, ""type"": ""Chemical""}, {""token"": ""L - Car"", ""start_span"": 161, ""end_span"": 168, ""type"": ""Chemical""}]"	train
Conversely, tumor cell expression of NCAM in a fibrosarcoma model ( T241) improved pericyte recruitment and increased perivascular deposition of ECM molecules.	tumor cell,12,22,Cell	NCAM,37,41,Gene_or_gene_product	fibrosarcoma,47,59,Cancer	T241,68,72,Cancer	pericyte,83,91,Cell	perivascular,118,130,Immaterial_anatomical_entity	ECM molecules,145,158,Cellular_component	"[{""token"": ""tumor cell"", ""start_span"": 12, ""end_span"": 22, ""type"": ""Cell""}, {""token"": ""NCAM"", ""start_span"": 37, ""end_span"": 41, ""type"": ""Gene_or_gene_product""}, {""token"": ""fibrosarcoma"", ""start_span"": 47, ""end_span"": 59, ""type"": ""Cancer""}, {""token"": ""T241"", ""start_span"": 68, ""end_span"": 72, ""type"": ""Cancer""}, {""token"": ""pericyte"", ""start_span"": 83, ""end_span"": 91, ""type"": ""Cell""}, {""token"": ""perivascular"", ""start_span"": 118, ""end_span"": 130, ""type"": ""Immaterial_anatomical_entity""}, {""token"": ""ECM molecules"", ""start_span"": 145, ""end_span"": 158, ""type"": ""Cellular_component""}]"	train
Overall, paclitaxel exerts its anti - tumour effects on cervical cancer cells by inducing apoptosis through intrinsic pathway, and rapamycin targeted to mTOR can sensitise paclitaxel - resistant cervical cancer cells.	paclitaxel,9,19,Chemical	tumour,38,44,Cancer	cervical cancer cells,56,77,Cell	rapamycin,131,140,Chemical	mTOR,153,157,Gene_or_gene_product	paclitaxel,172,182,Chemical	cervical cancer cells,195,216,Cell	"[{""token"": ""paclitaxel"", ""start_span"": 9, ""end_span"": 19, ""type"": ""Chemical""}, {""token"": ""tumour"", ""start_span"": 38, ""end_span"": 44, ""type"": ""Cancer""}, {""token"": ""cervical cancer cells"", ""start_span"": 56, ""end_span"": 77, ""type"": ""Cell""}, {""token"": ""rapamycin"", ""start_span"": 131, ""end_span"": 140, ""type"": ""Chemical""}, {""token"": ""mTOR"", ""start_span"": 153, ""end_span"": 157, ""type"": ""Gene_or_gene_product""}, {""token"": ""paclitaxel"", ""start_span"": 172, ""end_span"": 182, ""type"": ""Chemical""}, {""token"": ""cervical cancer cells"", ""start_span"": 195, ""end_span"": 216, ""type"": ""Cell""}]"	train
PCNSLs with HRK methylation also showed methylation of multiple genes, such as p14ARF, p16INK4a, RB1, p27Kip1 and O6 - MGMT.	PCNSLs,0,6,Cancer	HRK,12,15,Gene_or_gene_product	p14ARF,79,85,Gene_or_gene_product	p16INK4a,87,95,Gene_or_gene_product	RB1,97,100,Gene_or_gene_product	p27Kip1,102,109,Gene_or_gene_product	O6 - MGMT,114,123,Gene_or_gene_product	"[{""token"": ""PCNSLs"", ""start_span"": 0, ""end_span"": 6, ""type"": ""Cancer""}, {""token"": ""HRK"", ""start_span"": 12, ""end_span"": 15, ""type"": ""Gene_or_gene_product""}, {""token"": ""p14ARF"", ""start_span"": 79, ""end_span"": 85, ""type"": ""Gene_or_gene_product""}, {""token"": ""p16INK4a"", ""start_span"": 87, ""end_span"": 95, ""type"": ""Gene_or_gene_product""}, {""token"": ""RB1"", ""start_span"": 97, ""end_span"": 100, ""type"": ""Gene_or_gene_product""}, {""token"": ""p27Kip1"", ""start_span"": 102, ""end_span"": 109, ""type"": ""Gene_or_gene_product""}, {""token"": ""O6 - MGMT"", ""start_span"": 114, ""end_span"": 123, ""type"": ""Gene_or_gene_product""}]"	train
In vitro studies using monolayer cultures of human tumor cell lines have shown that 2 - DG selectively inhibits energy - dependent DNA repair and cellular recovery processes in cancer cells.	monolayer cultures,23,41,Cell	human,45,50,Organism	tumor cell lines,51,67,Cell	2 - DG,84,90,Chemical	DNA,131,134,Cellular_component	cellular,146,154,Cell	cancer cells,177,189,Cell	"[{""token"": ""monolayer cultures"", ""start_span"": 23, ""end_span"": 41, ""type"": ""Cell""}, {""token"": ""human"", ""start_span"": 45, ""end_span"": 50, ""type"": ""Organism""}, {""token"": ""tumor cell lines"", ""start_span"": 51, ""end_span"": 67, ""type"": ""Cell""}, {""token"": ""2 - DG"", ""start_span"": 84, ""end_span"": 90, ""type"": ""Chemical""}, {""token"": ""DNA"", ""start_span"": 131, ""end_span"": 134, ""type"": ""Cellular_component""}, {""token"": ""cellular"", ""start_span"": 146, ""end_span"": 154, ""type"": ""Cell""}, {""token"": ""cancer cells"", ""start_span"": 177, ""end_span"": 189, ""type"": ""Cell""}]"	train
The present study compares the radiomodification by 2 - DG in monolayer cultures and spheroids of a human glioma cell line ( BMG - 1) to gain insight into the effects in solid tumors.	2 - DG,52,58,Chemical	monolayer cultures,62,80,Cell	spheroids,85,94,Cell	human,100,105,Organism	glioma cell line,106,122,Cell	BMG - 1,125,132,Cell	solid tumors,170,182,Cancer	"[{""token"": ""2 - DG"", ""start_span"": 52, ""end_span"": 58, ""type"": ""Chemical""}, {""token"": ""monolayer cultures"", ""start_span"": 62, ""end_span"": 80, ""type"": ""Cell""}, {""token"": ""spheroids"", ""start_span"": 85, ""end_span"": 94, ""type"": ""Cell""}, {""token"": ""human"", ""start_span"": 100, ""end_span"": 105, ""type"": ""Organism""}, {""token"": ""glioma cell line"", ""start_span"": 106, ""end_span"": 122, ""type"": ""Cell""}, {""token"": ""BMG - 1"", ""start_span"": 125, ""end_span"": 132, ""type"": ""Cell""}, {""token"": ""solid tumors"", ""start_span"": 170, ""end_span"": 182, ""type"": ""Cancer""}]"	train
Although the Bcl - 2 and Bax levels were significantly higher in spheroids, Bcl - 2 / Bax ratio was similar in monolayers and spheroids.	Bcl - 2,13,20,Gene_or_gene_product	Bax,25,28,Gene_or_gene_product	spheroids,65,74,Cell	Bcl - 2,76,83,Gene_or_gene_product	Bax,86,89,Gene_or_gene_product	monolayers,111,121,Cell	spheroids,126,135,Cell	"[{""token"": ""Bcl - 2"", ""start_span"": 13, ""end_span"": 20, ""type"": ""Gene_or_gene_product""}, {""token"": ""Bax"", ""start_span"": 25, ""end_span"": 28, ""type"": ""Gene_or_gene_product""}, {""token"": ""spheroids"", ""start_span"": 65, ""end_span"": 74, ""type"": ""Cell""}, {""token"": ""Bcl - 2"", ""start_span"": 76, ""end_span"": 83, ""type"": ""Gene_or_gene_product""}, {""token"": ""Bax"", ""start_span"": 86, ""end_span"": 89, ""type"": ""Gene_or_gene_product""}, {""token"": ""monolayers"", ""start_span"": 111, ""end_span"": 121, ""type"": ""Cell""}, {""token"": ""spheroids"", ""start_span"": 126, ""end_span"": 135, ""type"": ""Cell""}]"	train
The tree / fruit can be divided into several anatomical compartments: ( 1) seed, ( 2) juice, ( 3) peel, ( 4) leaf, ( 5) flower, ( 6) bark, and ( 7) roots, each of which has interesting pharmacologic activity.	seed,75,79,Developing_anatomical_structure	juice,86,91,Organism_substance	peel,98,102,Tissue	leaf,109,113,Organ	flower,120,126,Organism_subdivision	bark,133,137,Tissue	roots,148,153,Organ	"[{""token"": ""seed"", ""start_span"": 75, ""end_span"": 79, ""type"": ""Developing_anatomical_structure""}, {""token"": ""juice"", ""start_span"": 86, ""end_span"": 91, ""type"": ""Organism_substance""}, {""token"": ""peel"", ""start_span"": 98, ""end_span"": 102, ""type"": ""Tissue""}, {""token"": ""leaf"", ""start_span"": 109, ""end_span"": 113, ""type"": ""Organ""}, {""token"": ""flower"", ""start_span"": 120, ""end_span"": 126, ""type"": ""Organism_subdivision""}, {""token"": ""bark"", ""start_span"": 133, ""end_span"": 137, ""type"": ""Tissue""}, {""token"": ""roots"", ""start_span"": 148, ""end_span"": 153, ""type"": ""Organ""}]"	train
Here we show that recombinant human prothrombin kringle - 2 ( rk - 2) inhibited bovine capillary endothelial cell migration with an IC ( 50) ( concentration for half maximal inhibition) of 38 nM and inhibited adhesion to extracellular matrix ( ECM) proteins.	human,30,35,Organism	prothrombin kringle - 2,36,59,Gene_or_gene_product	rk - 2,62,68,Gene_or_gene_product	bovine,80,86,Organism	capillary endothelial cell,87,113,Cell	extracellular matrix,221,241,Cellular_component	ECM,244,247,Cellular_component	"[{""token"": ""human"", ""start_span"": 30, ""end_span"": 35, ""type"": ""Organism""}, {""token"": ""prothrombin kringle - 2"", ""start_span"": 36, ""end_span"": 59, ""type"": ""Gene_or_gene_product""}, {""token"": ""rk - 2"", ""start_span"": 62, ""end_span"": 68, ""type"": ""Gene_or_gene_product""}, {""token"": ""bovine"", ""start_span"": 80, ""end_span"": 86, ""type"": ""Organism""}, {""token"": ""capillary endothelial cell"", ""start_span"": 87, ""end_span"": 113, ""type"": ""Cell""}, {""token"": ""extracellular matrix"", ""start_span"": 221, ""end_span"": 241, ""type"": ""Cellular_component""}, {""token"": ""ECM"", ""start_span"": 244, ""end_span"": 247, ""type"": ""Cellular_component""}]"	train
In 32 evaluated breast cancer patients with endocrine - dependent distant metastases treated with a new immunotherapy schedule ( cyclic administration of beta - interferon and interleukin - 2), cellular immunity, cytokines and CRP were related to the clinical course.	breast cancer,16,29,Cancer	patients,30,38,Organism	endocrine,44,53,Anatomical_system	beta - interferon,154,171,Gene_or_gene_product	interleukin - 2,176,191,Gene_or_gene_product	cellular,194,202,Cell	CRP,227,230,Gene_or_gene_product	"[{""token"": ""breast cancer"", ""start_span"": 16, ""end_span"": 29, ""type"": ""Cancer""}, {""token"": ""patients"", ""start_span"": 30, ""end_span"": 38, ""type"": ""Organism""}, {""token"": ""endocrine"", ""start_span"": 44, ""end_span"": 53, ""type"": ""Anatomical_system""}, {""token"": ""beta - interferon"", ""start_span"": 154, ""end_span"": 171, ""type"": ""Gene_or_gene_product""}, {""token"": ""interleukin - 2"", ""start_span"": 176, ""end_span"": 191, ""type"": ""Gene_or_gene_product""}, {""token"": ""cellular"", ""start_span"": 194, ""end_span"": 202, ""type"": ""Cell""}, {""token"": ""CRP"", ""start_span"": 227, ""end_span"": 230, ""type"": ""Gene_or_gene_product""}]"	train
The present study used JB6 P + mouse epidermal cells and AP - 1 - luciferase reporter transgenic mice to identify whether exposure to Cum - OOH caused activation of AP - 1, oxidative stress, depletion of antioxidants and tumor formation during two - stage carcinogenesis.	mouse,31,36,Organism	AP - 1,57,63,Gene_or_gene_product	luciferase,66,76,Gene_or_gene_product	mice,97,101,Organism	Cum - OOH,134,143,Chemical	AP - 1,165,171,Gene_or_gene_product	tumor,221,226,Cancer	"[{""token"": ""mouse"", ""start_span"": 31, ""end_span"": 36, ""type"": ""Organism""}, {""token"": ""AP - 1"", ""start_span"": 57, ""end_span"": 63, ""type"": ""Gene_or_gene_product""}, {""token"": ""luciferase"", ""start_span"": 66, ""end_span"": 76, ""type"": ""Gene_or_gene_product""}, {""token"": ""mice"", ""start_span"": 97, ""end_span"": 101, ""type"": ""Organism""}, {""token"": ""Cum - OOH"", ""start_span"": 134, ""end_span"": 143, ""type"": ""Chemical""}, {""token"": ""AP - 1"", ""start_span"": 165, ""end_span"": 171, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 221, ""end_span"": 226, ""type"": ""Cancer""}]"	train
In vitro studies found that exposure to Cum - OOH reduced the level of glutathione ( GSH) in mouse epidermal cells ( JB6 P +) and caused the induction of AP - 1.	Cum - OOH,40,49,Chemical	glutathione,71,82,Chemical	GSH,85,88,Chemical	mouse,93,98,Organism	epidermal cells,99,114,Cell	JB6 P +,117,124,Cell	AP - 1,154,160,Gene_or_gene_product	"[{""token"": ""Cum - OOH"", ""start_span"": 40, ""end_span"": 49, ""type"": ""Chemical""}, {""token"": ""glutathione"", ""start_span"": 71, ""end_span"": 82, ""type"": ""Chemical""}, {""token"": ""GSH"", ""start_span"": 85, ""end_span"": 88, ""type"": ""Chemical""}, {""token"": ""mouse"", ""start_span"": 93, ""end_span"": 98, ""type"": ""Organism""}, {""token"": ""epidermal cells"", ""start_span"": 99, ""end_span"": 114, ""type"": ""Cell""}, {""token"": ""JB6 P +"", ""start_span"": 117, ""end_span"": 124, ""type"": ""Cell""}, {""token"": ""AP - 1"", ""start_span"": 154, ""end_span"": 160, ""type"": ""Gene_or_gene_product""}]"	train
Vascular development is dependent on various growth factors and certain modifiers critical for providing arterial or venous identity, interaction with the surrounding stroma and tissues, hierarchic network formation, and recruitment of pericytes.	Vascular,0,8,Multi	arterial,105,113,Multi	venous,117,123,Multi	stroma,167,173,Tissue	tissues,178,185,Tissue	hierarchic network,187,205,Tissue	pericytes,236,245,Cell	"[{""token"": ""Vascular"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Multi""}, {""token"": ""arterial"", ""start_span"": 105, ""end_span"": 113, ""type"": ""Multi""}, {""token"": ""venous"", ""start_span"": 117, ""end_span"": 123, ""type"": ""Multi""}, {""token"": ""stroma"", ""start_span"": 167, ""end_span"": 173, ""type"": ""Tissue""}, {""token"": ""tissues"", ""start_span"": 178, ""end_span"": 185, ""type"": ""Tissue""}, {""token"": ""hierarchic network"", ""start_span"": 187, ""end_span"": 205, ""type"": ""Tissue""}, {""token"": ""pericytes"", ""start_span"": 236, ""end_span"": 245, ""type"": ""Cell""}]"	train
The role of SWAP - 70 in oncogenic transformation of mouse embryo fibroblasts ( MEFs) by v - Src was examined by use of MEFs defective in SWAP - 70.	SWAP - 70,12,21,Gene_or_gene_product	mouse,53,58,Organism	embryo fibroblasts,59,77,Cell	MEFs,80,84,Cell	v - Src,89,96,Gene_or_gene_product	MEFs,120,124,Cell	SWAP - 70,138,147,Gene_or_gene_product	"[{""token"": ""SWAP - 70"", ""start_span"": 12, ""end_span"": 21, ""type"": ""Gene_or_gene_product""}, {""token"": ""mouse"", ""start_span"": 53, ""end_span"": 58, ""type"": ""Organism""}, {""token"": ""embryo fibroblasts"", ""start_span"": 59, ""end_span"": 77, ""type"": ""Cell""}, {""token"": ""MEFs"", ""start_span"": 80, ""end_span"": 84, ""type"": ""Cell""}, {""token"": ""v - Src"", ""start_span"": 89, ""end_span"": 96, ""type"": ""Gene_or_gene_product""}, {""token"": ""MEFs"", ""start_span"": 120, ""end_span"": 124, ""type"": ""Cell""}, {""token"": ""SWAP - 70"", ""start_span"": 138, ""end_span"": 147, ""type"": ""Gene_or_gene_product""}]"	train
In animal studies, 1B3 significantly enhanced the antitumor and the anti - angiogenic activities of DC101, an antibody directed against mouse vascular endothelial growth factor receptor 2, in a pancreatic ( BxPC - 3) and a non - small cell lung ( NCI - H460) tumor xenograft models.	1B3,19,22,Chemical	antitumor,50,59,Cancer	DC101,100,105,Chemical	mouse,136,141,Organism	vascular endothelial growth factor receptor 2,142,187,Gene_or_gene_product	pancreatic,194,204,Cancer	BxPC - 3,207,215,Cancer	"[{""token"": ""1B3"", ""start_span"": 19, ""end_span"": 22, ""type"": ""Chemical""}, {""token"": ""antitumor"", ""start_span"": 50, ""end_span"": 59, ""type"": ""Cancer""}, {""token"": ""DC101"", ""start_span"": 100, ""end_span"": 105, ""type"": ""Chemical""}, {""token"": ""mouse"", ""start_span"": 136, ""end_span"": 141, ""type"": ""Organism""}, {""token"": ""vascular endothelial growth factor receptor 2"", ""start_span"": 142, ""end_span"": 187, ""type"": ""Gene_or_gene_product""}, {""token"": ""pancreatic"", ""start_span"": 194, ""end_span"": 204, ""type"": ""Cancer""}, {""token"": ""BxPC - 3"", ""start_span"": 207, ""end_span"": 215, ""type"": ""Cancer""}]"	train
Caffeine inhibits adenosine - induced accumulation of hypoxia - inducible factor - 1alpha, vascular endothelial growth factor, and interleukin - 8 expression in hypoxic human colon cancer cells.	Caffeine,0,8,Chemical	adenosine,18,27,Chemical	hypoxia - inducible factor - 1alpha,54,89,Gene_or_gene_product	vascular endothelial growth factor,91,125,Gene_or_gene_product	interleukin - 8,131,146,Gene_or_gene_product	human,169,174,Organism	colon cancer cells,175,193,Cell	"[{""token"": ""Caffeine"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Chemical""}, {""token"": ""adenosine"", ""start_span"": 18, ""end_span"": 27, ""type"": ""Chemical""}, {""token"": ""hypoxia - inducible factor - 1alpha"", ""start_span"": 54, ""end_span"": 89, ""type"": ""Gene_or_gene_product""}, {""token"": ""vascular endothelial growth factor"", ""start_span"": 91, ""end_span"": 125, ""type"": ""Gene_or_gene_product""}, {""token"": ""interleukin - 8"", ""start_span"": 131, ""end_span"": 146, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 169, ""end_span"": 174, ""type"": ""Organism""}, {""token"": ""colon cancer cells"", ""start_span"": 175, ""end_span"": 193, ""type"": ""Cell""}]"	train
The induction of vascular endothelial growth factor ( VEGF) and interleukin - 8 ( IL - 8) is an essential feature of tumor angiogenesis, and the hypoxia - inducible factor - 1 ( HIF - 1) transcription factor is known to be a key regulator of this process.	vascular endothelial growth factor,17,51,Gene_or_gene_product	VEGF,54,58,Gene_or_gene_product	interleukin - 8,64,79,Gene_or_gene_product	IL - 8,82,88,Gene_or_gene_product	tumor,117,122,Cancer	hypoxia - inducible factor - 1,145,175,Gene_or_gene_product	HIF - 1,178,185,Gene_or_gene_product	"[{""token"": ""vascular endothelial growth factor"", ""start_span"": 17, ""end_span"": 51, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 54, ""end_span"": 58, ""type"": ""Gene_or_gene_product""}, {""token"": ""interleukin - 8"", ""start_span"": 64, ""end_span"": 79, ""type"": ""Gene_or_gene_product""}, {""token"": ""IL - 8"", ""start_span"": 82, ""end_span"": 88, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 117, ""end_span"": 122, ""type"": ""Cancer""}, {""token"": ""hypoxia - inducible factor - 1"", ""start_span"": 145, ""end_span"": 175, ""type"": ""Gene_or_gene_product""}, {""token"": ""HIF - 1"", ""start_span"": 178, ""end_span"": 185, ""type"": ""Gene_or_gene_product""}]"	train
These data provide evidence that adenosine could modulate the migration of colon cancer cells by an HIF - 1alpha / VEGF / IL - 8 - dependent mechanism and that caffeine has the potential to inhibit colon cancer cell growth.	adenosine,33,42,Chemical	colon cancer cells,75,93,Cell	HIF - 1alpha,100,112,Gene_or_gene_product	VEGF,115,119,Gene_or_gene_product	IL - 8,122,128,Gene_or_gene_product	caffeine,160,168,Chemical	colon cancer cell,198,215,Cell	"[{""token"": ""adenosine"", ""start_span"": 33, ""end_span"": 42, ""type"": ""Chemical""}, {""token"": ""colon cancer cells"", ""start_span"": 75, ""end_span"": 93, ""type"": ""Cell""}, {""token"": ""HIF - 1alpha"", ""start_span"": 100, ""end_span"": 112, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 115, ""end_span"": 119, ""type"": ""Gene_or_gene_product""}, {""token"": ""IL - 8"", ""start_span"": 122, ""end_span"": 128, ""type"": ""Gene_or_gene_product""}, {""token"": ""caffeine"", ""start_span"": 160, ""end_span"": 168, ""type"": ""Chemical""}, {""token"": ""colon cancer cell"", ""start_span"": 198, ""end_span"": 215, ""type"": ""Cell""}]"	train
BAG - 1L was nucleoplasmic and nucleolar, whereas BAG - 1S and BAG - 1M were cytoplasmic and nucleoplasmic in localisation.	BAG - 1L,0,8,Gene_or_gene_product	nucleoplasmic,13,26,Organism_substance	nucleolar,31,40,Cellular_component	BAG - 1S,50,58,Gene_or_gene_product	BAG - 1M,63,71,Gene_or_gene_product	cytoplasmic,77,88,Organism_substance	nucleoplasmic,93,106,Organism_substance	"[{""token"": ""BAG - 1L"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Gene_or_gene_product""}, {""token"": ""nucleoplasmic"", ""start_span"": 13, ""end_span"": 26, ""type"": ""Organism_substance""}, {""token"": ""nucleolar"", ""start_span"": 31, ""end_span"": 40, ""type"": ""Cellular_component""}, {""token"": ""BAG - 1S"", ""start_span"": 50, ""end_span"": 58, ""type"": ""Gene_or_gene_product""}, {""token"": ""BAG - 1M"", ""start_span"": 63, ""end_span"": 71, ""type"": ""Gene_or_gene_product""}, {""token"": ""cytoplasmic"", ""start_span"": 77, ""end_span"": 88, ""type"": ""Organism_substance""}, {""token"": ""nucleoplasmic"", ""start_span"": 93, ""end_span"": 106, ""type"": ""Organism_substance""}]"	train
BAG - 1L also potentiated transactivation of known vitamin - D - responsive gene promoters, osteocalcin and 24 - hydroxylase, and enhanced VDR - dependent transcription and protein expression of the keratinocyte differentiation marker, involucrin.	BAG - 1L,0,8,Gene_or_gene_product	vitamin - D,51,62,Chemical	osteocalcin,92,103,Gene_or_gene_product	24 - hydroxylase,108,124,Gene_or_gene_product	VDR,139,142,Gene_or_gene_product	keratinocyte,199,211,Cell	involucrin,236,246,Gene_or_gene_product	"[{""token"": ""BAG - 1L"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Gene_or_gene_product""}, {""token"": ""vitamin - D"", ""start_span"": 51, ""end_span"": 62, ""type"": ""Chemical""}, {""token"": ""osteocalcin"", ""start_span"": 92, ""end_span"": 103, ""type"": ""Gene_or_gene_product""}, {""token"": ""24 - hydroxylase"", ""start_span"": 108, ""end_span"": 124, ""type"": ""Gene_or_gene_product""}, {""token"": ""VDR"", ""start_span"": 139, ""end_span"": 142, ""type"": ""Gene_or_gene_product""}, {""token"": ""keratinocyte"", ""start_span"": 199, ""end_span"": 211, ""type"": ""Cell""}, {""token"": ""involucrin"", ""start_span"": 236, ""end_span"": 246, ""type"": ""Gene_or_gene_product""}]"	train
These results demonstrate endogenous gene regulation by BAG - 1L by potentiating nuclear hormone receptor function and suggest a role for BAG - 1L in 24 - hydroxylase regulation of vitamin D metabolism and the cellular response of oral keratinocytes to 1alpha, 25 - dihydroxyvitamin D3.	BAG - 1L,56,64,Gene_or_gene_product	nuclear hormone receptor,81,105,Gene_or_gene_product	BAG - 1L,138,146,Gene_or_gene_product	24 - hydroxylase,150,166,Gene_or_gene_product	vitamin D,181,190,Chemical	cellular,210,218,Cell	oral keratinocytes,231,249,Cell	"[{""token"": ""BAG - 1L"", ""start_span"": 56, ""end_span"": 64, ""type"": ""Gene_or_gene_product""}, {""token"": ""nuclear hormone receptor"", ""start_span"": 81, ""end_span"": 105, ""type"": ""Gene_or_gene_product""}, {""token"": ""BAG - 1L"", ""start_span"": 138, ""end_span"": 146, ""type"": ""Gene_or_gene_product""}, {""token"": ""24 - hydroxylase"", ""start_span"": 150, ""end_span"": 166, ""type"": ""Gene_or_gene_product""}, {""token"": ""vitamin D"", ""start_span"": 181, ""end_span"": 190, ""type"": ""Chemical""}, {""token"": ""cellular"", ""start_span"": 210, ""end_span"": 218, ""type"": ""Cell""}, {""token"": ""oral keratinocytes"", ""start_span"": 231, ""end_span"": 249, ""type"": ""Cell""}]"	train
The steady - state extraction ratio of enalapril, a substrate that enters the liver rapidly via Oatp1a1 and primarily undergoes metabolism by the carboxylesterases, was unaffected by liver metastasis at week 4 regardless of its delivery via the portal vein or hepatic artery into the perfused liver preparations.	enalapril,39,48,Chemical	liver,78,83,Organ	Oatp1a1,96,103,Gene_or_gene_product	liver,183,188,Organ	portal vein,245,256,Multi	hepatic artery,260,274,Multi	liver,293,298,Organ	"[{""token"": ""enalapril"", ""start_span"": 39, ""end_span"": 48, ""type"": ""Chemical""}, {""token"": ""liver"", ""start_span"": 78, ""end_span"": 83, ""type"": ""Organ""}, {""token"": ""Oatp1a1"", ""start_span"": 96, ""end_span"": 103, ""type"": ""Gene_or_gene_product""}, {""token"": ""liver"", ""start_span"": 183, ""end_span"": 188, ""type"": ""Organ""}, {""token"": ""portal vein"", ""start_span"": 245, ""end_span"": 256, ""type"": ""Multi""}, {""token"": ""hepatic artery"", ""start_span"": 260, ""end_span"": 274, ""type"": ""Multi""}, {""token"": ""liver"", ""start_span"": 293, ""end_span"": 298, ""type"": ""Organ""}]"	train
Recent studies using avian retrovirus - mediated introduction of oncogenes into a small subset of somatic mammary cells suggest that polyoma middle T antigen ( PyMT) may also preferentially transform stem / progenitor cells.	avian retrovirus,21,37,Organism	somatic mammary cells,98,119,Cell	polyoma,133,140,Organism	middle T antigen,141,157,Gene_or_gene_product	PyMT,160,164,Gene_or_gene_product	stem,200,204,Cell	progenitor cells,207,223,Cell	"[{""token"": ""avian retrovirus"", ""start_span"": 21, ""end_span"": 37, ""type"": ""Organism""}, {""token"": ""somatic mammary cells"", ""start_span"": 98, ""end_span"": 119, ""type"": ""Cell""}, {""token"": ""polyoma"", ""start_span"": 133, ""end_span"": 140, ""type"": ""Organism""}, {""token"": ""middle T antigen"", ""start_span"": 141, ""end_span"": 157, ""type"": ""Gene_or_gene_product""}, {""token"": ""PyMT"", ""start_span"": 160, ""end_span"": 164, ""type"": ""Gene_or_gene_product""}, {""token"": ""stem"", ""start_span"": 200, ""end_span"": 204, ""type"": ""Cell""}, {""token"": ""progenitor cells"", ""start_span"": 207, ""end_span"": 223, ""type"": ""Cell""}]"	train
These data demonstrate for the first time that hCAP - 18 / LL - 37 is significantly overexpressed in ovarian tumors and suggest LL - 37 may contribute to ovarian tumorigenesis through direct stimulation of tumor cells, initiation of angiogenesis and recruitment of immune cells.	hCAP - 18,47,56,Gene_or_gene_product	LL - 37,59,66,Gene_or_gene_product	ovarian tumors,101,115,Cancer	LL - 37,128,135,Gene_or_gene_product	ovarian,154,161,Organ	tumor cells,206,217,Cell	immune cells,265,277,Cell	"[{""token"": ""hCAP - 18"", ""start_span"": 47, ""end_span"": 56, ""type"": ""Gene_or_gene_product""}, {""token"": ""LL - 37"", ""start_span"": 59, ""end_span"": 66, ""type"": ""Gene_or_gene_product""}, {""token"": ""ovarian tumors"", ""start_span"": 101, ""end_span"": 115, ""type"": ""Cancer""}, {""token"": ""LL - 37"", ""start_span"": 128, ""end_span"": 135, ""type"": ""Gene_or_gene_product""}, {""token"": ""ovarian"", ""start_span"": 154, ""end_span"": 161, ""type"": ""Organ""}, {""token"": ""tumor cells"", ""start_span"": 206, ""end_span"": 217, ""type"": ""Cell""}, {""token"": ""immune cells"", ""start_span"": 265, ""end_span"": 277, ""type"": ""Cell""}]"	train
RESULTS: Mice bearing subcutaneous tumor of rAAV2 / 5 - VAS pretreated Lewis lung carcinoma cells showed > 50% reduction in primary tumor volume and reduced spontaneous pulmonary metastases.	Mice,9,13,Organism	subcutaneous tumor,22,40,Cancer	rAAV2,44,49,Organism	5 - VAS,52,59,Organism	Lewis lung carcinoma cells,71,97,Cell	tumor,132,137,Cancer	pulmonary,169,178,Organ	"[{""token"": ""Mice"", ""start_span"": 9, ""end_span"": 13, ""type"": ""Organism""}, {""token"": ""subcutaneous tumor"", ""start_span"": 22, ""end_span"": 40, ""type"": ""Cancer""}, {""token"": ""rAAV2"", ""start_span"": 44, ""end_span"": 49, ""type"": ""Organism""}, {""token"": ""5 - VAS"", ""start_span"": 52, ""end_span"": 59, ""type"": ""Organism""}, {""token"": ""Lewis lung carcinoma cells"", ""start_span"": 71, ""end_span"": 97, ""type"": ""Cell""}, {""token"": ""tumor"", ""start_span"": 132, ""end_span"": 137, ""type"": ""Cancer""}, {""token"": ""pulmonary"", ""start_span"": 169, ""end_span"": 178, ""type"": ""Organ""}]"	train
The tumor - suppressive action of rAAV2 / 5 - VAS in subcutaneous human lung tumor A549 xenograft correlated with a reduced number of capillary vessels in tumors.	tumor,4,9,Cancer	rAAV2,34,39,Organism	5 - VAS,42,49,Organism	human,66,71,Organism	lung tumor A549 xenograft,72,97,Cancer	capillary vessels,134,151,Tissue	tumors,155,161,Cancer	"[{""token"": ""tumor"", ""start_span"": 4, ""end_span"": 9, ""type"": ""Cancer""}, {""token"": ""rAAV2"", ""start_span"": 34, ""end_span"": 39, ""type"": ""Organism""}, {""token"": ""5 - VAS"", ""start_span"": 42, ""end_span"": 49, ""type"": ""Organism""}, {""token"": ""human"", ""start_span"": 66, ""end_span"": 71, ""type"": ""Organism""}, {""token"": ""lung tumor A549 xenograft"", ""start_span"": 72, ""end_span"": 97, ""type"": ""Cancer""}, {""token"": ""capillary vessels"", ""start_span"": 134, ""end_span"": 151, ""type"": ""Tissue""}, {""token"": ""tumors"", ""start_span"": 155, ""end_span"": 161, ""type"": ""Cancer""}]"	train
CONCLUSION: Our results show the effectiveness of rAAV2 / 5 - VAS as an angiogenesis inhibitor in suppressing tumor growth during different stages of tumor progression, validating the application of rAAV2 / 5 - VAS gene therapy in treatment against lung cancer.	rAAV2,50,55,Organism	5 - VAS,58,65,Organism	tumor,110,115,Cancer	tumor,150,155,Cancer	rAAV2,199,204,Organism	5 - VAS,207,214,Organism	lung cancer,249,260,Cancer	"[{""token"": ""rAAV2"", ""start_span"": 50, ""end_span"": 55, ""type"": ""Organism""}, {""token"": ""5 - VAS"", ""start_span"": 58, ""end_span"": 65, ""type"": ""Organism""}, {""token"": ""tumor"", ""start_span"": 110, ""end_span"": 115, ""type"": ""Cancer""}, {""token"": ""tumor"", ""start_span"": 150, ""end_span"": 155, ""type"": ""Cancer""}, {""token"": ""rAAV2"", ""start_span"": 199, ""end_span"": 204, ""type"": ""Organism""}, {""token"": ""5 - VAS"", ""start_span"": 207, ""end_span"": 214, ""type"": ""Organism""}, {""token"": ""lung cancer"", ""start_span"": 249, ""end_span"": 260, ""type"": ""Cancer""}]"	train
We tested this using HT - 1080, NCI, and Shac fibrosarcoma - derived cell lines and anthrax lethal toxin ( LeTx), a bacterial toxin that inactivates MKKs.	HT - 1080,21,30,Cell	NCI,32,35,Cell	Shac fibrosarcoma - derived cell lines,41,79,Cell	anthrax,84,91,Organism	lethal toxin,92,104,Chemical	LeTx,107,111,Chemical	MKKs,149,153,Gene_or_gene_product	"[{""token"": ""HT - 1080"", ""start_span"": 21, ""end_span"": 30, ""type"": ""Cell""}, {""token"": ""NCI"", ""start_span"": 32, ""end_span"": 35, ""type"": ""Cell""}, {""token"": ""Shac fibrosarcoma - derived cell lines"", ""start_span"": 41, ""end_span"": 79, ""type"": ""Cell""}, {""token"": ""anthrax"", ""start_span"": 84, ""end_span"": 91, ""type"": ""Organism""}, {""token"": ""lethal toxin"", ""start_span"": 92, ""end_span"": 104, ""type"": ""Chemical""}, {""token"": ""LeTx"", ""start_span"": 107, ""end_span"": 111, ""type"": ""Chemical""}, {""token"": ""MKKs"", ""start_span"": 149, ""end_span"": 153, ""type"": ""Gene_or_gene_product""}]"	train
These cells were negative for Hep par - 1, carcinoembryonic antigen, neural cell adhesion molecule, CD34, CD31 and HMB45.	cells,6,11,Cell	Hep par - 1,30,41,Gene_or_gene_product	carcinoembryonic antigen,43,67,Gene_or_gene_product	neural cell adhesion molecule,69,98,Gene_or_gene_product	CD34,100,104,Gene_or_gene_product	CD31,106,110,Gene_or_gene_product	HMB45,115,120,Gene_or_gene_product	"[{""token"": ""cells"", ""start_span"": 6, ""end_span"": 11, ""type"": ""Cell""}, {""token"": ""Hep par - 1"", ""start_span"": 30, ""end_span"": 41, ""type"": ""Gene_or_gene_product""}, {""token"": ""carcinoembryonic antigen"", ""start_span"": 43, ""end_span"": 67, ""type"": ""Gene_or_gene_product""}, {""token"": ""neural cell adhesion molecule"", ""start_span"": 69, ""end_span"": 98, ""type"": ""Gene_or_gene_product""}, {""token"": ""CD34"", ""start_span"": 100, ""end_span"": 104, ""type"": ""Gene_or_gene_product""}, {""token"": ""CD31"", ""start_span"": 106, ""end_span"": 110, ""type"": ""Gene_or_gene_product""}, {""token"": ""HMB45"", ""start_span"": 115, ""end_span"": 120, ""type"": ""Gene_or_gene_product""}]"	train
METHOD: Wild - type and phosphatase - inactive ( C124A) PTEN plasmids were transfected into ovarian epithelial cancer A2780 cells, and their effects on cell apoptosis, cell proliferation, cell migration and cell invasion were analyzed by flow cytometry analysis, TUNEL assay, MTT assay, wound - healing assay and transwell assay.	PTEN,56,60,Gene_or_gene_product	ovarian epithelial cancer A2780 cells,92,129,Cell	cell,152,156,Cell	cell,168,172,Cell	cell,188,192,Cell	cell,207,211,Cell	wound,287,292,Pathological_formation	"[{""token"": ""PTEN"", ""start_span"": 56, ""end_span"": 60, ""type"": ""Gene_or_gene_product""}, {""token"": ""ovarian epithelial cancer A2780 cells"", ""start_span"": 92, ""end_span"": 129, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 152, ""end_span"": 156, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 168, ""end_span"": 172, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 188, ""end_span"": 192, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 207, ""end_span"": 211, ""type"": ""Cell""}, {""token"": ""wound"", ""start_span"": 287, ""end_span"": 292, ""type"": ""Pathological_formation""}]"	train
RESULTS: Both wild - type and mutant PTEN can upregulate the expression of PTEN gene dramatically; however, it is wild - type PTEN not phosphatase - inactive PTEN that can induce apoptosis and decrease cell migration, invasion and proliferation in ovarian cancer cells.	PTEN,37,41,Gene_or_gene_product	PTEN,75,79,Gene_or_gene_product	PTEN,126,130,Gene_or_gene_product	phosphatase,135,146,Chemical	PTEN,158,162,Gene_or_gene_product	cell,202,206,Cell	ovarian cancer cells,248,268,Cell	"[{""token"": ""PTEN"", ""start_span"": 37, ""end_span"": 41, ""type"": ""Gene_or_gene_product""}, {""token"": ""PTEN"", ""start_span"": 75, ""end_span"": 79, ""type"": ""Gene_or_gene_product""}, {""token"": ""PTEN"", ""start_span"": 126, ""end_span"": 130, ""type"": ""Gene_or_gene_product""}, {""token"": ""phosphatase"", ""start_span"": 135, ""end_span"": 146, ""type"": ""Chemical""}, {""token"": ""PTEN"", ""start_span"": 158, ""end_span"": 162, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 202, ""end_span"": 206, ""type"": ""Cell""}, {""token"": ""ovarian cancer cells"", ""start_span"": 248, ""end_span"": 268, ""type"": ""Cell""}]"	train
Three weeks after injection, blood perfusion and capillary density were significantly higher in the FM - MSC and BM - MSC groups than in the phosphate - buffered saline group, and allogeneic FM - MSC and BM - MSC were still observed.	blood,29,34,Organism_substance	capillary,49,58,Tissue	FM - MSC,100,108,Cell	BM - MSC,113,121,Cell	phosphate - buffered saline,141,168,Chemical	FM - MSC,191,199,Cell	BM - MSC,204,212,Cell	"[{""token"": ""blood"", ""start_span"": 29, ""end_span"": 34, ""type"": ""Organism_substance""}, {""token"": ""capillary"", ""start_span"": 49, ""end_span"": 58, ""type"": ""Tissue""}, {""token"": ""FM - MSC"", ""start_span"": 100, ""end_span"": 108, ""type"": ""Cell""}, {""token"": ""BM - MSC"", ""start_span"": 113, ""end_span"": 121, ""type"": ""Cell""}, {""token"": ""phosphate - buffered saline"", ""start_span"": 141, ""end_span"": 168, ""type"": ""Chemical""}, {""token"": ""FM - MSC"", ""start_span"": 191, ""end_span"": 199, ""type"": ""Cell""}, {""token"": ""BM - MSC"", ""start_span"": 204, ""end_span"": 212, ""type"": ""Cell""}]"	train
RESEARCH DESIGN AND METHODS: Adipose tissue samples from visceral ( VAT) and subcutaneous ( SAT) sites, obtained from 36 obese patients ( mean BMI 46. 5 kg / m ( 2)) during bariatric surgery, were layered on chick chorioallantoic membrane ( CAM).	Adipose tissue samples,29,51,Tissue	visceral,57,65,Tissue	VAT,68,71,Tissue	patients,127,135,Organism	chick,208,213,Organism	chorioallantoic membrane,214,238,Multi	CAM,241,244,Multi	"[{""token"": ""Adipose tissue samples"", ""start_span"": 29, ""end_span"": 51, ""type"": ""Tissue""}, {""token"": ""visceral"", ""start_span"": 57, ""end_span"": 65, ""type"": ""Tissue""}, {""token"": ""VAT"", ""start_span"": 68, ""end_span"": 71, ""type"": ""Tissue""}, {""token"": ""patients"", ""start_span"": 127, ""end_span"": 135, ""type"": ""Organism""}, {""token"": ""chick"", ""start_span"": 208, ""end_span"": 213, ""type"": ""Organism""}, {""token"": ""chorioallantoic membrane"", ""start_span"": 214, ""end_span"": 238, ""type"": ""Multi""}, {""token"": ""CAM"", ""start_span"": 241, ""end_span"": 244, ""type"": ""Multi""}]"	train
The angiogenic potency of adipose tissue was not related to its localization ( with an angiogenic stimulation in 60% of SAT samples and 61% of VAT samples) or to adipocyte size or inflammatory infiltrate assessed in adipose samples before the graft on CAM.	adipose tissue,26,40,Tissue	SAT samples,120,131,Tissue	VAT samples,143,154,Tissue	adipocyte,162,171,Cell	adipose samples,216,231,Tissue	graft,243,248,Tissue	CAM,252,255,Multi	"[{""token"": ""adipose tissue"", ""start_span"": 26, ""end_span"": 40, ""type"": ""Tissue""}, {""token"": ""SAT samples"", ""start_span"": 120, ""end_span"": 131, ""type"": ""Tissue""}, {""token"": ""VAT samples"", ""start_span"": 143, ""end_span"": 154, ""type"": ""Tissue""}, {""token"": ""adipocyte"", ""start_span"": 162, ""end_span"": 171, ""type"": ""Cell""}, {""token"": ""adipose samples"", ""start_span"": 216, ""end_span"": 231, ""type"": ""Tissue""}, {""token"": ""graft"", ""start_span"": 243, ""end_span"": 248, ""type"": ""Tissue""}, {""token"": ""CAM"", ""start_span"": 252, ""end_span"": 255, ""type"": ""Multi""}]"	train
Finally, mutating the Sp1 binding sites within the VEGF promoter or inhibiting ERK decreased VEGF promoter activity in M - CSF - treated human monocytes.	Sp1,22,25,Gene_or_gene_product	VEGF,51,55,Gene_or_gene_product	ERK,79,82,Gene_or_gene_product	VEGF,93,97,Gene_or_gene_product	M - CSF,119,126,Gene_or_gene_product	human,137,142,Organism	monocytes,143,152,Cell	"[{""token"": ""Sp1"", ""start_span"": 22, ""end_span"": 25, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 51, ""end_span"": 55, ""type"": ""Gene_or_gene_product""}, {""token"": ""ERK"", ""start_span"": 79, ""end_span"": 82, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 93, ""end_span"": 97, ""type"": ""Gene_or_gene_product""}, {""token"": ""M - CSF"", ""start_span"": 119, ""end_span"": 126, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 137, ""end_span"": 142, ""type"": ""Organism""}, {""token"": ""monocytes"", ""start_span"": 143, ""end_span"": 152, ""type"": ""Cell""}]"	train
In this study, we investigated whether the nuclear transcription factor NF - kappaB, implicated in PC metastasis, is involved in transcriptional regulation and activation of BMP - 2 or BMP - 4 / Smad signaling in PC cells.	nuclear,43,50,Cellular_component	NF - kappaB,72,83,Gene_or_gene_product	PC,99,101,Cancer	BMP - 2,174,181,Gene_or_gene_product	BMP - 4,185,192,Gene_or_gene_product	Smad,195,199,Gene_or_gene_product	PC cells,213,221,Cell	"[{""token"": ""nuclear"", ""start_span"": 43, ""end_span"": 50, ""type"": ""Cellular_component""}, {""token"": ""NF - kappaB"", ""start_span"": 72, ""end_span"": 83, ""type"": ""Gene_or_gene_product""}, {""token"": ""PC"", ""start_span"": 99, ""end_span"": 101, ""type"": ""Cancer""}, {""token"": ""BMP - 2"", ""start_span"": 174, ""end_span"": 181, ""type"": ""Gene_or_gene_product""}, {""token"": ""BMP - 4"", ""start_span"": 185, ""end_span"": 192, ""type"": ""Gene_or_gene_product""}, {""token"": ""Smad"", ""start_span"": 195, ""end_span"": 199, ""type"": ""Gene_or_gene_product""}, {""token"": ""PC cells"", ""start_span"": 213, ""end_span"": 221, ""type"": ""Cell""}]"	train
RESULTS: PCR and chimeric BMP - 2 and BMP - 4 luciferase assays demonstrate that NF - kappaB confers robust and selective activation of BMP - 2 in p65 overexpressing or rhTNF - alpha - stimulated PC cells.	BMP - 2,26,33,Gene_or_gene_product	BMP - 4,38,45,Gene_or_gene_product	NF - kappaB,81,92,Gene_or_gene_product	BMP - 2,136,143,Gene_or_gene_product	p65,147,150,Gene_or_gene_product	rhTNF - alpha,169,182,Gene_or_gene_product	PC cells,196,204,Cell	"[{""token"": ""BMP - 2"", ""start_span"": 26, ""end_span"": 33, ""type"": ""Gene_or_gene_product""}, {""token"": ""BMP - 4"", ""start_span"": 38, ""end_span"": 45, ""type"": ""Gene_or_gene_product""}, {""token"": ""NF - kappaB"", ""start_span"": 81, ""end_span"": 92, ""type"": ""Gene_or_gene_product""}, {""token"": ""BMP - 2"", ""start_span"": 136, ""end_span"": 143, ""type"": ""Gene_or_gene_product""}, {""token"": ""p65"", ""start_span"": 147, ""end_span"": 150, ""type"": ""Gene_or_gene_product""}, {""token"": ""rhTNF - alpha"", ""start_span"": 169, ""end_span"": 182, ""type"": ""Gene_or_gene_product""}, {""token"": ""PC cells"", ""start_span"": 196, ""end_span"": 204, ""type"": ""Cell""}]"	train
Furthermore, suppression of NF - kappaB activation decreased the transcript levels and BMP - 2 - induced phosphorylation of Smad1 / 5 / 8, critical downstream targets of BMP - 2 signaling in PC cells.	NF - kappaB,28,39,Gene_or_gene_product	BMP - 2,87,94,Gene_or_gene_product	Smad1,124,129,Gene_or_gene_product	5,132,133,Gene_or_gene_product	8,136,137,Gene_or_gene_product	BMP - 2,170,177,Gene_or_gene_product	PC cells,191,199,Cell	"[{""token"": ""NF - kappaB"", ""start_span"": 28, ""end_span"": 39, ""type"": ""Gene_or_gene_product""}, {""token"": ""BMP - 2"", ""start_span"": 87, ""end_span"": 94, ""type"": ""Gene_or_gene_product""}, {""token"": ""Smad1"", ""start_span"": 124, ""end_span"": 129, ""type"": ""Gene_or_gene_product""}, {""token"": ""5"", ""start_span"": 132, ""end_span"": 133, ""type"": ""Gene_or_gene_product""}, {""token"": ""8"", ""start_span"": 136, ""end_span"": 137, ""type"": ""Gene_or_gene_product""}, {""token"": ""BMP - 2"", ""start_span"": 170, ""end_span"": 177, ""type"": ""Gene_or_gene_product""}, {""token"": ""PC cells"", ""start_span"": 191, ""end_span"": 199, ""type"": ""Cell""}]"	train
CONCLUSIONS: The data suggest that PI3K / Akt - NF - kappaB axis may promote PC bone metastasis in part by regulating transcription and activation of the BMP - 2 - Smad signaling cascade in osteotropic PC cells.	PI3K,35,39,Gene_or_gene_product	Akt,42,45,Gene_or_gene_product	NF - kappaB,48,59,Gene_or_gene_product	PC bone,77,84,Multi	BMP - 2,154,161,Gene_or_gene_product	Smad,164,168,Gene_or_gene_product	osteotropic PC cells,190,210,Cell	"[{""token"": ""PI3K"", ""start_span"": 35, ""end_span"": 39, ""type"": ""Gene_or_gene_product""}, {""token"": ""Akt"", ""start_span"": 42, ""end_span"": 45, ""type"": ""Gene_or_gene_product""}, {""token"": ""NF - kappaB"", ""start_span"": 48, ""end_span"": 59, ""type"": ""Gene_or_gene_product""}, {""token"": ""PC bone"", ""start_span"": 77, ""end_span"": 84, ""type"": ""Multi""}, {""token"": ""BMP - 2"", ""start_span"": 154, ""end_span"": 161, ""type"": ""Gene_or_gene_product""}, {""token"": ""Smad"", ""start_span"": 164, ""end_span"": 168, ""type"": ""Gene_or_gene_product""}, {""token"": ""osteotropic PC cells"", ""start_span"": 190, ""end_span"": 210, ""type"": ""Cell""}]"	train
Outcomes measures included transcutaneous blood gas levels, histology, total RNA content and analysis of alpha2 ( I) collagen ( COL - I), type IV collagen ( COL - IV), alpha1 ( V) collagen ( COL - V), and vascular endothelial growth factor ( VEGF) expression using real - time quantitative PCR.	blood,42,47,Organism_substance	COL - I,128,135,Gene_or_gene_product	type IV collagen,138,154,Gene_or_gene_product	COL - IV,157,165,Gene_or_gene_product	COL - V,191,198,Gene_or_gene_product	vascular endothelial growth factor,205,239,Gene_or_gene_product	VEGF,242,246,Gene_or_gene_product	"[{""token"": ""blood"", ""start_span"": 42, ""end_span"": 47, ""type"": ""Organism_substance""}, {""token"": ""COL - I"", ""start_span"": 128, ""end_span"": 135, ""type"": ""Gene_or_gene_product""}, {""token"": ""type IV collagen"", ""start_span"": 138, ""end_span"": 154, ""type"": ""Gene_or_gene_product""}, {""token"": ""COL - IV"", ""start_span"": 157, ""end_span"": 165, ""type"": ""Gene_or_gene_product""}, {""token"": ""COL - V"", ""start_span"": 191, ""end_span"": 198, ""type"": ""Gene_or_gene_product""}, {""token"": ""vascular endothelial growth factor"", ""start_span"": 205, ""end_span"": 239, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 242, ""end_span"": 246, ""type"": ""Gene_or_gene_product""}]"	train
OBJECTIVES: Strategies to inhibit the VEGF pathway, including antibodies to VEGF, antibodies to the extracellular domain of VEGFR - 1 or VEGFR - 2, decoy receptors for VEGF and tyrosine kinase inhibitors of VEGFRs, are summarized.	VEGF,38,42,Gene_or_gene_product	antibodies to VEGF,62,80,Gene_or_gene_product	antibodies to the extracellular domain of VEGFR - 1,82,133,Gene_or_gene_product	VEGFR - 2,137,146,Gene_or_gene_product	VEGF,168,172,Gene_or_gene_product	tyrosine kinase inhibitors,177,203,Chemical	VEGFRs,207,213,Gene_or_gene_product	"[{""token"": ""VEGF"", ""start_span"": 38, ""end_span"": 42, ""type"": ""Gene_or_gene_product""}, {""token"": ""antibodies to VEGF"", ""start_span"": 62, ""end_span"": 80, ""type"": ""Gene_or_gene_product""}, {""token"": ""antibodies to the extracellular domain of VEGFR - 1"", ""start_span"": 82, ""end_span"": 133, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGFR - 2"", ""start_span"": 137, ""end_span"": 146, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 168, ""end_span"": 172, ""type"": ""Gene_or_gene_product""}, {""token"": ""tyrosine kinase inhibitors"", ""start_span"": 177, ""end_span"": 203, ""type"": ""Chemical""}, {""token"": ""VEGFRs"", ""start_span"": 207, ""end_span"": 213, ""type"": ""Gene_or_gene_product""}]"	train
Oxygent perfusion medium increased the TET epithelial PtO ( 2) ( 51. 2 + / - 0. 3 mm Hg vs. 33. 4 + / - 0. 3 mm Hg at 200 microm thickness; 12. 5 + / - 0. 1 mm Hg vs. 3. 1 + / - 0. 1 mm Hg at 400 microm thickness, p less than 0. 01) and decreased the lactate concentration ( 0. 63 + / - 0. 08 vs. 0. 80 + / - 0. 06 mmol / L, p less than 0. 05), lactate / pyruvate ( 1. 87 + / - 0. 26 vs. 3. 36 + / - 10. 13, p less than 0. 05), and lactate / glucose ratios ( 0. 10 + / - 0. 00 vs. 0. 29 + / - 0. 14, p less than 0. 05).	Oxygent,0,7,Chemical	TET epithelial,39,53,Tissue	lactate,251,258,Chemical	lactate,345,352,Chemical	pyruvate,355,363,Chemical	lactate,432,439,Chemical	glucose,442,449,Chemical	"[{""token"": ""Oxygent"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Chemical""}, {""token"": ""TET epithelial"", ""start_span"": 39, ""end_span"": 53, ""type"": ""Tissue""}, {""token"": ""lactate"", ""start_span"": 251, ""end_span"": 258, ""type"": ""Chemical""}, {""token"": ""lactate"", ""start_span"": 345, ""end_span"": 352, ""type"": ""Chemical""}, {""token"": ""pyruvate"", ""start_span"": 355, ""end_span"": 363, ""type"": ""Chemical""}, {""token"": ""lactate"", ""start_span"": 432, ""end_span"": 439, ""type"": ""Chemical""}, {""token"": ""glucose"", ""start_span"": 442, ""end_span"": 449, ""type"": ""Chemical""}]"	train
Semaphorins and their cognate receptors, Plexins and neuropilins, are involved in neuronal pathfinding, immune function, and tumor progression through effects on blood vessel growth and cell migration.	Semaphorins,0,11,Gene_or_gene_product	Plexins,41,48,Gene_or_gene_product	neuropilins,53,64,Gene_or_gene_product	neuronal,82,90,Cell	tumor,125,130,Cancer	blood vessel,162,174,Multi	cell,186,190,Cell	"[{""token"": ""Semaphorins"", ""start_span"": 0, ""end_span"": 11, ""type"": ""Gene_or_gene_product""}, {""token"": ""Plexins"", ""start_span"": 41, ""end_span"": 48, ""type"": ""Gene_or_gene_product""}, {""token"": ""neuropilins"", ""start_span"": 53, ""end_span"": 64, ""type"": ""Gene_or_gene_product""}, {""token"": ""neuronal"", ""start_span"": 82, ""end_span"": 90, ""type"": ""Cell""}, {""token"": ""tumor"", ""start_span"": 125, ""end_span"": 130, ""type"": ""Cancer""}, {""token"": ""blood vessel"", ""start_span"": 162, ""end_span"": 174, ""type"": ""Multi""}, {""token"": ""cell"", ""start_span"": 186, ""end_span"": 190, ""type"": ""Cell""}]"	train
Here we investigated this possibility by examining the role of FOXO3a in the cellular response to nicotine - derived nitrosaminoketone ( NNK), a lung carcinogen implicated as a cause of human LAC.	FOXO3a,63,69,Gene_or_gene_product	cellular,77,85,Cell	nicotine - derived nitrosaminoketone,98,134,Chemical	NNK,137,140,Chemical	lung,145,149,Organ	human,186,191,Organism	LAC,192,195,Cancer	"[{""token"": ""FOXO3a"", ""start_span"": 63, ""end_span"": 69, ""type"": ""Gene_or_gene_product""}, {""token"": ""cellular"", ""start_span"": 77, ""end_span"": 85, ""type"": ""Cell""}, {""token"": ""nicotine - derived nitrosaminoketone"", ""start_span"": 98, ""end_span"": 134, ""type"": ""Chemical""}, {""token"": ""NNK"", ""start_span"": 137, ""end_span"": 140, ""type"": ""Chemical""}, {""token"": ""lung"", ""start_span"": 145, ""end_span"": 149, ""type"": ""Organ""}, {""token"": ""human"", ""start_span"": 186, ""end_span"": 191, ""type"": ""Organism""}, {""token"": ""LAC"", ""start_span"": 192, ""end_span"": 195, ""type"": ""Cancer""}]"	train
The more pronounced effects of Bmi - 1 over - expression in culture were largely attributable to the attenuated induction of p16 ( Ink4a) and p19 ( Arf) in culture, proteins that are generally not expressed by neural stem / progenitor cells in young mice in vivo.	Bmi - 1,31,38,Gene_or_gene_product	p16,125,128,Gene_or_gene_product	Ink4a,131,136,Gene_or_gene_product	p19,142,145,Gene_or_gene_product	Arf,148,151,Gene_or_gene_product	neural stem / progenitor cells,210,240,Cell	mice,250,254,Organism	"[{""token"": ""Bmi - 1"", ""start_span"": 31, ""end_span"": 38, ""type"": ""Gene_or_gene_product""}, {""token"": ""p16"", ""start_span"": 125, ""end_span"": 128, ""type"": ""Gene_or_gene_product""}, {""token"": ""Ink4a"", ""start_span"": 131, ""end_span"": 136, ""type"": ""Gene_or_gene_product""}, {""token"": ""p19"", ""start_span"": 142, ""end_span"": 145, ""type"": ""Gene_or_gene_product""}, {""token"": ""Arf"", ""start_span"": 148, ""end_span"": 151, ""type"": ""Gene_or_gene_product""}, {""token"": ""neural stem / progenitor cells"", ""start_span"": 210, ""end_span"": 240, ""type"": ""Cell""}, {""token"": ""mice"", ""start_span"": 250, ""end_span"": 254, ""type"": ""Organism""}]"	train
Since Akt phosphorylates Chk1 - Ser ( 280), the effect of Erbb2 on phosphatidyl inositol - 3 - kinase ( PI3K) / Akt signaling during UV - induced cell cycle arrest was determined.	Akt,6,9,Gene_or_gene_product	Chk1,25,29,Gene_or_gene_product	Erbb2,58,63,Gene_or_gene_product	phosphatidyl inositol - 3 - kinase,67,101,Gene_or_gene_product	PI3K,104,108,Gene_or_gene_product	Akt,112,115,Gene_or_gene_product	cell,146,150,Cell	"[{""token"": ""Akt"", ""start_span"": 6, ""end_span"": 9, ""type"": ""Gene_or_gene_product""}, {""token"": ""Chk1"", ""start_span"": 25, ""end_span"": 29, ""type"": ""Gene_or_gene_product""}, {""token"": ""Erbb2"", ""start_span"": 58, ""end_span"": 63, ""type"": ""Gene_or_gene_product""}, {""token"": ""phosphatidyl inositol - 3 - kinase"", ""start_span"": 67, ""end_span"": 101, ""type"": ""Gene_or_gene_product""}, {""token"": ""PI3K"", ""start_span"": 104, ""end_span"": 108, ""type"": ""Gene_or_gene_product""}, {""token"": ""Akt"", ""start_span"": 112, ""end_span"": 115, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 146, ""end_span"": 150, ""type"": ""Cell""}]"	train
We have shown that Arf6 and its effector AMAP1 ( DDEF1, DEF1, ASAP1 and centaurin beta4) are abnormally overexpressed in some breast cancers and used for their invasion and metastasis.	Arf6,19,23,Gene_or_gene_product	AMAP1,41,46,Gene_or_gene_product	DDEF1,49,54,Gene_or_gene_product	DEF1,56,60,Gene_or_gene_product	ASAP1,62,67,Gene_or_gene_product	centaurin beta4,72,87,Gene_or_gene_product	breast cancers,126,140,Cancer	"[{""token"": ""Arf6"", ""start_span"": 19, ""end_span"": 23, ""type"": ""Gene_or_gene_product""}, {""token"": ""AMAP1"", ""start_span"": 41, ""end_span"": 46, ""type"": ""Gene_or_gene_product""}, {""token"": ""DDEF1"", ""start_span"": 49, ""end_span"": 54, ""type"": ""Gene_or_gene_product""}, {""token"": ""DEF1"", ""start_span"": 56, ""end_span"": 60, ""type"": ""Gene_or_gene_product""}, {""token"": ""ASAP1"", ""start_span"": 62, ""end_span"": 67, ""type"": ""Gene_or_gene_product""}, {""token"": ""centaurin beta4"", ""start_span"": 72, ""end_span"": 87, ""type"": ""Gene_or_gene_product""}, {""token"": ""breast cancers"", ""start_span"": 126, ""end_span"": 140, ""type"": ""Cancer""}]"	train
Activated platelets enhance SKOV3 human ovarian cancer cell invasion through Matrigel and increase the amount of uPA and VEGF secreted into SKOV3 cell conditioned medium.	platelets,10,19,Cell	SKOV3,28,33,Cell	human,34,39,Organism	ovarian cancer cell,40,59,Cell	uPA,113,116,Gene_or_gene_product	VEGF,121,125,Gene_or_gene_product	SKOV3 cell,140,150,Cell	"[{""token"": ""platelets"", ""start_span"": 10, ""end_span"": 19, ""type"": ""Cell""}, {""token"": ""SKOV3"", ""start_span"": 28, ""end_span"": 33, ""type"": ""Cell""}, {""token"": ""human"", ""start_span"": 34, ""end_span"": 39, ""type"": ""Organism""}, {""token"": ""ovarian cancer cell"", ""start_span"": 40, ""end_span"": 59, ""type"": ""Cell""}, {""token"": ""uPA"", ""start_span"": 113, ""end_span"": 116, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 121, ""end_span"": 125, ""type"": ""Gene_or_gene_product""}, {""token"": ""SKOV3 cell"", ""start_span"": 140, ""end_span"": 150, ""type"": ""Cell""}]"	train
In addition, filopodia formation, a feature of motile cells, was inhibited in PECAM - 1 - null endothelial cells as well as in human endothelial cells treated with either anti - PECAM - 1 antibody or PECAM - 1 siRNA.	filopodia,13,22,Cellular_component	cells,54,59,Cell	PECAM - 1,78,87,Gene_or_gene_product	human,127,132,Organism	endothelial cells,133,150,Cell	anti - PECAM - 1 antibody,171,196,Gene_or_gene_product	PECAM - 1,200,209,Gene_or_gene_product	"[{""token"": ""filopodia"", ""start_span"": 13, ""end_span"": 22, ""type"": ""Cellular_component""}, {""token"": ""cells"", ""start_span"": 54, ""end_span"": 59, ""type"": ""Cell""}, {""token"": ""PECAM - 1"", ""start_span"": 78, ""end_span"": 87, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 127, ""end_span"": 132, ""type"": ""Organism""}, {""token"": ""endothelial cells"", ""start_span"": 133, ""end_span"": 150, ""type"": ""Cell""}, {""token"": ""anti - PECAM - 1 antibody"", ""start_span"": 171, ""end_span"": 196, ""type"": ""Gene_or_gene_product""}, {""token"": ""PECAM - 1"", ""start_span"": 200, ""end_span"": 209, ""type"": ""Gene_or_gene_product""}]"	train
The expression of metallothionein - 1 ( Mt - 1) gene, which is regulated by GR, was induced significantly by the combination of DMI and FA, and enhanced significantly by pretreatment with FA but not DMI.	metallothionein - 1,18,37,Gene_or_gene_product	Mt - 1,40,46,Gene_or_gene_product	GR,76,78,Gene_or_gene_product	DMI,128,131,Chemical	FA,136,138,Chemical	FA,188,190,Chemical	DMI,199,202,Chemical	"[{""token"": ""metallothionein - 1"", ""start_span"": 18, ""end_span"": 37, ""type"": ""Gene_or_gene_product""}, {""token"": ""Mt - 1"", ""start_span"": 40, ""end_span"": 46, ""type"": ""Gene_or_gene_product""}, {""token"": ""GR"", ""start_span"": 76, ""end_span"": 78, ""type"": ""Gene_or_gene_product""}, {""token"": ""DMI"", ""start_span"": 128, ""end_span"": 131, ""type"": ""Chemical""}, {""token"": ""FA"", ""start_span"": 136, ""end_span"": 138, ""type"": ""Chemical""}, {""token"": ""FA"", ""start_span"": 188, ""end_span"": 190, ""type"": ""Chemical""}, {""token"": ""DMI"", ""start_span"": 199, ""end_span"": 202, ""type"": ""Chemical""}]"	train
On the basis of earlier findings that ERK5 deficiency in mouse EC results in massive defects in vessel architecture, we focused on the impact of the MEK5 / ERK5 signaling pathway on EC migration.	ERK5,38,42,Gene_or_gene_product	mouse,57,62,Organism	EC,63,65,Cell	vessel architecture,96,115,Multi	MEK5,149,153,Gene_or_gene_product	ERK5,156,160,Gene_or_gene_product	EC,182,184,Cell	"[{""token"": ""ERK5"", ""start_span"": 38, ""end_span"": 42, ""type"": ""Gene_or_gene_product""}, {""token"": ""mouse"", ""start_span"": 57, ""end_span"": 62, ""type"": ""Organism""}, {""token"": ""EC"", ""start_span"": 63, ""end_span"": 65, ""type"": ""Cell""}, {""token"": ""vessel architecture"", ""start_span"": 96, ""end_span"": 115, ""type"": ""Multi""}, {""token"": ""MEK5"", ""start_span"": 149, ""end_span"": 153, ""type"": ""Gene_or_gene_product""}, {""token"": ""ERK5"", ""start_span"": 156, ""end_span"": 160, ""type"": ""Gene_or_gene_product""}, {""token"": ""EC"", ""start_span"": 182, ""end_span"": 184, ""type"": ""Cell""}]"	train
In vitro cell proliferation, combination studies and vascular endothelial growth factor ( VEGF) secretion analyses were performed on endothelial ( HMVEC - d) and colorectal cancer ( HT - 29) cells exposed for 144 h to metronomic concentrations of SN - 38, the active metabolite of CPT - 11, L - OHP and 5 - FU.	cell,9,13,Cell	vascular endothelial growth factor,53,87,Gene_or_gene_product	VEGF,90,94,Gene_or_gene_product	SN - 38,247,254,Chemical	CPT - 11,281,289,Chemical	L - OHP,291,298,Chemical	5 - FU,303,309,Chemical	"[{""token"": ""cell"", ""start_span"": 9, ""end_span"": 13, ""type"": ""Cell""}, {""token"": ""vascular endothelial growth factor"", ""start_span"": 53, ""end_span"": 87, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 90, ""end_span"": 94, ""type"": ""Gene_or_gene_product""}, {""token"": ""SN - 38"", ""start_span"": 247, ""end_span"": 254, ""type"": ""Chemical""}, {""token"": ""CPT - 11"", ""start_span"": 281, ""end_span"": 289, ""type"": ""Chemical""}, {""token"": ""L - OHP"", ""start_span"": 291, ""end_span"": 298, ""type"": ""Chemical""}, {""token"": ""5 - FU"", ""start_span"": 303, ""end_span"": 309, ""type"": ""Chemical""}]"	train
The beneficial effect of IL - 1Ra on most islet endothelial / OS / immune cells / fibrosis parameters analyzed highlights a major endothelial - related role for IL - 1 in GK islet alterations.	IL - 1Ra,25,33,Chemical	islet endothelial,42,59,Cell	immune cells,67,79,Cell	endothelial,130,141,Cell	IL - 1,161,167,Gene_or_gene_product	GK,171,173,Organism	islet,174,179,Multi	"[{""token"": ""IL - 1Ra"", ""start_span"": 25, ""end_span"": 33, ""type"": ""Chemical""}, {""token"": ""islet endothelial"", ""start_span"": 42, ""end_span"": 59, ""type"": ""Cell""}, {""token"": ""immune cells"", ""start_span"": 67, ""end_span"": 79, ""type"": ""Cell""}, {""token"": ""endothelial"", ""start_span"": 130, ""end_span"": 141, ""type"": ""Cell""}, {""token"": ""IL - 1"", ""start_span"": 161, ""end_span"": 167, ""type"": ""Gene_or_gene_product""}, {""token"": ""GK"", ""start_span"": 171, ""end_span"": 173, ""type"": ""Organism""}, {""token"": ""islet"", ""start_span"": 174, ""end_span"": 179, ""type"": ""Multi""}]"	train
CONCLUSION: Osteopontin siRNA can inhibit U251 cells invasion via the down - regulation of uPA, MMP - 2 and MMP - 9 levels, and promote apoptosis through induction of Bax expression and inhibition of Bcl 2 level.	Osteopontin,12,23,Gene_or_gene_product	U251 cells,42,52,Cell	uPA,91,94,Gene_or_gene_product	MMP - 2,96,103,Gene_or_gene_product	MMP - 9,108,115,Gene_or_gene_product	Bax,167,170,Gene_or_gene_product	Bcl 2,200,205,Gene_or_gene_product	"[{""token"": ""Osteopontin"", ""start_span"": 12, ""end_span"": 23, ""type"": ""Gene_or_gene_product""}, {""token"": ""U251 cells"", ""start_span"": 42, ""end_span"": 52, ""type"": ""Cell""}, {""token"": ""uPA"", ""start_span"": 91, ""end_span"": 94, ""type"": ""Gene_or_gene_product""}, {""token"": ""MMP - 2"", ""start_span"": 96, ""end_span"": 103, ""type"": ""Gene_or_gene_product""}, {""token"": ""MMP - 9"", ""start_span"": 108, ""end_span"": 115, ""type"": ""Gene_or_gene_product""}, {""token"": ""Bax"", ""start_span"": 167, ""end_span"": 170, ""type"": ""Gene_or_gene_product""}, {""token"": ""Bcl 2"", ""start_span"": 200, ""end_span"": 205, ""type"": ""Gene_or_gene_product""}]"	train
Calculations of the sources of energy for adenosine triphosphate synthesis indicated that on the average about one - third of the respiratory adenosine triphosphate is generated by electron flow originating from cytosolic NADH via the malate - aspartate shuttle.	adenosine triphosphate,42,64,Chemical	adenosine triphosphate,142,164,Chemical	electron,181,189,Chemical	cytosolic,212,221,Cellular_component	NADH,222,226,Chemical	malate,235,241,Chemical	aspartate,244,253,Chemical	"[{""token"": ""adenosine triphosphate"", ""start_span"": 42, ""end_span"": 64, ""type"": ""Chemical""}, {""token"": ""adenosine triphosphate"", ""start_span"": 142, ""end_span"": 164, ""type"": ""Chemical""}, {""token"": ""electron"", ""start_span"": 181, ""end_span"": 189, ""type"": ""Chemical""}, {""token"": ""cytosolic"", ""start_span"": 212, ""end_span"": 221, ""type"": ""Cellular_component""}, {""token"": ""NADH"", ""start_span"": 222, ""end_span"": 226, ""type"": ""Chemical""}, {""token"": ""malate"", ""start_span"": 235, ""end_span"": 241, ""type"": ""Chemical""}, {""token"": ""aspartate"", ""start_span"": 244, ""end_span"": 253, ""type"": ""Chemical""}]"	train
The treatment of ovarian cancer cells with luteinizing hormone, follicle - stimulating hormone, and estrogen induced a significant upregulation of SEMA3B, whereas SEMA3F was upregulated only by estrogen.	ovarian cancer cells,17,37,Cell	luteinizing hormone,43,62,Gene_or_gene_product	follicle - stimulating hormone,64,94,Gene_or_gene_product	estrogen,100,108,Chemical	SEMA3B,147,153,Gene_or_gene_product	SEMA3F,163,169,Gene_or_gene_product	estrogen,194,202,Chemical	"[{""token"": ""ovarian cancer cells"", ""start_span"": 17, ""end_span"": 37, ""type"": ""Cell""}, {""token"": ""luteinizing hormone"", ""start_span"": 43, ""end_span"": 62, ""type"": ""Gene_or_gene_product""}, {""token"": ""follicle - stimulating hormone"", ""start_span"": 64, ""end_span"": 94, ""type"": ""Gene_or_gene_product""}, {""token"": ""estrogen"", ""start_span"": 100, ""end_span"": 108, ""type"": ""Chemical""}, {""token"": ""SEMA3B"", ""start_span"": 147, ""end_span"": 153, ""type"": ""Gene_or_gene_product""}, {""token"": ""SEMA3F"", ""start_span"": 163, ""end_span"": 169, ""type"": ""Gene_or_gene_product""}, {""token"": ""estrogen"", ""start_span"": 194, ""end_span"": 202, ""type"": ""Chemical""}]"	train
Using MDA - MB - 231 cells, in which FOXO3a activity can be induced by 4 - hydroxytamoxifen, we showed that FOXO3a induction up - regulates PI3K - Akt activity and enhanced doxorubicin resistance.	MDA - MB - 231 cells,6,26,Cell	FOXO3a,37,43,Gene_or_gene_product	4 - hydroxytamoxifen,71,91,Chemical	FOXO3a,108,114,Gene_or_gene_product	PI3K,140,144,Gene_or_gene_product	Akt,147,150,Gene_or_gene_product	doxorubicin,173,184,Chemical	"[{""token"": ""MDA - MB - 231 cells"", ""start_span"": 6, ""end_span"": 26, ""type"": ""Cell""}, {""token"": ""FOXO3a"", ""start_span"": 37, ""end_span"": 43, ""type"": ""Gene_or_gene_product""}, {""token"": ""4 - hydroxytamoxifen"", ""start_span"": 71, ""end_span"": 91, ""type"": ""Chemical""}, {""token"": ""FOXO3a"", ""start_span"": 108, ""end_span"": 114, ""type"": ""Gene_or_gene_product""}, {""token"": ""PI3K"", ""start_span"": 140, ""end_span"": 144, ""type"": ""Gene_or_gene_product""}, {""token"": ""Akt"", ""start_span"": 147, ""end_span"": 150, ""type"": ""Gene_or_gene_product""}, {""token"": ""doxorubicin"", ""start_span"": 173, ""end_span"": 184, ""type"": ""Chemical""}]"	train
Here, we show that the downregulation of Brk1 results in abnormal actin stress fiber formation and vinculin distribution and loss of Arp2 / 3 and Wave proteins at the cellular protrusions.	Brk1,41,45,Gene_or_gene_product	actin,66,71,Gene_or_gene_product	stress fiber,72,84,Cellular_component	vinculin,99,107,Gene_or_gene_product	Arp2 / 3,133,141,Gene_or_gene_product	Wave,146,150,Gene_or_gene_product	cellular,167,175,Cell	"[{""token"": ""Brk1"", ""start_span"": 41, ""end_span"": 45, ""type"": ""Gene_or_gene_product""}, {""token"": ""actin"", ""start_span"": 66, ""end_span"": 71, ""type"": ""Gene_or_gene_product""}, {""token"": ""stress fiber"", ""start_span"": 72, ""end_span"": 84, ""type"": ""Cellular_component""}, {""token"": ""vinculin"", ""start_span"": 99, ""end_span"": 107, ""type"": ""Gene_or_gene_product""}, {""token"": ""Arp2 / 3"", ""start_span"": 133, ""end_span"": 141, ""type"": ""Gene_or_gene_product""}, {""token"": ""Wave"", ""start_span"": 146, ""end_span"": 150, ""type"": ""Gene_or_gene_product""}, {""token"": ""cellular"", ""start_span"": 167, ""end_span"": 175, ""type"": ""Cell""}]"	train
Ras p21 onco - protein in the sera of mice carrying an experimentally induced tumor and in human cancer patients.	Ras p21,0,7,Gene_or_gene_product	sera,30,34,Organism_substance	mice,38,42,Organism	tumor,78,83,Cancer	human,91,96,Organism	cancer,97,103,Cancer	patients,104,112,Organism	"[{""token"": ""Ras p21"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Gene_or_gene_product""}, {""token"": ""sera"", ""start_span"": 30, ""end_span"": 34, ""type"": ""Organism_substance""}, {""token"": ""mice"", ""start_span"": 38, ""end_span"": 42, ""type"": ""Organism""}, {""token"": ""tumor"", ""start_span"": 78, ""end_span"": 83, ""type"": ""Cancer""}, {""token"": ""human"", ""start_span"": 91, ""end_span"": 96, ""type"": ""Organism""}, {""token"": ""cancer"", ""start_span"": 97, ""end_span"": 103, ""type"": ""Cancer""}, {""token"": ""patients"", ""start_span"": 104, ""end_span"": 112, ""type"": ""Organism""}]"	train
By transcriptional activation and other means, p53 is able to contribute to the regulation of glycolysis, oxidative phosphorylation, glutaminolysis, insulin sensitivity, nucleotide biosynthesis, mitochondrial integrity, fatty acid oxidation, antioxidant response, autophagy and mTOR signalling.	p53,47,50,Gene_or_gene_product	insulin,149,156,Gene_or_gene_product	nucleotide,170,180,Chemical	mitochondrial,195,208,Cellular_component	fatty acid,220,230,Chemical	antioxidant,242,253,Chemical	mTOR,278,282,Gene_or_gene_product	"[{""token"": ""p53"", ""start_span"": 47, ""end_span"": 50, ""type"": ""Gene_or_gene_product""}, {""token"": ""insulin"", ""start_span"": 149, ""end_span"": 156, ""type"": ""Gene_or_gene_product""}, {""token"": ""nucleotide"", ""start_span"": 170, ""end_span"": 180, ""type"": ""Chemical""}, {""token"": ""mitochondrial"", ""start_span"": 195, ""end_span"": 208, ""type"": ""Cellular_component""}, {""token"": ""fatty acid"", ""start_span"": 220, ""end_span"": 230, ""type"": ""Chemical""}, {""token"": ""antioxidant"", ""start_span"": 242, ""end_span"": 253, ""type"": ""Chemical""}, {""token"": ""mTOR"", ""start_span"": 278, ""end_span"": 282, ""type"": ""Gene_or_gene_product""}]"	train
DNA microarray analysis of treated tumor xenografts revealed significantly decreased expression of genes regulating glucose and thymidine metabolism and revealed changes in apoptotic genes, suggesting that the imaging tracers FDG, 3 - deoxy - 3 - [ ( 18) F] fluorothymidine, and annexin V could serve as potential imaging biomarkers for RAF265 therapy monitoring.	DNA,0,3,Cellular_component	tumor xenografts,35,51,Cancer	glucose,116,123,Chemical	thymidine,128,137,Chemical	FDG,226,229,Chemical	annexin V,279,288,Gene_or_gene_product	RAF265,337,343,Chemical	"[{""token"": ""DNA"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Cellular_component""}, {""token"": ""tumor xenografts"", ""start_span"": 35, ""end_span"": 51, ""type"": ""Cancer""}, {""token"": ""glucose"", ""start_span"": 116, ""end_span"": 123, ""type"": ""Chemical""}, {""token"": ""thymidine"", ""start_span"": 128, ""end_span"": 137, ""type"": ""Chemical""}, {""token"": ""FDG"", ""start_span"": 226, ""end_span"": 229, ""type"": ""Chemical""}, {""token"": ""annexin V"", ""start_span"": 279, ""end_span"": 288, ""type"": ""Gene_or_gene_product""}, {""token"": ""RAF265"", ""start_span"": 337, ""end_span"": 343, ""type"": ""Chemical""}]"	train
This cell line is not invasive by nature and secretes moderate amounts of VEGF - C; intrauterine injection of HEC1A cells into Balb / c nude mice resulted in uterine cancer with lymph node metastasis after 8 weeks.	cell line,5,14,Cell	VEGF - C,74,82,Gene_or_gene_product	intrauterine,84,96,Immaterial_anatomical_entity	HEC1A cells,110,121,Cell	Balb / c nude mice,127,145,Organism	uterine cancer,158,172,Cancer	lymph node,178,188,Multi	"[{""token"": ""cell line"", ""start_span"": 5, ""end_span"": 14, ""type"": ""Cell""}, {""token"": ""VEGF - C"", ""start_span"": 74, ""end_span"": 82, ""type"": ""Gene_or_gene_product""}, {""token"": ""intrauterine"", ""start_span"": 84, ""end_span"": 96, ""type"": ""Immaterial_anatomical_entity""}, {""token"": ""HEC1A cells"", ""start_span"": 110, ""end_span"": 121, ""type"": ""Cell""}, {""token"": ""Balb / c nude mice"", ""start_span"": 127, ""end_span"": 145, ""type"": ""Organism""}, {""token"": ""uterine cancer"", ""start_span"": 158, ""end_span"": 172, ""type"": ""Cancer""}, {""token"": ""lymph node"", ""start_span"": 178, ""end_span"": 188, ""type"": ""Multi""}]"	train
IL - 17F ablation decreased IL - 1beta and Cox - 2 expression as well as IL - 17 receptor C ( IL - 17RC) expression, which were increased in tumors from Apc ( Min / +) mice.	IL - 17F,0,8,Gene_or_gene_product	IL - 1beta,28,38,Gene_or_gene_product	Cox - 2,43,50,Gene_or_gene_product	IL - 17 receptor C,73,91,Gene_or_gene_product	IL - 17RC,94,103,Gene_or_gene_product	tumors,141,147,Cancer	Apc,153,156,Gene_or_gene_product	"[{""token"": ""IL - 17F"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Gene_or_gene_product""}, {""token"": ""IL - 1beta"", ""start_span"": 28, ""end_span"": 38, ""type"": ""Gene_or_gene_product""}, {""token"": ""Cox - 2"", ""start_span"": 43, ""end_span"": 50, ""type"": ""Gene_or_gene_product""}, {""token"": ""IL - 17 receptor C"", ""start_span"": 73, ""end_span"": 91, ""type"": ""Gene_or_gene_product""}, {""token"": ""IL - 17RC"", ""start_span"": 94, ""end_span"": 103, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumors"", ""start_span"": 141, ""end_span"": 147, ""type"": ""Cancer""}, {""token"": ""Apc"", ""start_span"": 153, ""end_span"": 156, ""type"": ""Gene_or_gene_product""}]"	train
Mechanistically, it reduced expression of molecular markers of cell proliferation ( Ki67) and angiogenesis ( factor VIII), antiapoptotic factor Bcl - 2, cell - cycle progression regulator cyclin D1, and survival factor AKT1.	cell,63,67,Cell	Ki67,84,88,Gene_or_gene_product	factor VIII,109,120,Gene_or_gene_product	Bcl - 2,144,151,Gene_or_gene_product	cell,153,157,Cell	cyclin D1,188,197,Gene_or_gene_product	AKT1,219,223,Gene_or_gene_product	"[{""token"": ""cell"", ""start_span"": 63, ""end_span"": 67, ""type"": ""Cell""}, {""token"": ""Ki67"", ""start_span"": 84, ""end_span"": 88, ""type"": ""Gene_or_gene_product""}, {""token"": ""factor VIII"", ""start_span"": 109, ""end_span"": 120, ""type"": ""Gene_or_gene_product""}, {""token"": ""Bcl - 2"", ""start_span"": 144, ""end_span"": 151, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 153, ""end_span"": 157, ""type"": ""Cell""}, {""token"": ""cyclin D1"", ""start_span"": 188, ""end_span"": 197, ""type"": ""Gene_or_gene_product""}, {""token"": ""AKT1"", ""start_span"": 219, ""end_span"": 223, ""type"": ""Gene_or_gene_product""}]"	train
In addition to giving a historical perspective on HTLV - 1 and other retrovirus research, this paper discusses the origin of HTLV - 1; the modes of transmission and global epidemiology of HTLV - 1 infection; the genome of HTLV - 1 and the mechanism of HTLV - 1 - induced leukemogenesis; the role of HTLV - 1 in other diseases, and recent breakthroughs in ATL therapy.	HTLV - 1,50,58,Organism	HTLV - 1,125,133,Organism	HTLV - 1,188,196,Organism	HTLV - 1,222,230,Organism	HTLV - 1,252,260,Organism	HTLV - 1,299,307,Organism	ATL,355,358,Cancer	"[{""token"": ""HTLV - 1"", ""start_span"": 50, ""end_span"": 58, ""type"": ""Organism""}, {""token"": ""HTLV - 1"", ""start_span"": 125, ""end_span"": 133, ""type"": ""Organism""}, {""token"": ""HTLV - 1"", ""start_span"": 188, ""end_span"": 196, ""type"": ""Organism""}, {""token"": ""HTLV - 1"", ""start_span"": 222, ""end_span"": 230, ""type"": ""Organism""}, {""token"": ""HTLV - 1"", ""start_span"": 252, ""end_span"": 260, ""type"": ""Organism""}, {""token"": ""HTLV - 1"", ""start_span"": 299, ""end_span"": 307, ""type"": ""Organism""}, {""token"": ""ATL"", ""start_span"": 355, ""end_span"": 358, ""type"": ""Cancer""}]"	train
OSCC sublines were established from a GFP - expressing parental cell line, GSAS, and designated GSAS / N3 and N5 according to the in vivo passage number after cervical lymph node metastasis by a serial orthotopic transplantation model.	OSCC sublines,0,13,Cell	GFP,38,41,Gene_or_gene_product	parental cell line,55,73,Cell	GSAS,75,79,Cell	GSAS / N3,96,105,Cell	N5,110,112,Cell	cervical lymph node,159,178,Multi	"[{""token"": ""OSCC sublines"", ""start_span"": 0, ""end_span"": 13, ""type"": ""Cell""}, {""token"": ""GFP"", ""start_span"": 38, ""end_span"": 41, ""type"": ""Gene_or_gene_product""}, {""token"": ""parental cell line"", ""start_span"": 55, ""end_span"": 73, ""type"": ""Cell""}, {""token"": ""GSAS"", ""start_span"": 75, ""end_span"": 79, ""type"": ""Cell""}, {""token"": ""GSAS / N3"", ""start_span"": 96, ""end_span"": 105, ""type"": ""Cell""}, {""token"": ""N5"", ""start_span"": 110, ""end_span"": 112, ""type"": ""Cell""}, {""token"": ""cervical lymph node"", ""start_span"": 159, ""end_span"": 178, ""type"": ""Multi""}]"	train
HTPB significantly suppresses tumor metastasis partly through inhibition of integrin - beta1 / FAK / MMP / RhoA / F - actin pathways.	HTPB,0,4,Chemical	tumor,30,35,Cancer	integrin - beta1,76,92,Gene_or_gene_product	FAK,95,98,Gene_or_gene_product	MMP,101,104,Gene_or_gene_product	RhoA,107,111,Gene_or_gene_product	F - actin,114,123,Gene_or_gene_product	"[{""token"": ""HTPB"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Chemical""}, {""token"": ""tumor"", ""start_span"": 30, ""end_span"": 35, ""type"": ""Cancer""}, {""token"": ""integrin - beta1"", ""start_span"": 76, ""end_span"": 92, ""type"": ""Gene_or_gene_product""}, {""token"": ""FAK"", ""start_span"": 95, ""end_span"": 98, ""type"": ""Gene_or_gene_product""}, {""token"": ""MMP"", ""start_span"": 101, ""end_span"": 104, ""type"": ""Gene_or_gene_product""}, {""token"": ""RhoA"", ""start_span"": 107, ""end_span"": 111, ""type"": ""Gene_or_gene_product""}, {""token"": ""F - actin"", ""start_span"": 114, ""end_span"": 123, ""type"": ""Gene_or_gene_product""}]"	train
Immunodetection was performed with a specific anti - bFGF mouse monoclonal antibody that was found to react with recombinant human bFGF in Western blot analysis, and to specifically neutralize the mitogenic activity of bFGF on bovine vascular endothelial cells.	bFGF,53,57,Gene_or_gene_product	mouse,58,63,Organism	human,125,130,Organism	bFGF,131,135,Gene_or_gene_product	bFGF,219,223,Gene_or_gene_product	bovine,227,233,Organism	vascular endothelial cells,234,260,Cell	"[{""token"": ""bFGF"", ""start_span"": 53, ""end_span"": 57, ""type"": ""Gene_or_gene_product""}, {""token"": ""mouse"", ""start_span"": 58, ""end_span"": 63, ""type"": ""Organism""}, {""token"": ""human"", ""start_span"": 125, ""end_span"": 130, ""type"": ""Organism""}, {""token"": ""bFGF"", ""start_span"": 131, ""end_span"": 135, ""type"": ""Gene_or_gene_product""}, {""token"": ""bFGF"", ""start_span"": 219, ""end_span"": 223, ""type"": ""Gene_or_gene_product""}, {""token"": ""bovine"", ""start_span"": 227, ""end_span"": 233, ""type"": ""Organism""}, {""token"": ""vascular endothelial cells"", ""start_span"": 234, ""end_span"": 260, ""type"": ""Cell""}]"	train
The activation of Na + transport is due to the exchange of protons formed via glucose conversion into lactate for Na +, i. e., to the stimulation of the Na + / H + - antiport.	Na +,18,22,Chemical	protons,59,66,Chemical	glucose,78,85,Chemical	lactate,102,109,Chemical	Na +,114,118,Chemical	Na +,153,157,Chemical	H +,160,163,Chemical	"[{""token"": ""Na +"", ""start_span"": 18, ""end_span"": 22, ""type"": ""Chemical""}, {""token"": ""protons"", ""start_span"": 59, ""end_span"": 66, ""type"": ""Chemical""}, {""token"": ""glucose"", ""start_span"": 78, ""end_span"": 85, ""type"": ""Chemical""}, {""token"": ""lactate"", ""start_span"": 102, ""end_span"": 109, ""type"": ""Chemical""}, {""token"": ""Na +"", ""start_span"": 114, ""end_span"": 118, ""type"": ""Chemical""}, {""token"": ""Na +"", ""start_span"": 153, ""end_span"": 157, ""type"": ""Chemical""}, {""token"": ""H +"", ""start_span"": 160, ""end_span"": 163, ""type"": ""Chemical""}]"	train
Measuring ouabain - sensitive 22Na efflux and using ouabain - sensitive lactate production as a measure of ATP hydrolysis by the Na + K + pump, it was shown that Nonidet P - 40 greatly decreased the efficiency of the Na + K + pump.	ouabain,10,17,Chemical	ouabain,52,59,Chemical	lactate,72,79,Chemical	ATP,107,110,Chemical	Na + K + pump,129,142,Gene_or_gene_product	Nonidet P - 40,162,176,Chemical	Na + K + pump,217,230,Gene_or_gene_product	"[{""token"": ""ouabain"", ""start_span"": 10, ""end_span"": 17, ""type"": ""Chemical""}, {""token"": ""ouabain"", ""start_span"": 52, ""end_span"": 59, ""type"": ""Chemical""}, {""token"": ""lactate"", ""start_span"": 72, ""end_span"": 79, ""type"": ""Chemical""}, {""token"": ""ATP"", ""start_span"": 107, ""end_span"": 110, ""type"": ""Chemical""}, {""token"": ""Na + K + pump"", ""start_span"": 129, ""end_span"": 142, ""type"": ""Gene_or_gene_product""}, {""token"": ""Nonidet P - 40"", ""start_span"": 162, ""end_span"": 176, ""type"": ""Chemical""}, {""token"": ""Na + K + pump"", ""start_span"": 217, ""end_span"": 230, ""type"": ""Gene_or_gene_product""}]"	train
Phosphorylation of Thr654 by protein kinase C decreases high affinity EGF binding and EGF - stimulated tyrosine protein kinase activity, providing a mechanism for heterologous regulation of the EGF receptor by tumor promoters and other ligand X receptor complexes.	Thr654,19,25,Amino_acid	protein kinase C,29,45,Gene_or_gene_product	EGF,70,73,Gene_or_gene_product	EGF,86,89,Gene_or_gene_product	EGF receptor,194,206,Gene_or_gene_product	tumor,210,215,Cancer	ligand X receptor,236,253,Gene_or_gene_product	"[{""token"": ""Thr654"", ""start_span"": 19, ""end_span"": 25, ""type"": ""Amino_acid""}, {""token"": ""protein kinase C"", ""start_span"": 29, ""end_span"": 45, ""type"": ""Gene_or_gene_product""}, {""token"": ""EGF"", ""start_span"": 70, ""end_span"": 73, ""type"": ""Gene_or_gene_product""}, {""token"": ""EGF"", ""start_span"": 86, ""end_span"": 89, ""type"": ""Gene_or_gene_product""}, {""token"": ""EGF receptor"", ""start_span"": 194, ""end_span"": 206, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 210, ""end_span"": 215, ""type"": ""Cancer""}, {""token"": ""ligand X receptor"", ""start_span"": 236, ""end_span"": 253, ""type"": ""Gene_or_gene_product""}]"	train
Infection of human or murine cells with murine leukemia viruses rapidly increases the expression of a number of genes that belong to the immunoglobulin superfamily and are involved in T - lymphocyte activation, including the class I major histocompatibility complex antigens.	human,13,18,Organism	murine,22,28,Organism	cells,29,34,Cell	murine leukemia viruses,40,63,Organism	immunoglobulin,137,151,Gene_or_gene_product	T - lymphocyte,184,198,Cell	class I major histocompatibility complex antigens,225,274,Gene_or_gene_product	"[{""token"": ""human"", ""start_span"": 13, ""end_span"": 18, ""type"": ""Organism""}, {""token"": ""murine"", ""start_span"": 22, ""end_span"": 28, ""type"": ""Organism""}, {""token"": ""cells"", ""start_span"": 29, ""end_span"": 34, ""type"": ""Cell""}, {""token"": ""murine leukemia viruses"", ""start_span"": 40, ""end_span"": 63, ""type"": ""Organism""}, {""token"": ""immunoglobulin"", ""start_span"": 137, ""end_span"": 151, ""type"": ""Gene_or_gene_product""}, {""token"": ""T - lymphocyte"", ""start_span"": 184, ""end_span"": 198, ""type"": ""Cell""}, {""token"": ""class I major histocompatibility complex antigens"", ""start_span"": 225, ""end_span"": 274, ""type"": ""Gene_or_gene_product""}]"	train
This hypothesis was tested using the 2G7 IgG2b, which neutralizes TGF - beta 1, - beta 2, and - beta 3, and the MDA - 231 human breast cancer cell line.	IgG2b,41,46,Gene_or_gene_product	TGF - beta 1,66,78,Gene_or_gene_product	- beta 2,80,88,Gene_or_gene_product	- beta 3,94,102,Gene_or_gene_product	MDA - 231,112,121,Cell	human,122,127,Organism	breast cancer cell line,128,151,Cell	"[{""token"": ""IgG2b"", ""start_span"": 41, ""end_span"": 46, ""type"": ""Gene_or_gene_product""}, {""token"": ""TGF - beta 1"", ""start_span"": 66, ""end_span"": 78, ""type"": ""Gene_or_gene_product""}, {""token"": ""- beta 2"", ""start_span"": 80, ""end_span"": 88, ""type"": ""Gene_or_gene_product""}, {""token"": ""- beta 3"", ""start_span"": 94, ""end_span"": 102, ""type"": ""Gene_or_gene_product""}, {""token"": ""MDA - 231"", ""start_span"": 112, ""end_span"": 121, ""type"": ""Cell""}, {""token"": ""human"", ""start_span"": 122, ""end_span"": 127, ""type"": ""Organism""}, {""token"": ""breast cancer cell line"", ""start_span"": 128, ""end_span"": 151, ""type"": ""Cell""}]"	train
Human umbilical vein endothelial cells ( HUVECs) and rat aorta smooth muscle cells ( RASMCs) infected with AdCMV. VEGF165 ( 5 and 20 plaque - forming units [ pfu] per cell) demonstrated VEGF mRNA expression and protein secretion into the supernatant.	Human umbilical vein endothelial cells,0,38,Cell	HUVECs,41,47,Cell	rat aorta smooth muscle cells,53,82,Cell	RASMCs,85,91,Cell	VEGF165,114,121,Gene_or_gene_product	cell,167,171,Cell	VEGF,186,190,Gene_or_gene_product	"[{""token"": ""Human umbilical vein endothelial cells"", ""start_span"": 0, ""end_span"": 38, ""type"": ""Cell""}, {""token"": ""HUVECs"", ""start_span"": 41, ""end_span"": 47, ""type"": ""Cell""}, {""token"": ""rat aorta smooth muscle cells"", ""start_span"": 53, ""end_span"": 82, ""type"": ""Cell""}, {""token"": ""RASMCs"", ""start_span"": 85, ""end_span"": 91, ""type"": ""Cell""}, {""token"": ""VEGF165"", ""start_span"": 114, ""end_span"": 121, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 167, ""end_span"": 171, ""type"": ""Cell""}, {""token"": ""VEGF"", ""start_span"": 186, ""end_span"": 190, ""type"": ""Gene_or_gene_product""}]"	train
In contrast, neither VEGF mRNA nor secreted protein was found in uninfected HUVECs or RASMCs or in cells infected with the control vector AdCMV. beta gal ( where beta gal is beta - galactosidase).	VEGF,21,25,Gene_or_gene_product	HUVECs,76,82,Cell	RASMCs,86,92,Cell	cells,99,104,Cell	beta gal,145,153,Gene_or_gene_product	beta gal,162,170,Gene_or_gene_product	beta - galactosidase,174,194,Gene_or_gene_product	"[{""token"": ""VEGF"", ""start_span"": 21, ""end_span"": 25, ""type"": ""Gene_or_gene_product""}, {""token"": ""HUVECs"", ""start_span"": 76, ""end_span"": 82, ""type"": ""Cell""}, {""token"": ""RASMCs"", ""start_span"": 86, ""end_span"": 92, ""type"": ""Cell""}, {""token"": ""cells"", ""start_span"": 99, ""end_span"": 104, ""type"": ""Cell""}, {""token"": ""beta gal"", ""start_span"": 145, ""end_span"": 153, ""type"": ""Gene_or_gene_product""}, {""token"": ""beta gal"", ""start_span"": 162, ""end_span"": 170, ""type"": ""Gene_or_gene_product""}, {""token"": ""beta - galactosidase"", ""start_span"": 174, ""end_span"": 194, ""type"": ""Gene_or_gene_product""}]"	train
A synthetic tetracycline, doxycycline, inhibits migration of human MDA - MB - 435 breast adenocarcinoma cells through a reconstituted basement membrane ( Matrigel), an assay used as an in vitro surrogate for the in vivo process of tumor invasion through basement membranes.	tetracycline,12,24,Chemical	doxycycline,26,37,Chemical	human,61,66,Organism	MDA - MB - 435 breast adenocarcinoma cells,67,109,Cell	basement membrane,134,151,Cellular_component	tumor,231,236,Cancer	basement membranes,254,272,Cellular_component	"[{""token"": ""tetracycline"", ""start_span"": 12, ""end_span"": 24, ""type"": ""Chemical""}, {""token"": ""doxycycline"", ""start_span"": 26, ""end_span"": 37, ""type"": ""Chemical""}, {""token"": ""human"", ""start_span"": 61, ""end_span"": 66, ""type"": ""Organism""}, {""token"": ""MDA - MB - 435 breast adenocarcinoma cells"", ""start_span"": 67, ""end_span"": 109, ""type"": ""Cell""}, {""token"": ""basement membrane"", ""start_span"": 134, ""end_span"": 151, ""type"": ""Cellular_component""}, {""token"": ""tumor"", ""start_span"": 231, ""end_span"": 236, ""type"": ""Cancer""}, {""token"": ""basement membranes"", ""start_span"": 254, ""end_span"": 272, ""type"": ""Cellular_component""}]"	train
9E3 / CEF4, which is released from transformed chicken embryo fibroblasts ( CEF), is a member of the platelet factor 4 family of inflammatory proteins and may be the avian homolog of interleukin - 8.	9E3,0,3,Gene_or_gene_product	CEF4,6,10,Gene_or_gene_product	chicken,47,54,Organism	embryo fibroblasts,55,73,Cell	CEF,76,79,Cell	platelet factor 4,101,118,Gene_or_gene_product	interleukin - 8,183,198,Gene_or_gene_product	"[{""token"": ""9E3"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene_or_gene_product""}, {""token"": ""CEF4"", ""start_span"": 6, ""end_span"": 10, ""type"": ""Gene_or_gene_product""}, {""token"": ""chicken"", ""start_span"": 47, ""end_span"": 54, ""type"": ""Organism""}, {""token"": ""embryo fibroblasts"", ""start_span"": 55, ""end_span"": 73, ""type"": ""Cell""}, {""token"": ""CEF"", ""start_span"": 76, ""end_span"": 79, ""type"": ""Cell""}, {""token"": ""platelet factor 4"", ""start_span"": 101, ""end_span"": 118, ""type"": ""Gene_or_gene_product""}, {""token"": ""interleukin - 8"", ""start_span"": 183, ""end_span"": 198, ""type"": ""Gene_or_gene_product""}]"	train
9E3 / CEF4 mRNA was expressed in chicken peripheral blood monocytes, and its expression was stimulated by incubation of the monocytes with lipopolysaccharide or phorbol myristic acetate.	9E3,0,3,Gene_or_gene_product	CEF4,6,10,Gene_or_gene_product	chicken,33,40,Organism	peripheral blood monocytes,41,67,Organism_substance	monocytes,124,133,Cell	lipopolysaccharide,139,157,Chemical	phorbol myristic acetate,161,185,Chemical	"[{""token"": ""9E3"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene_or_gene_product""}, {""token"": ""CEF4"", ""start_span"": 6, ""end_span"": 10, ""type"": ""Gene_or_gene_product""}, {""token"": ""chicken"", ""start_span"": 33, ""end_span"": 40, ""type"": ""Organism""}, {""token"": ""peripheral blood monocytes"", ""start_span"": 41, ""end_span"": 67, ""type"": ""Organism_substance""}, {""token"": ""monocytes"", ""start_span"": 124, ""end_span"": 133, ""type"": ""Cell""}, {""token"": ""lipopolysaccharide"", ""start_span"": 139, ""end_span"": 157, ""type"": ""Chemical""}, {""token"": ""phorbol myristic acetate"", ""start_span"": 161, ""end_span"": 185, ""type"": ""Chemical""}]"	train
BACKGROUND: The murine nm23 gene suppresses the metastatic behavior of malignant rodent tumor lines, and reduced nm23 expression correlates with increased likelihood of lymph node metastases in human breast cancers.	murine,16,22,Organism	nm23,23,27,Gene_or_gene_product	malignant rodent tumor lines,71,99,Cell	nm23,113,117,Gene_or_gene_product	lymph node,169,179,Multi	human,194,199,Organism	breast cancers,200,214,Cancer	"[{""token"": ""murine"", ""start_span"": 16, ""end_span"": 22, ""type"": ""Organism""}, {""token"": ""nm23"", ""start_span"": 23, ""end_span"": 27, ""type"": ""Gene_or_gene_product""}, {""token"": ""malignant rodent tumor lines"", ""start_span"": 71, ""end_span"": 99, ""type"": ""Cell""}, {""token"": ""nm23"", ""start_span"": 113, ""end_span"": 117, ""type"": ""Gene_or_gene_product""}, {""token"": ""lymph node"", ""start_span"": 169, ""end_span"": 179, ""type"": ""Multi""}, {""token"": ""human"", ""start_span"": 194, ""end_span"": 199, ""type"": ""Organism""}, {""token"": ""breast cancers"", ""start_span"": 200, ""end_span"": 214, ""type"": ""Cancer""}]"	train
METHODS: We used ribonuclease protection assays to analyze human colon tumors for the level of nm23 - H1 ( 43 samples) and nm23 - H2 ( 41 samples) transcript ( mRNA) expression and the presence of mutations that could inactivate potential suppressor function.	ribonuclease,17,29,Gene_or_gene_product	human,59,64,Organism	colon tumors,65,77,Cancer	nm23 - H1,95,104,Gene_or_gene_product	samples,110,117,Cancer	nm23 - H2,123,132,Gene_or_gene_product	samples,138,145,Cancer	"[{""token"": ""ribonuclease"", ""start_span"": 17, ""end_span"": 29, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 59, ""end_span"": 64, ""type"": ""Organism""}, {""token"": ""colon tumors"", ""start_span"": 65, ""end_span"": 77, ""type"": ""Cancer""}, {""token"": ""nm23 - H1"", ""start_span"": 95, ""end_span"": 104, ""type"": ""Gene_or_gene_product""}, {""token"": ""samples"", ""start_span"": 110, ""end_span"": 117, ""type"": ""Cancer""}, {""token"": ""nm23 - H2"", ""start_span"": 123, ""end_span"": 132, ""type"": ""Gene_or_gene_product""}, {""token"": ""samples"", ""start_span"": 138, ""end_span"": 145, ""type"": ""Cancer""}]"	train
We have investigated the putative role of rho proteins from Aplysia californica as transforming GTPases utilizing the wild - type and a Val - 14 mutant, equivalent to the oncogenic Val - 12 mutation of ras genes found in animal and human tumors.	rho,42,45,Gene_or_gene_product	Aplysia californica,60,79,Organism	GTPases,96,103,Gene_or_gene_product	Val - 14 mutant,136,151,Organism	ras,202,205,Gene_or_gene_product	human,232,237,Organism	tumors,238,244,Cancer	"[{""token"": ""rho"", ""start_span"": 42, ""end_span"": 45, ""type"": ""Gene_or_gene_product""}, {""token"": ""Aplysia californica"", ""start_span"": 60, ""end_span"": 79, ""type"": ""Organism""}, {""token"": ""GTPases"", ""start_span"": 96, ""end_span"": 103, ""type"": ""Gene_or_gene_product""}, {""token"": ""Val - 14 mutant"", ""start_span"": 136, ""end_span"": 151, ""type"": ""Organism""}, {""token"": ""ras"", ""start_span"": 202, ""end_span"": 205, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 232, ""end_span"": 237, ""type"": ""Organism""}, {""token"": ""tumors"", ""start_span"": 238, ""end_span"": 244, ""type"": ""Cancer""}]"	train
OPN promoted EC migration in vitro; and VPF / VEGF induction of alphavbeta3 was accompanied by increased EC migration toward OPN.	OPN,0,3,Gene_or_gene_product	EC,13,15,Cell	VPF,40,43,Gene_or_gene_product	VEGF,46,50,Gene_or_gene_product	alphavbeta3,64,75,Gene_or_gene_product	EC,105,107,Cell	OPN,125,128,Gene_or_gene_product	"[{""token"": ""OPN"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene_or_gene_product""}, {""token"": ""EC"", ""start_span"": 13, ""end_span"": 15, ""type"": ""Cell""}, {""token"": ""VPF"", ""start_span"": 40, ""end_span"": 43, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 46, ""end_span"": 50, ""type"": ""Gene_or_gene_product""}, {""token"": ""alphavbeta3"", ""start_span"": 64, ""end_span"": 75, ""type"": ""Gene_or_gene_product""}, {""token"": ""EC"", ""start_span"": 105, ""end_span"": 107, ""type"": ""Cell""}, {""token"": ""OPN"", ""start_span"": 125, ""end_span"": 128, ""type"": ""Gene_or_gene_product""}]"	train
These findings also illustrate an operational link between VPF / VEGF induction of EC gene expression and VPF / VEGF enhancement of microvascular permeability, suggesting that these distinct biological activities may act accordingly to stimulate EC migration during angiogenesis.	VPF,59,62,Gene_or_gene_product	VEGF,65,69,Gene_or_gene_product	EC,83,85,Cell	VPF,106,109,Gene_or_gene_product	VEGF,112,116,Gene_or_gene_product	microvascular,132,145,Tissue	EC,246,248,Cell	"[{""token"": ""VPF"", ""start_span"": 59, ""end_span"": 62, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 65, ""end_span"": 69, ""type"": ""Gene_or_gene_product""}, {""token"": ""EC"", ""start_span"": 83, ""end_span"": 85, ""type"": ""Cell""}, {""token"": ""VPF"", ""start_span"": 106, ""end_span"": 109, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 112, ""end_span"": 116, ""type"": ""Gene_or_gene_product""}, {""token"": ""microvascular"", ""start_span"": 132, ""end_span"": 145, ""type"": ""Tissue""}, {""token"": ""EC"", ""start_span"": 246, ""end_span"": 248, ""type"": ""Cell""}]"	train
Transformants induced by 5 - azacytidine lost c - myc - induced apoptotic cell death, whereas MnSO4 - induced transformants showed a higher degree of apoptosis than the parental Rat 6 / c - myc cells.	Transformants,0,13,Cell	5 - azacytidine,25,40,Chemical	c - myc,46,53,Gene_or_gene_product	cell,74,78,Cell	MnSO4,94,99,Chemical	transformants,110,123,Cell	c - myc,186,193,Gene_or_gene_product	"[{""token"": ""Transformants"", ""start_span"": 0, ""end_span"": 13, ""type"": ""Cell""}, {""token"": ""5 - azacytidine"", ""start_span"": 25, ""end_span"": 40, ""type"": ""Chemical""}, {""token"": ""c - myc"", ""start_span"": 46, ""end_span"": 53, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 74, ""end_span"": 78, ""type"": ""Cell""}, {""token"": ""MnSO4"", ""start_span"": 94, ""end_span"": 99, ""type"": ""Chemical""}, {""token"": ""transformants"", ""start_span"": 110, ""end_span"": 123, ""type"": ""Cell""}, {""token"": ""c - myc"", ""start_span"": 186, ""end_span"": 193, ""type"": ""Gene_or_gene_product""}]"	train
To further elucidate the biological significance of WT1 in leukemic cell growth, we overexpressed exogenous WT1 in murine M1 myeloblastic leukemia cells using the isopropyl - beta - D - thiogalactoside ( IPTG) - controlled expression system.	WT1,52,55,Gene_or_gene_product	cell,68,72,Cell	WT1,108,111,Gene_or_gene_product	murine,115,121,Organism	M1 myeloblastic leukemia cells,122,152,Cell	isopropyl - beta - D - thiogalactoside,163,201,Chemical	IPTG,204,208,Chemical	"[{""token"": ""WT1"", ""start_span"": 52, ""end_span"": 55, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 68, ""end_span"": 72, ""type"": ""Cell""}, {""token"": ""WT1"", ""start_span"": 108, ""end_span"": 111, ""type"": ""Gene_or_gene_product""}, {""token"": ""murine"", ""start_span"": 115, ""end_span"": 121, ""type"": ""Organism""}, {""token"": ""M1 myeloblastic leukemia cells"", ""start_span"": 122, ""end_span"": 152, ""type"": ""Cell""}, {""token"": ""isopropyl - beta - D - thiogalactoside"", ""start_span"": 163, ""end_span"": 201, ""type"": ""Chemical""}, {""token"": ""IPTG"", ""start_span"": 204, ""end_span"": 208, ""type"": ""Chemical""}]"	train
The only CD8 + CD56 + postthymic T - cell lymphoma also expressed all three cytolytic markers, two CD8 - ALCL expressed TIA1; other postthymic T - cell, T - lymphoblastic, and B - cell lymphomas were consistently negative.	CD8,9,12,Gene_or_gene_product	CD56,15,19,Gene_or_gene_product	CD8,99,102,Gene_or_gene_product	TIA1,120,124,Gene_or_gene_product	postthymic T - cell,132,151,Cancer	T - lymphoblastic,153,170,Cancer	B - cell lymphomas,176,194,Cancer	"[{""token"": ""CD8"", ""start_span"": 9, ""end_span"": 12, ""type"": ""Gene_or_gene_product""}, {""token"": ""CD56"", ""start_span"": 15, ""end_span"": 19, ""type"": ""Gene_or_gene_product""}, {""token"": ""CD8"", ""start_span"": 99, ""end_span"": 102, ""type"": ""Gene_or_gene_product""}, {""token"": ""TIA1"", ""start_span"": 120, ""end_span"": 124, ""type"": ""Gene_or_gene_product""}, {""token"": ""postthymic T - cell"", ""start_span"": 132, ""end_span"": 151, ""type"": ""Cancer""}, {""token"": ""T - lymphoblastic"", ""start_span"": 153, ""end_span"": 170, ""type"": ""Cancer""}, {""token"": ""B - cell lymphomas"", ""start_span"": 176, ""end_span"": 194, ""type"": ""Cancer""}]"	train
Simian virus 40 large T antigen ( SV40 Tag) was introduced into a normal human first trimester invasive EVT cell line, HTR8, established in our laboratory.	Simian virus 40,0,15,Organism	large T antigen,16,31,Gene_or_gene_product	SV40,34,38,Organism	Tag,39,42,Gene_or_gene_product	human,73,78,Organism	EVT cell line,104,117,Cell	HTR8,119,123,Cell	"[{""token"": ""Simian virus 40"", ""start_span"": 0, ""end_span"": 15, ""type"": ""Organism""}, {""token"": ""large T antigen"", ""start_span"": 16, ""end_span"": 31, ""type"": ""Gene_or_gene_product""}, {""token"": ""SV40"", ""start_span"": 34, ""end_span"": 38, ""type"": ""Organism""}, {""token"": ""Tag"", ""start_span"": 39, ""end_span"": 42, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 73, ""end_span"": 78, ""type"": ""Organism""}, {""token"": ""EVT cell line"", ""start_span"": 104, ""end_span"": 117, ""type"": ""Cell""}, {""token"": ""HTR8"", ""start_span"": 119, ""end_span"": 123, ""type"": ""Cell""}]"	train
RNA encoding glucokinase ( GK), the high - Km HK isozyme, was found only in cancer cells originating from liver and pancreas, which express GK under normal conditions.	glucokinase,13,24,Gene_or_gene_product	GK,27,29,Gene_or_gene_product	HK,46,48,Gene_or_gene_product	cancer cells,76,88,Cell	liver,106,111,Organ	pancreas,116,124,Organ	GK,140,142,Gene_or_gene_product	"[{""token"": ""glucokinase"", ""start_span"": 13, ""end_span"": 24, ""type"": ""Gene_or_gene_product""}, {""token"": ""GK"", ""start_span"": 27, ""end_span"": 29, ""type"": ""Gene_or_gene_product""}, {""token"": ""HK"", ""start_span"": 46, ""end_span"": 48, ""type"": ""Gene_or_gene_product""}, {""token"": ""cancer cells"", ""start_span"": 76, ""end_span"": 88, ""type"": ""Cell""}, {""token"": ""liver"", ""start_span"": 106, ""end_span"": 111, ""type"": ""Organ""}, {""token"": ""pancreas"", ""start_span"": 116, ""end_span"": 124, ""type"": ""Organ""}, {""token"": ""GK"", ""start_span"": 140, ""end_span"": 142, ""type"": ""Gene_or_gene_product""}]"	train
MATERIALS AND METHODS: U - 995 was designed to study human umbilical vein endothelial cell ( HUVEC) migration and proliferation in vitro and angiogenesis induced by TNF alpha in chicken chorioallantoic membrane ( CAM).	U - 995,23,30,Gene_or_gene_product	human umbilical vein endothelial cell,53,90,Cell	HUVEC,93,98,Cell	TNF alpha,165,174,Gene_or_gene_product	chicken,178,185,Organism	chorioallantoic membrane,186,210,Multi	CAM,213,216,Multi	"[{""token"": ""U - 995"", ""start_span"": 23, ""end_span"": 30, ""type"": ""Gene_or_gene_product""}, {""token"": ""human umbilical vein endothelial cell"", ""start_span"": 53, ""end_span"": 90, ""type"": ""Cell""}, {""token"": ""HUVEC"", ""start_span"": 93, ""end_span"": 98, ""type"": ""Cell""}, {""token"": ""TNF alpha"", ""start_span"": 165, ""end_span"": 174, ""type"": ""Gene_or_gene_product""}, {""token"": ""chicken"", ""start_span"": 178, ""end_span"": 185, ""type"": ""Organism""}, {""token"": ""chorioallantoic membrane"", ""start_span"": 186, ""end_span"": 210, ""type"": ""Multi""}, {""token"": ""CAM"", ""start_span"": 213, ""end_span"": 216, ""type"": ""Multi""}]"	train
UFT, an anticancer agent that is composed of tegafur ( FT) and uracil at a molar ratio of 1: 4, is widely used in clinical practice in Japan to treat cancer patients requiring a long - term chemotherapy, and it is associated with few side effects, if any.	UFT,0,3,Chemical	anticancer,8,18,Cancer	tegafur,45,52,Chemical	FT,55,57,Chemical	uracil,63,69,Chemical	cancer,150,156,Cancer	patients,157,165,Organism	"[{""token"": ""UFT"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Chemical""}, {""token"": ""anticancer"", ""start_span"": 8, ""end_span"": 18, ""type"": ""Cancer""}, {""token"": ""tegafur"", ""start_span"": 45, ""end_span"": 52, ""type"": ""Chemical""}, {""token"": ""FT"", ""start_span"": 55, ""end_span"": 57, ""type"": ""Chemical""}, {""token"": ""uracil"", ""start_span"": 63, ""end_span"": 69, ""type"": ""Chemical""}, {""token"": ""cancer"", ""start_span"": 150, ""end_span"": 156, ""type"": ""Cancer""}, {""token"": ""patients"", ""start_span"": 157, ""end_span"": 165, ""type"": ""Organism""}]"	valid
It was suggested that UFT has a stronger angiogenesis - inhibitory effect than did other fluorinated pyrimidines, partly due to its pharmacokinetic properties characterized by maintaining of higher and long - lasting blood levels of 5 - FU and partly due the inhibitory effects derived from gamma - hydroxybutyric acid and gamma - butyrolactone, UFT - specific metabolites.	UFT,22,25,Chemical	fluorinated pyrimidines,89,112,Chemical	blood,217,222,Organism_substance	5 - FU,233,239,Chemical	gamma - hydroxybutyric acid,291,318,Chemical	gamma - butyrolactone,323,344,Chemical	UFT,346,349,Chemical	"[{""token"": ""UFT"", ""start_span"": 22, ""end_span"": 25, ""type"": ""Chemical""}, {""token"": ""fluorinated pyrimidines"", ""start_span"": 89, ""end_span"": 112, ""type"": ""Chemical""}, {""token"": ""blood"", ""start_span"": 217, ""end_span"": 222, ""type"": ""Organism_substance""}, {""token"": ""5 - FU"", ""start_span"": 233, ""end_span"": 239, ""type"": ""Chemical""}, {""token"": ""gamma - hydroxybutyric acid"", ""start_span"": 291, ""end_span"": 318, ""type"": ""Chemical""}, {""token"": ""gamma - butyrolactone"", ""start_span"": 323, ""end_span"": 344, ""type"": ""Chemical""}, {""token"": ""UFT"", ""start_span"": 346, ""end_span"": 349, ""type"": ""Chemical""}]"	valid
Formation of apoptotic bodies was preceded by lowering of intracellular polyamines, particularly putrescine, and both dose - and time - dependent inhibitory and activation effect by ACA on ornithine decarboxylase ( ODC) and spermidine / spermine N ( 1) - acetyltransferase ( SSAT), respectively.	apoptotic bodies,13,29,Cellular_component	intracellular,58,71,Immaterial_anatomical_entity	putrescine,97,107,Chemical	ACA,182,185,Chemical	ornithine decarboxylase,189,212,Gene_or_gene_product	ODC,215,218,Gene_or_gene_product	SSAT,275,279,Gene_or_gene_product	"[{""token"": ""apoptotic bodies"", ""start_span"": 13, ""end_span"": 29, ""type"": ""Cellular_component""}, {""token"": ""intracellular"", ""start_span"": 58, ""end_span"": 71, ""type"": ""Immaterial_anatomical_entity""}, {""token"": ""putrescine"", ""start_span"": 97, ""end_span"": 107, ""type"": ""Chemical""}, {""token"": ""ACA"", ""start_span"": 182, ""end_span"": 185, ""type"": ""Chemical""}, {""token"": ""ornithine decarboxylase"", ""start_span"": 189, ""end_span"": 212, ""type"": ""Gene_or_gene_product""}, {""token"": ""ODC"", ""start_span"": 215, ""end_span"": 218, ""type"": ""Gene_or_gene_product""}, {""token"": ""SSAT"", ""start_span"": 275, ""end_span"": 279, ""type"": ""Gene_or_gene_product""}]"	valid
The effect of von Hippel - Lindau ( VHL) gene and hypoxia on VEGF - B and VEGF - C expression in the renal carcinoma cell line 786 - 0 transfected with wild - type and mutant VHL was determined by growing cells under 21% O2 - and 0. 1% O2.	von Hippel - Lindau,14,33,Gene_or_gene_product	VHL,36,39,Gene_or_gene_product	VEGF - B,61,69,Gene_or_gene_product	VEGF - C,74,82,Gene_or_gene_product	renal carcinoma cell line 786 - 0,101,134,Cell	VHL,175,178,Gene_or_gene_product	cells,205,210,Cell	"[{""token"": ""von Hippel - Lindau"", ""start_span"": 14, ""end_span"": 33, ""type"": ""Gene_or_gene_product""}, {""token"": ""VHL"", ""start_span"": 36, ""end_span"": 39, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF - B"", ""start_span"": 61, ""end_span"": 69, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF - C"", ""start_span"": 74, ""end_span"": 82, ""type"": ""Gene_or_gene_product""}, {""token"": ""renal carcinoma cell line 786 - 0"", ""start_span"": 101, ""end_span"": 134, ""type"": ""Cell""}, {""token"": ""VHL"", ""start_span"": 175, ""end_span"": 178, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 205, ""end_span"": 210, ""type"": ""Cell""}]"	valid
Vascular abnormalities in the retina were compared between patients with vascularized ( n = 34, group 1) and nonvascularized ( n = 7, group 2) PED on indocyanine green angiography and correlated with the size of the PED and the presence of serous retinal detachment.	Vascular,0,8,Multi	retina,30,36,Multi	patients,59,67,Organism	PED,143,146,Pathological_formation	indocyanine green,150,167,Chemical	PED,216,219,Pathological_formation	serous retinal,240,254,Multi	"[{""token"": ""Vascular"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Multi""}, {""token"": ""retina"", ""start_span"": 30, ""end_span"": 36, ""type"": ""Multi""}, {""token"": ""patients"", ""start_span"": 59, ""end_span"": 67, ""type"": ""Organism""}, {""token"": ""PED"", ""start_span"": 143, ""end_span"": 146, ""type"": ""Pathological_formation""}, {""token"": ""indocyanine green"", ""start_span"": 150, ""end_span"": 167, ""type"": ""Chemical""}, {""token"": ""PED"", ""start_span"": 216, ""end_span"": 219, ""type"": ""Pathological_formation""}, {""token"": ""serous retinal"", ""start_span"": 240, ""end_span"": 254, ""type"": ""Multi""}]"	valid
Blocking the activation of p44 / 42 mitogen - activated protein kinase ( MAPK) by the specific mitogen - induced extracellular kinase ( MEK) inhibitor, U0126, impaired modestly the ability of FVIIa to promote cell survival.	p44 / 42 mitogen - activated protein kinase,27,70,Gene_or_gene_product	MAPK,73,77,Gene_or_gene_product	mitogen - induced extracellular kinase,95,133,Gene_or_gene_product	MEK,136,139,Gene_or_gene_product	U0126,152,157,Chemical	FVIIa,192,197,Gene_or_gene_product	cell,209,213,Cell	"[{""token"": ""p44 / 42 mitogen - activated protein kinase"", ""start_span"": 27, ""end_span"": 70, ""type"": ""Gene_or_gene_product""}, {""token"": ""MAPK"", ""start_span"": 73, ""end_span"": 77, ""type"": ""Gene_or_gene_product""}, {""token"": ""mitogen - induced extracellular kinase"", ""start_span"": 95, ""end_span"": 133, ""type"": ""Gene_or_gene_product""}, {""token"": ""MEK"", ""start_span"": 136, ""end_span"": 139, ""type"": ""Gene_or_gene_product""}, {""token"": ""U0126"", ""start_span"": 152, ""end_span"": 157, ""type"": ""Chemical""}, {""token"": ""FVIIa"", ""start_span"": 192, ""end_span"": 197, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 209, ""end_span"": 213, ""type"": ""Cell""}]"	valid
CONCLUSION: Not only tumor cells but also TAMs secrete the VEGF - C in OSCC, and TAMs may play a major role in peritumoral lymphatic neoangiogenesis and lymphatic metastasis.	tumor cells,21,32,Cell	TAMs,42,46,Cell	VEGF - C,59,67,Gene_or_gene_product	OSCC,71,75,Cancer	TAMs,81,85,Cell	peritumoral lymphatic,111,132,Multi	lymphatic,153,162,Organ	"[{""token"": ""tumor cells"", ""start_span"": 21, ""end_span"": 32, ""type"": ""Cell""}, {""token"": ""TAMs"", ""start_span"": 42, ""end_span"": 46, ""type"": ""Cell""}, {""token"": ""VEGF - C"", ""start_span"": 59, ""end_span"": 67, ""type"": ""Gene_or_gene_product""}, {""token"": ""OSCC"", ""start_span"": 71, ""end_span"": 75, ""type"": ""Cancer""}, {""token"": ""TAMs"", ""start_span"": 81, ""end_span"": 85, ""type"": ""Cell""}, {""token"": ""peritumoral lymphatic"", ""start_span"": 111, ""end_span"": 132, ""type"": ""Multi""}, {""token"": ""lymphatic"", ""start_span"": 153, ""end_span"": 162, ""type"": ""Organ""}]"	valid
We used a series of cell clones from a human teratocarcinoma cell line, PA - 1, to study the effect of transformation by an activated N - ras oncogene on the expression of genes involved in retinoic acid ( RA) - induced differentiation and growth regulation.	cell clones,20,31,Cell	human,39,44,Organism	teratocarcinoma cell line,45,70,Cell	PA - 1,72,78,Cell	N - ras,134,141,Gene_or_gene_product	retinoic acid,190,203,Chemical	RA,206,208,Chemical	"[{""token"": ""cell clones"", ""start_span"": 20, ""end_span"": 31, ""type"": ""Cell""}, {""token"": ""human"", ""start_span"": 39, ""end_span"": 44, ""type"": ""Organism""}, {""token"": ""teratocarcinoma cell line"", ""start_span"": 45, ""end_span"": 70, ""type"": ""Cell""}, {""token"": ""PA - 1"", ""start_span"": 72, ""end_span"": 78, ""type"": ""Cell""}, {""token"": ""N - ras"", ""start_span"": 134, ""end_span"": 141, ""type"": ""Gene_or_gene_product""}, {""token"": ""retinoic acid"", ""start_span"": 190, ""end_span"": 203, ""type"": ""Chemical""}, {""token"": ""RA"", ""start_span"": 206, ""end_span"": 208, ""type"": ""Chemical""}]"	valid
These observations provide evidence that enhanced proliferation in N - ras - transformed cells compromises teratocarcinoma cell differentiation by a mechanism that transiently suppresses homeobox gene induction and implies a central role for homeobox genes in RA - induced cell differentiation.	N - ras,67,74,Gene_or_gene_product	cells,89,94,Cell	teratocarcinoma cell,107,127,Cell	homeobox,187,195,Gene_or_gene_product	homeobox,242,250,Gene_or_gene_product	RA,260,262,Chemical	cell,273,277,Cell	"[{""token"": ""N - ras"", ""start_span"": 67, ""end_span"": 74, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 89, ""end_span"": 94, ""type"": ""Cell""}, {""token"": ""teratocarcinoma cell"", ""start_span"": 107, ""end_span"": 127, ""type"": ""Cell""}, {""token"": ""homeobox"", ""start_span"": 187, ""end_span"": 195, ""type"": ""Gene_or_gene_product""}, {""token"": ""homeobox"", ""start_span"": 242, ""end_span"": 250, ""type"": ""Gene_or_gene_product""}, {""token"": ""RA"", ""start_span"": 260, ""end_span"": 262, ""type"": ""Chemical""}, {""token"": ""cell"", ""start_span"": 273, ""end_span"": 277, ""type"": ""Cell""}]"	valid
Furthermore, Ang II stimulated sFlt - 1 production in a dose - and time - dependent manner from human villous explants and cultured trophoblasts but not from endothelial cells, suggesting that trophoblasts are the primary source of sFlt - 1 during pregnancy.	Ang II,13,19,Gene_or_gene_product	sFlt - 1,31,39,Gene_or_gene_product	human,96,101,Organism	trophoblasts,132,144,Cell	endothelial cells,158,175,Cell	trophoblasts,193,205,Cell	sFlt - 1,232,240,Gene_or_gene_product	"[{""token"": ""Ang II"", ""start_span"": 13, ""end_span"": 19, ""type"": ""Gene_or_gene_product""}, {""token"": ""sFlt - 1"", ""start_span"": 31, ""end_span"": 39, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 96, ""end_span"": 101, ""type"": ""Organism""}, {""token"": ""trophoblasts"", ""start_span"": 132, ""end_span"": 144, ""type"": ""Cell""}, {""token"": ""endothelial cells"", ""start_span"": 158, ""end_span"": 175, ""type"": ""Cell""}, {""token"": ""trophoblasts"", ""start_span"": 193, ""end_span"": 205, ""type"": ""Cell""}, {""token"": ""sFlt - 1"", ""start_span"": 232, ""end_span"": 240, ""type"": ""Gene_or_gene_product""}]"	valid
These findings reveal a previously unrecognized regulatory role for Ang II on sFlt - 1 expression in murine and human pregnancy and suggest that elevated sFlt - 1 levels in preeclampsia may be caused by a dysregulation of the local renin / angiotensin system.	Ang II,68,74,Gene_or_gene_product	sFlt - 1,78,86,Gene_or_gene_product	murine,101,107,Organism	human,112,117,Organism	sFlt - 1,154,162,Gene_or_gene_product	renin,232,237,Gene_or_gene_product	angiotensin,240,251,Gene_or_gene_product	"[{""token"": ""Ang II"", ""start_span"": 68, ""end_span"": 74, ""type"": ""Gene_or_gene_product""}, {""token"": ""sFlt - 1"", ""start_span"": 78, ""end_span"": 86, ""type"": ""Gene_or_gene_product""}, {""token"": ""murine"", ""start_span"": 101, ""end_span"": 107, ""type"": ""Organism""}, {""token"": ""human"", ""start_span"": 112, ""end_span"": 117, ""type"": ""Organism""}, {""token"": ""sFlt - 1"", ""start_span"": 154, ""end_span"": 162, ""type"": ""Gene_or_gene_product""}, {""token"": ""renin"", ""start_span"": 232, ""end_span"": 237, ""type"": ""Gene_or_gene_product""}, {""token"": ""angiotensin"", ""start_span"": 240, ""end_span"": 251, ""type"": ""Gene_or_gene_product""}]"	valid
Ectopic decorin expression up - regulates VEGF expression in mouse cerebral endothelial cells via activation of the transcription factors Sp1, HIF1alpha, and Stat3.	decorin,8,15,Gene_or_gene_product	VEGF,42,46,Gene_or_gene_product	mouse,61,66,Organism	cerebral endothelial cells,67,93,Cell	Sp1,138,141,Gene_or_gene_product	HIF1alpha,143,152,Gene_or_gene_product	Stat3,158,163,Gene_or_gene_product	"[{""token"": ""decorin"", ""start_span"": 8, ""end_span"": 15, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 42, ""end_span"": 46, ""type"": ""Gene_or_gene_product""}, {""token"": ""mouse"", ""start_span"": 61, ""end_span"": 66, ""type"": ""Organism""}, {""token"": ""cerebral endothelial cells"", ""start_span"": 67, ""end_span"": 93, ""type"": ""Cell""}, {""token"": ""Sp1"", ""start_span"": 138, ""end_span"": 141, ""type"": ""Gene_or_gene_product""}, {""token"": ""HIF1alpha"", ""start_span"": 143, ""end_span"": 152, ""type"": ""Gene_or_gene_product""}, {""token"": ""Stat3"", ""start_span"": 158, ""end_span"": 163, ""type"": ""Gene_or_gene_product""}]"	valid
"Correlation between D2 - 40 + LVI and menopausal - status, HER2 - status and histological type was not significant, while there was a significant correlation of D2 - 40 and so called "" triple negative "" tumors ( ER / PR and HER2neu - negative)."	D2 - 40,20,27,Gene_or_gene_product	HER2,59,63,Gene_or_gene_product	D2 - 40,161,168,Gene_or_gene_product	tumors,203,209,Cancer	ER,212,214,Gene_or_gene_product	PR,217,219,Gene_or_gene_product	HER2neu,224,231,Gene_or_gene_product	"[{""token"": ""D2 - 40"", ""start_span"": 20, ""end_span"": 27, ""type"": ""Gene_or_gene_product""}, {""token"": ""HER2"", ""start_span"": 59, ""end_span"": 63, ""type"": ""Gene_or_gene_product""}, {""token"": ""D2 - 40"", ""start_span"": 161, ""end_span"": 168, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumors"", ""start_span"": 203, ""end_span"": 209, ""type"": ""Cancer""}, {""token"": ""ER"", ""start_span"": 212, ""end_span"": 214, ""type"": ""Gene_or_gene_product""}, {""token"": ""PR"", ""start_span"": 217, ""end_span"": 219, ""type"": ""Gene_or_gene_product""}, {""token"": ""HER2neu"", ""start_span"": 224, ""end_span"": 231, ""type"": ""Gene_or_gene_product""}]"	valid
In human endothelial cells, cediranib inhibited VEGF - E - induced phosphorylation of VEGFR - 2 and VEGF - C156S - induced phosphorylation of VEGFR - 3 at concentrations of less than / = 1nmol / L and inhibited activation of downstream signaling molecules.	human,3,8,Organism	endothelial cells,9,26,Cell	cediranib,28,37,Chemical	VEGF - E,48,56,Gene_or_gene_product	VEGFR - 2,86,95,Gene_or_gene_product	VEGF - C156S,100,112,Gene_or_gene_product	VEGFR - 3,142,151,Gene_or_gene_product	"[{""token"": ""human"", ""start_span"": 3, ""end_span"": 8, ""type"": ""Organism""}, {""token"": ""endothelial cells"", ""start_span"": 9, ""end_span"": 26, ""type"": ""Cell""}, {""token"": ""cediranib"", ""start_span"": 28, ""end_span"": 37, ""type"": ""Chemical""}, {""token"": ""VEGF - E"", ""start_span"": 48, ""end_span"": 56, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGFR - 2"", ""start_span"": 86, ""end_span"": 95, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF - C156S"", ""start_span"": 100, ""end_span"": 112, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGFR - 3"", ""start_span"": 142, ""end_span"": 151, ""type"": ""Gene_or_gene_product""}]"	valid
Consistent with the decrease in lymph node metastasis, tumor lymphangiogenesis and expression of vascular endothelial growth factor C ( VEGF - C) was significantly decreased in artemisinin - treated mice, as compared to control mice.	lymph node,32,42,Multi	tumor,55,60,Cancer	vascular endothelial growth factor C,97,133,Gene_or_gene_product	VEGF - C,136,144,Gene_or_gene_product	artemisinin,177,188,Chemical	mice,199,203,Organism	mice,228,232,Organism	"[{""token"": ""lymph node"", ""start_span"": 32, ""end_span"": 42, ""type"": ""Multi""}, {""token"": ""tumor"", ""start_span"": 55, ""end_span"": 60, ""type"": ""Cancer""}, {""token"": ""vascular endothelial growth factor C"", ""start_span"": 97, ""end_span"": 133, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF - C"", ""start_span"": 136, ""end_span"": 144, ""type"": ""Gene_or_gene_product""}, {""token"": ""artemisinin"", ""start_span"": 177, ""end_span"": 188, ""type"": ""Chemical""}, {""token"": ""mice"", ""start_span"": 199, ""end_span"": 203, ""type"": ""Organism""}, {""token"": ""mice"", ""start_span"": 228, ""end_span"": 232, ""type"": ""Organism""}]"	valid
Antibodies developed to human endosialin were used to investigate endosialin expression and function in human prenatal brain pericytes and pericytes residing in tumors.	human,24,29,Organism	endosialin,30,40,Gene_or_gene_product	endosialin,66,76,Gene_or_gene_product	human,104,109,Organism	prenatal brain pericytes,110,134,Cell	pericytes,139,148,Cell	tumors,161,167,Cancer	"[{""token"": ""human"", ""start_span"": 24, ""end_span"": 29, ""type"": ""Organism""}, {""token"": ""endosialin"", ""start_span"": 30, ""end_span"": 40, ""type"": ""Gene_or_gene_product""}, {""token"": ""endosialin"", ""start_span"": 66, ""end_span"": 76, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 104, ""end_span"": 109, ""type"": ""Organism""}, {""token"": ""prenatal brain pericytes"", ""start_span"": 110, ""end_span"": 134, ""type"": ""Cell""}, {""token"": ""pericytes"", ""start_span"": 139, ""end_span"": 148, ""type"": ""Cell""}, {""token"": ""tumors"", ""start_span"": 161, ""end_span"": 167, ""type"": ""Cancer""}]"	valid
The Interferon - inducible gene IFI16, a member of the HIN200 family, is activated by oxidative stress and cell density, in addition to Interferons, and it is implicated in the regulation of endothelial cell proliferation and vessel formation in vitro.	Interferon,4,14,Gene_or_gene_product	IFI16,32,37,Gene_or_gene_product	HIN200,55,61,Gene_or_gene_product	cell,107,111,Cell	Interferons,136,147,Gene_or_gene_product	endothelial cell,191,207,Cell	vessel,226,232,Multi	"[{""token"": ""Interferon"", ""start_span"": 4, ""end_span"": 14, ""type"": ""Gene_or_gene_product""}, {""token"": ""IFI16"", ""start_span"": 32, ""end_span"": 37, ""type"": ""Gene_or_gene_product""}, {""token"": ""HIN200"", ""start_span"": 55, ""end_span"": 61, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 107, ""end_span"": 111, ""type"": ""Cell""}, {""token"": ""Interferons"", ""start_span"": 136, ""end_span"": 147, ""type"": ""Gene_or_gene_product""}, {""token"": ""endothelial cell"", ""start_span"": 191, ""end_span"": 207, ""type"": ""Cell""}, {""token"": ""vessel"", ""start_span"": 226, ""end_span"": 232, ""type"": ""Multi""}]"	valid
To examine whether IFI16 induction might be extended to other proinflammatory cytokines such as tumor necrosis factor ( TNF) - alpha, we used the strategy of the RNA interference to knock down IFI16 expression, and analyze the capability of TNF - alpha to stimulate intercellular adhesion molecule - 1 ( ICAM - 1 or CD54) expression in the absence of functional IFI16.	IFI16,19,24,Gene_or_gene_product	IFI16,193,198,Gene_or_gene_product	TNF - alpha,241,252,Gene_or_gene_product	intercellular adhesion molecule - 1,266,301,Gene_or_gene_product	ICAM - 1,304,312,Gene_or_gene_product	CD54,316,320,Gene_or_gene_product	IFI16,362,367,Gene_or_gene_product	"[{""token"": ""IFI16"", ""start_span"": 19, ""end_span"": 24, ""type"": ""Gene_or_gene_product""}, {""token"": ""IFI16"", ""start_span"": 193, ""end_span"": 198, ""type"": ""Gene_or_gene_product""}, {""token"": ""TNF - alpha"", ""start_span"": 241, ""end_span"": 252, ""type"": ""Gene_or_gene_product""}, {""token"": ""intercellular adhesion molecule - 1"", ""start_span"": 266, ""end_span"": 301, ""type"": ""Gene_or_gene_product""}, {""token"": ""ICAM - 1"", ""start_span"": 304, ""end_span"": 312, ""type"": ""Gene_or_gene_product""}, {""token"": ""CD54"", ""start_span"": 316, ""end_span"": 320, ""type"": ""Gene_or_gene_product""}, {""token"": ""IFI16"", ""start_span"": 362, ""end_span"": 367, ""type"": ""Gene_or_gene_product""}]"	valid
These results suggest that CSC contribute to tumor angiogenesis by promoting both local endothelial cell activity and systemic angiogenic processes involving bone marrow - derived EPC in a vascular endothelial growth factor - dependent and stromal - derived factor 1 - dependent manner.	CSC,27,30,Cell	tumor,45,50,Cancer	endothelial cell,88,104,Cell	bone marrow,158,169,Multi	EPC,180,183,Cell	vascular endothelial growth factor,189,223,Gene_or_gene_product	stromal - derived factor 1,240,266,Gene_or_gene_product	"[{""token"": ""CSC"", ""start_span"": 27, ""end_span"": 30, ""type"": ""Cell""}, {""token"": ""tumor"", ""start_span"": 45, ""end_span"": 50, ""type"": ""Cancer""}, {""token"": ""endothelial cell"", ""start_span"": 88, ""end_span"": 104, ""type"": ""Cell""}, {""token"": ""bone marrow"", ""start_span"": 158, ""end_span"": 169, ""type"": ""Multi""}, {""token"": ""EPC"", ""start_span"": 180, ""end_span"": 183, ""type"": ""Cell""}, {""token"": ""vascular endothelial growth factor"", ""start_span"": 189, ""end_span"": 223, ""type"": ""Gene_or_gene_product""}, {""token"": ""stromal - derived factor 1"", ""start_span"": 240, ""end_span"": 266, ""type"": ""Gene_or_gene_product""}]"	valid
METHODS: We assessed the role of CDC4 / FBXW7 in gastric cancer, through loss of heterozygosity ( LOH) and multiplex ligation - dependent probe amplification ( MLPA) on 47 flow - sorted gastric carcinomas including early - onset gastric cancers ( EOGC) and xenografted conventional gastric carcinomas.	CDC4,33,37,Gene_or_gene_product	FBXW7,40,45,Gene_or_gene_product	gastric cancer,49,63,Cancer	gastric carcinomas,186,204,Cancer	early - onset gastric cancers,215,244,Cancer	EOGC,247,251,Cancer	gastric carcinomas,282,300,Cancer	"[{""token"": ""CDC4"", ""start_span"": 33, ""end_span"": 37, ""type"": ""Gene_or_gene_product""}, {""token"": ""FBXW7"", ""start_span"": 40, ""end_span"": 45, ""type"": ""Gene_or_gene_product""}, {""token"": ""gastric cancer"", ""start_span"": 49, ""end_span"": 63, ""type"": ""Cancer""}, {""token"": ""gastric carcinomas"", ""start_span"": 186, ""end_span"": 204, ""type"": ""Cancer""}, {""token"": ""early - onset gastric cancers"", ""start_span"": 215, ""end_span"": 244, ""type"": ""Cancer""}, {""token"": ""EOGC"", ""start_span"": 247, ""end_span"": 251, ""type"": ""Cancer""}, {""token"": ""gastric carcinomas"", ""start_span"": 282, ""end_span"": 300, ""type"": ""Cancer""}]"	valid
CONCLUSION: Loss of CDC4 / FBXW7 appears to play a role in both EOGC and conventional gastric carcinogenesis, and c - myc overexpression is likely to be an important oncogenic consequence of CDC4 / FBXW7 loss.	CDC4,20,24,Gene_or_gene_product	FBXW7,27,32,Gene_or_gene_product	EOGC,64,68,Cancer	gastric,86,93,Organ	c - myc,114,121,Gene_or_gene_product	CDC4,191,195,Gene_or_gene_product	FBXW7,198,203,Gene_or_gene_product	"[{""token"": ""CDC4"", ""start_span"": 20, ""end_span"": 24, ""type"": ""Gene_or_gene_product""}, {""token"": ""FBXW7"", ""start_span"": 27, ""end_span"": 32, ""type"": ""Gene_or_gene_product""}, {""token"": ""EOGC"", ""start_span"": 64, ""end_span"": 68, ""type"": ""Cancer""}, {""token"": ""gastric"", ""start_span"": 86, ""end_span"": 93, ""type"": ""Organ""}, {""token"": ""c - myc"", ""start_span"": 114, ""end_span"": 121, ""type"": ""Gene_or_gene_product""}, {""token"": ""CDC4"", ""start_span"": 191, ""end_span"": 195, ""type"": ""Gene_or_gene_product""}, {""token"": ""FBXW7"", ""start_span"": 198, ""end_span"": 203, ""type"": ""Gene_or_gene_product""}]"	valid
Our initial investigations show that the naturally occurring organoselenium compound selenomethionine ( SM) and the synthetic 1, 4 - phenylenebis ( methylene) selenocyanate ( p - XSC) can inhibit human prostate cancer cell viability; however, in contrast to SM, p - XSC is active at physiologically relevant doses.	selenomethionine,85,101,Chemical	SM,104,106,Chemical	p - XSC,175,182,Chemical	human,196,201,Organism	prostate cancer cell,202,222,Cell	SM,258,260,Chemical	p - XSC,262,269,Chemical	"[{""token"": ""selenomethionine"", ""start_span"": 85, ""end_span"": 101, ""type"": ""Chemical""}, {""token"": ""SM"", ""start_span"": 104, ""end_span"": 106, ""type"": ""Chemical""}, {""token"": ""p - XSC"", ""start_span"": 175, ""end_span"": 182, ""type"": ""Chemical""}, {""token"": ""human"", ""start_span"": 196, ""end_span"": 201, ""type"": ""Organism""}, {""token"": ""prostate cancer cell"", ""start_span"": 202, ""end_span"": 222, ""type"": ""Cell""}, {""token"": ""SM"", ""start_span"": 258, ""end_span"": 260, ""type"": ""Chemical""}, {""token"": ""p - XSC"", ""start_span"": 262, ""end_span"": 269, ""type"": ""Chemical""}]"	valid
Inhibition of Akt, however, does not fully attenuate p - XSC - mediated downregulation of AR activity, suggesting that inhibition of AR signaling by p - XSC does not occur solely through alterations in the phosphatidylinositol 3 - kinase / Akt survival pathway.	Akt,14,17,Gene_or_gene_product	p - XSC,53,60,Chemical	AR,90,92,Gene_or_gene_product	AR,133,135,Gene_or_gene_product	p - XSC,149,156,Chemical	phosphatidylinositol 3 - kinase,206,237,Gene_or_gene_product	Akt,240,243,Gene_or_gene_product	"[{""token"": ""Akt"", ""start_span"": 14, ""end_span"": 17, ""type"": ""Gene_or_gene_product""}, {""token"": ""p - XSC"", ""start_span"": 53, ""end_span"": 60, ""type"": ""Chemical""}, {""token"": ""AR"", ""start_span"": 90, ""end_span"": 92, ""type"": ""Gene_or_gene_product""}, {""token"": ""AR"", ""start_span"": 133, ""end_span"": 135, ""type"": ""Gene_or_gene_product""}, {""token"": ""p - XSC"", ""start_span"": 149, ""end_span"": 156, ""type"": ""Chemical""}, {""token"": ""phosphatidylinositol 3 - kinase"", ""start_span"": 206, ""end_span"": 237, ""type"": ""Gene_or_gene_product""}, {""token"": ""Akt"", ""start_span"": 240, ""end_span"": 243, ""type"": ""Gene_or_gene_product""}]"	valid
By interacting with Sp1, HMGA2 interferes with the recruitment of HDAC2 to the hTERT proximal promoter, enhancing localized histone H3 - K9 acetylation and thereby stimulating hTERT expression and telomerase activity.	Sp1,20,23,Gene_or_gene_product	HMGA2,25,30,Gene_or_gene_product	HDAC2,66,71,Gene_or_gene_product	hTERT,79,84,Gene_or_gene_product	histone H3,124,134,Gene_or_gene_product	hTERT,176,181,Gene_or_gene_product	telomerase,197,207,Gene_or_gene_product	"[{""token"": ""Sp1"", ""start_span"": 20, ""end_span"": 23, ""type"": ""Gene_or_gene_product""}, {""token"": ""HMGA2"", ""start_span"": 25, ""end_span"": 30, ""type"": ""Gene_or_gene_product""}, {""token"": ""HDAC2"", ""start_span"": 66, ""end_span"": 71, ""type"": ""Gene_or_gene_product""}, {""token"": ""hTERT"", ""start_span"": 79, ""end_span"": 84, ""type"": ""Gene_or_gene_product""}, {""token"": ""histone H3"", ""start_span"": 124, ""end_span"": 134, ""type"": ""Gene_or_gene_product""}, {""token"": ""hTERT"", ""start_span"": 176, ""end_span"": 181, ""type"": ""Gene_or_gene_product""}, {""token"": ""telomerase"", ""start_span"": 197, ""end_span"": 207, ""type"": ""Gene_or_gene_product""}]"	valid
This study investigated the expression of TS and DPD in cervical lymph node metastases and its relationship with primary OSCC, as well as the interaction between these enzymes and Kangai 1 ( KAI1 / CD82) which is a metastasis suppressor protein.	TS,42,44,Gene_or_gene_product	DPD,49,52,Gene_or_gene_product	cervical lymph node,56,75,Multi	primary OSCC,113,125,Cancer	Kangai 1,180,188,Gene_or_gene_product	KAI1,191,195,Gene_or_gene_product	CD82,198,202,Gene_or_gene_product	"[{""token"": ""TS"", ""start_span"": 42, ""end_span"": 44, ""type"": ""Gene_or_gene_product""}, {""token"": ""DPD"", ""start_span"": 49, ""end_span"": 52, ""type"": ""Gene_or_gene_product""}, {""token"": ""cervical lymph node"", ""start_span"": 56, ""end_span"": 75, ""type"": ""Multi""}, {""token"": ""primary OSCC"", ""start_span"": 113, ""end_span"": 125, ""type"": ""Cancer""}, {""token"": ""Kangai 1"", ""start_span"": 180, ""end_span"": 188, ""type"": ""Gene_or_gene_product""}, {""token"": ""KAI1"", ""start_span"": 191, ""end_span"": 195, ""type"": ""Gene_or_gene_product""}, {""token"": ""CD82"", ""start_span"": 198, ""end_span"": 202, ""type"": ""Gene_or_gene_product""}]"	valid
Therefore, our results indicate that emodin inhibits HER - 2 / neu tyrosine kinase activity and preferentially suppresses growth and induces differentiation of HER - 2 / neu - overexpressing cancer cells.	emodin,37,43,Chemical	HER - 2,53,60,Gene_or_gene_product	neu,63,66,Gene_or_gene_product	tyrosine,67,75,Amino_acid	HER - 2,160,167,Gene_or_gene_product	neu,170,173,Gene_or_gene_product	cancer cells,191,203,Cell	"[{""token"": ""emodin"", ""start_span"": 37, ""end_span"": 43, ""type"": ""Chemical""}, {""token"": ""HER - 2"", ""start_span"": 53, ""end_span"": 60, ""type"": ""Gene_or_gene_product""}, {""token"": ""neu"", ""start_span"": 63, ""end_span"": 66, ""type"": ""Gene_or_gene_product""}, {""token"": ""tyrosine"", ""start_span"": 67, ""end_span"": 75, ""type"": ""Amino_acid""}, {""token"": ""HER - 2"", ""start_span"": 160, ""end_span"": 167, ""type"": ""Gene_or_gene_product""}, {""token"": ""neu"", ""start_span"": 170, ""end_span"": 173, ""type"": ""Gene_or_gene_product""}, {""token"": ""cancer cells"", ""start_span"": 191, ""end_span"": 203, ""type"": ""Cell""}]"	valid
This study was designed to evaluate the potential implication of stromelysin - 3 ( ST3), a newly identified member of the matrix - degrading metalloproteinase family, and of BM - 40 / SPARC, a glycoprotein associated with the extracellular matrix, during the progression of human colorectal cancers.	stromelysin - 3,65,80,Gene_or_gene_product	ST3,83,86,Gene_or_gene_product	BM - 40,174,181,Gene_or_gene_product	SPARC,184,189,Gene_or_gene_product	extracellular matrix,226,246,Cellular_component	human,274,279,Organism	colorectal cancers,280,298,Cancer	"[{""token"": ""stromelysin - 3"", ""start_span"": 65, ""end_span"": 80, ""type"": ""Gene_or_gene_product""}, {""token"": ""ST3"", ""start_span"": 83, ""end_span"": 86, ""type"": ""Gene_or_gene_product""}, {""token"": ""BM - 40"", ""start_span"": 174, ""end_span"": 181, ""type"": ""Gene_or_gene_product""}, {""token"": ""SPARC"", ""start_span"": 184, ""end_span"": 189, ""type"": ""Gene_or_gene_product""}, {""token"": ""extracellular matrix"", ""start_span"": 226, ""end_span"": 246, ""type"": ""Cellular_component""}, {""token"": ""human"", ""start_span"": 274, ""end_span"": 279, ""type"": ""Organism""}, {""token"": ""colorectal cancers"", ""start_span"": 280, ""end_span"": 298, ""type"": ""Cancer""}]"	valid
We analyzed the relative abundance of ST3 and BM - 40 / SPARC transcripts by Northern blot, and their distribution by in situ hybridization, in normal mucosa, benign adenomas, and primary colorectal adenocarcinomas and their liver metastases.	ST3,38,41,Gene_or_gene_product	BM - 40,46,53,Gene_or_gene_product	SPARC,56,61,Gene_or_gene_product	mucosa,151,157,Multi	benign adenomas,159,174,Pathological_formation	colorectal adenocarcinomas,188,214,Cancer	liver,225,230,Organ	"[{""token"": ""ST3"", ""start_span"": 38, ""end_span"": 41, ""type"": ""Gene_or_gene_product""}, {""token"": ""BM - 40"", ""start_span"": 46, ""end_span"": 53, ""type"": ""Gene_or_gene_product""}, {""token"": ""SPARC"", ""start_span"": 56, ""end_span"": 61, ""type"": ""Gene_or_gene_product""}, {""token"": ""mucosa"", ""start_span"": 151, ""end_span"": 157, ""type"": ""Multi""}, {""token"": ""benign adenomas"", ""start_span"": 159, ""end_span"": 174, ""type"": ""Pathological_formation""}, {""token"": ""colorectal adenocarcinomas"", ""start_span"": 188, ""end_span"": 214, ""type"": ""Cancer""}, {""token"": ""liver"", ""start_span"": 225, ""end_span"": 230, ""type"": ""Organ""}]"	valid
No [ 13C] glucose utilization was detected in H4 spheroids, but uptake of alanine and accumulation of labeled lactate, glutamate and glutamine indicated oxidation via the tricarboxylic acid ( TCA) cycle.	H4 spheroids,46,58,Cell	alanine,74,81,Amino_acid	lactate,110,117,Chemical	glutamate,119,128,Amino_acid	glutamine,133,142,Amino_acid	tricarboxylic acid,171,189,Chemical	TCA,192,195,Chemical	"[{""token"": ""H4 spheroids"", ""start_span"": 46, ""end_span"": 58, ""type"": ""Cell""}, {""token"": ""alanine"", ""start_span"": 74, ""end_span"": 81, ""type"": ""Amino_acid""}, {""token"": ""lactate"", ""start_span"": 110, ""end_span"": 117, ""type"": ""Chemical""}, {""token"": ""glutamate"", ""start_span"": 119, ""end_span"": 128, ""type"": ""Amino_acid""}, {""token"": ""glutamine"", ""start_span"": 133, ""end_span"": 142, ""type"": ""Amino_acid""}, {""token"": ""tricarboxylic acid"", ""start_span"": 171, ""end_span"": 189, ""type"": ""Chemical""}, {""token"": ""TCA"", ""start_span"": 192, ""end_span"": 195, ""type"": ""Chemical""}]"	valid
Human cytomegalovirus ( HCMV), like other DNA tumor viruses, induces morphological transformation of cells in vitro and stimulates host cell macromolecular synthesis in infected cells.	Human cytomegalovirus,0,21,Organism	HCMV,24,28,Organism	DNA,42,45,Cellular_component	tumor,46,51,Cancer	cells,101,106,Cell	cell,136,140,Cell	cells,178,183,Cell	"[{""token"": ""Human cytomegalovirus"", ""start_span"": 0, ""end_span"": 21, ""type"": ""Organism""}, {""token"": ""HCMV"", ""start_span"": 24, ""end_span"": 28, ""type"": ""Organism""}, {""token"": ""DNA"", ""start_span"": 42, ""end_span"": 45, ""type"": ""Cellular_component""}, {""token"": ""tumor"", ""start_span"": 46, ""end_span"": 51, ""type"": ""Cancer""}, {""token"": ""cells"", ""start_span"": 101, ""end_span"": 106, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 136, ""end_span"": 140, ""type"": ""Cell""}, {""token"": ""cells"", ""start_span"": 178, ""end_span"": 183, ""type"": ""Cell""}]"	valid
Vascular and neoplastic tissue from 14 colonic adenocarcinomas, 13 carcinoids, 6 renal - cell carcinomas and 7 malignant lymphomas were analyzed for somatostatin receptors by use of quantitative receptor autoradiography.	Vascular,0,8,Tissue	neoplastic tissue,13,30,Tissue	colonic adenocarcinomas,39,62,Cancer	carcinoids,67,77,Cancer	renal - cell carcinomas,81,104,Cancer	malignant lymphomas,111,130,Cancer	somatostatin receptors,149,171,Gene_or_gene_product	"[{""token"": ""Vascular"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Tissue""}, {""token"": ""neoplastic tissue"", ""start_span"": 13, ""end_span"": 30, ""type"": ""Tissue""}, {""token"": ""colonic adenocarcinomas"", ""start_span"": 39, ""end_span"": 62, ""type"": ""Cancer""}, {""token"": ""carcinoids"", ""start_span"": 67, ""end_span"": 77, ""type"": ""Cancer""}, {""token"": ""renal - cell carcinomas"", ""start_span"": 81, ""end_span"": 104, ""type"": ""Cancer""}, {""token"": ""malignant lymphomas"", ""start_span"": 111, ""end_span"": 130, ""type"": ""Cancer""}, {""token"": ""somatostatin receptors"", ""start_span"": 149, ""end_span"": 171, ""type"": ""Gene_or_gene_product""}]"	valid
The results suggest that somatostatin and somatostatin receptors may play a regulatory role for hemodynamic tumor - host interactions, possibly involving tumor stroma generation, tumor environment, angiogenesis and, particularly, vascular drainage of poorly differentiated neoplasms.	somatostatin,25,37,Gene_or_gene_product	somatostatin receptors,42,64,Gene_or_gene_product	tumor,108,113,Cancer	tumor stroma,154,166,Tissue	tumor,179,184,Cancer	vascular,230,238,Multi	neoplasms,273,282,Cancer	"[{""token"": ""somatostatin"", ""start_span"": 25, ""end_span"": 37, ""type"": ""Gene_or_gene_product""}, {""token"": ""somatostatin receptors"", ""start_span"": 42, ""end_span"": 64, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 108, ""end_span"": 113, ""type"": ""Cancer""}, {""token"": ""tumor stroma"", ""start_span"": 154, ""end_span"": 166, ""type"": ""Tissue""}, {""token"": ""tumor"", ""start_span"": 179, ""end_span"": 184, ""type"": ""Cancer""}, {""token"": ""vascular"", ""start_span"": 230, ""end_span"": 238, ""type"": ""Multi""}, {""token"": ""neoplasms"", ""start_span"": 273, ""end_span"": 282, ""type"": ""Cancer""}]"	valid
In order to better understand the coordinated regulation of cell - cell and cell - matrix interactions during malignant transformation, we have studied the expression of syndecan - 1 in malignant mammary tumor cells genetically manipulated for E - cadherin expression.	cell,60,64,Cell	cell,67,71,Cell	cell,76,80,Cell	matrix,83,89,Cellular_component	syndecan - 1,170,182,Gene_or_gene_product	malignant mammary tumor cells,186,215,Cell	E - cadherin,244,256,Gene_or_gene_product	"[{""token"": ""cell"", ""start_span"": 60, ""end_span"": 64, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 67, ""end_span"": 71, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 76, ""end_span"": 80, ""type"": ""Cell""}, {""token"": ""matrix"", ""start_span"": 83, ""end_span"": 89, ""type"": ""Cellular_component""}, {""token"": ""syndecan - 1"", ""start_span"": 170, ""end_span"": 182, ""type"": ""Gene_or_gene_product""}, {""token"": ""malignant mammary tumor cells"", ""start_span"": 186, ""end_span"": 215, ""type"": ""Cell""}, {""token"": ""E - cadherin"", ""start_span"": 244, ""end_span"": 256, ""type"": ""Gene_or_gene_product""}]"	valid
The aim of this study was to compare the incidence of BRCA1 promoter region methylation in tumours in which loss of BRCA1 has been shown to play a role in pathogenesis ( breast and ovarian carcinomas) with the incidence in tumours in which BRCA1 is unlikely to play a role in pathogenesis.	BRCA1,54,59,Gene_or_gene_product	tumours,91,98,Cancer	BRCA1,116,121,Gene_or_gene_product	breast,170,176,Cancer	ovarian carcinomas,181,199,Cancer	tumours,223,230,Cancer	BRCA1,240,245,Gene_or_gene_product	"[{""token"": ""BRCA1"", ""start_span"": 54, ""end_span"": 59, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumours"", ""start_span"": 91, ""end_span"": 98, ""type"": ""Cancer""}, {""token"": ""BRCA1"", ""start_span"": 116, ""end_span"": 121, ""type"": ""Gene_or_gene_product""}, {""token"": ""breast"", ""start_span"": 170, ""end_span"": 176, ""type"": ""Cancer""}, {""token"": ""ovarian carcinomas"", ""start_span"": 181, ""end_span"": 199, ""type"": ""Cancer""}, {""token"": ""tumours"", ""start_span"": 223, ""end_span"": 230, ""type"": ""Cancer""}, {""token"": ""BRCA1"", ""start_span"": 240, ""end_span"": 245, ""type"": ""Gene_or_gene_product""}]"	test
Promoter region hypermethylation was significantly more common ( P < 0. 008) in breast and ovarian cancer ( 6 / 38 tumours methylated) than in colon cancer ( 0 / 35 tumours methylated) or in leukaemias ( 0 / 19 samples methylated).	breast,80,86,Cancer	ovarian cancer,91,105,Cancer	tumours,115,122,Cancer	colon cancer,143,155,Cancer	tumours,165,172,Cancer	leukaemias,191,201,Cancer	samples,211,218,Cancer	"[{""token"": ""breast"", ""start_span"": 80, ""end_span"": 86, ""type"": ""Cancer""}, {""token"": ""ovarian cancer"", ""start_span"": 91, ""end_span"": 105, ""type"": ""Cancer""}, {""token"": ""tumours"", ""start_span"": 115, ""end_span"": 122, ""type"": ""Cancer""}, {""token"": ""colon cancer"", ""start_span"": 143, ""end_span"": 155, ""type"": ""Cancer""}, {""token"": ""tumours"", ""start_span"": 165, ""end_span"": 172, ""type"": ""Cancer""}, {""token"": ""leukaemias"", ""start_span"": 191, ""end_span"": 201, ""type"": ""Cancer""}, {""token"": ""samples"", ""start_span"": 211, ""end_span"": 218, ""type"": ""Cancer""}]"	test
The nm23 - H1 mRNA expression levels in CBM with lymph nodes metastases were lower than those in CBM without metastases ( P < 0. 05), while no significance of nm23 - H2 mRNA expression levels was found between CBM with and CBM without metastasis ( P > 0. 05).	nm23 - H1,4,13,Gene_or_gene_product	CBM,40,43,Cancer	lymph nodes,49,60,Multi	CBM,97,100,Cancer	nm23 - H2,159,168,Gene_or_gene_product	CBM,210,213,Cancer	CBM,223,226,Cancer	"[{""token"": ""nm23 - H1"", ""start_span"": 4, ""end_span"": 13, ""type"": ""Gene_or_gene_product""}, {""token"": ""CBM"", ""start_span"": 40, ""end_span"": 43, ""type"": ""Cancer""}, {""token"": ""lymph nodes"", ""start_span"": 49, ""end_span"": 60, ""type"": ""Multi""}, {""token"": ""CBM"", ""start_span"": 97, ""end_span"": 100, ""type"": ""Cancer""}, {""token"": ""nm23 - H2"", ""start_span"": 159, ""end_span"": 168, ""type"": ""Gene_or_gene_product""}, {""token"": ""CBM"", ""start_span"": 210, ""end_span"": 213, ""type"": ""Cancer""}, {""token"": ""CBM"", ""start_span"": 223, ""end_span"": 226, ""type"": ""Cancer""}]"	test
In the current article we demonstrate that TnI inhibits both bFGF - stimulated and basal levels of endothelial cell proliferation, and we hypothesize that this inhibition is occurring, at least in part, via an interaction of TnI with the cell - surface bFGF receptor on capillary endothelial cells.	TnI,43,46,Gene_or_gene_product	bFGF,61,65,Gene_or_gene_product	endothelial cell,99,115,Cell	TnI,225,228,Gene_or_gene_product	cell - surface,238,252,Cellular_component	bFGF receptor,253,266,Gene_or_gene_product	capillary endothelial cells,270,297,Cell	"[{""token"": ""TnI"", ""start_span"": 43, ""end_span"": 46, ""type"": ""Gene_or_gene_product""}, {""token"": ""bFGF"", ""start_span"": 61, ""end_span"": 65, ""type"": ""Gene_or_gene_product""}, {""token"": ""endothelial cell"", ""start_span"": 99, ""end_span"": 115, ""type"": ""Cell""}, {""token"": ""TnI"", ""start_span"": 225, ""end_span"": 228, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell - surface"", ""start_span"": 238, ""end_span"": 252, ""type"": ""Cellular_component""}, {""token"": ""bFGF receptor"", ""start_span"": 253, ""end_span"": 266, ""type"": ""Gene_or_gene_product""}, {""token"": ""capillary endothelial cells"", ""start_span"": 270, ""end_span"": 297, ""type"": ""Cell""}]"	test
Notably, three immortalizing E6 mutants that do not induce direct p53 degradation but do interact with hADA3 induced the abrogation of p53 - mediated transactivation and G ( 1) cell cycle arrest after DNA damage, comparable to wild - type E6.	E6,29,31,Gene_or_gene_product	p53,66,69,Gene_or_gene_product	hADA3,103,108,Gene_or_gene_product	p53,135,138,Gene_or_gene_product	cell,177,181,Cell	DNA,201,204,Cellular_component	E6,239,241,Gene_or_gene_product	"[{""token"": ""E6"", ""start_span"": 29, ""end_span"": 31, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 66, ""end_span"": 69, ""type"": ""Gene_or_gene_product""}, {""token"": ""hADA3"", ""start_span"": 103, ""end_span"": 108, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 135, ""end_span"": 138, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 177, ""end_span"": 181, ""type"": ""Cell""}, {""token"": ""DNA"", ""start_span"": 201, ""end_span"": 204, ""type"": ""Cellular_component""}, {""token"": ""E6"", ""start_span"": 239, ""end_span"": 241, ""type"": ""Gene_or_gene_product""}]"	test
317615 x 2HCl was an active antitumor agent against the MX - 1 xenograft and increased the tumor growth delay produced by paclitaxel by 1. 7 - fold and the tumor growth delay produced by carboplatin by 3. 8 - fold.	317615 x 2HCl,0,13,Chemical	antitumor,28,37,Cancer	MX - 1 xenograft,56,72,Cancer	tumor,91,96,Cancer	paclitaxel,122,132,Chemical	tumor,156,161,Cancer	carboplatin,187,198,Chemical	"[{""token"": ""317615 x 2HCl"", ""start_span"": 0, ""end_span"": 13, ""type"": ""Chemical""}, {""token"": ""antitumor"", ""start_span"": 28, ""end_span"": 37, ""type"": ""Cancer""}, {""token"": ""MX - 1 xenograft"", ""start_span"": 56, ""end_span"": 72, ""type"": ""Cancer""}, {""token"": ""tumor"", ""start_span"": 91, ""end_span"": 96, ""type"": ""Cancer""}, {""token"": ""paclitaxel"", ""start_span"": 122, ""end_span"": 132, ""type"": ""Chemical""}, {""token"": ""tumor"", ""start_span"": 156, ""end_span"": 161, ""type"": ""Cancer""}, {""token"": ""carboplatin"", ""start_span"": 187, ""end_span"": 198, ""type"": ""Chemical""}]"	test
Blockade of PAF - R by WEB - 2170, a PAF - R antagonist, abolished the CD154 - dependent motility, indicating a role for PAF synthesized after CD154 stimulation in renal carcinoma cell motility.	PAF - R,12,19,Gene_or_gene_product	WEB - 2170,23,33,Chemical	PAF - R,37,44,Gene_or_gene_product	CD154,71,76,Gene_or_gene_product	PAF,121,124,Chemical	CD154,143,148,Gene_or_gene_product	renal carcinoma cell,164,184,Cell	"[{""token"": ""PAF - R"", ""start_span"": 12, ""end_span"": 19, ""type"": ""Gene_or_gene_product""}, {""token"": ""WEB - 2170"", ""start_span"": 23, ""end_span"": 33, ""type"": ""Chemical""}, {""token"": ""PAF - R"", ""start_span"": 37, ""end_span"": 44, ""type"": ""Gene_or_gene_product""}, {""token"": ""CD154"", ""start_span"": 71, ""end_span"": 76, ""type"": ""Gene_or_gene_product""}, {""token"": ""PAF"", ""start_span"": 121, ""end_span"": 124, ""type"": ""Chemical""}, {""token"": ""CD154"", ""start_span"": 143, ""end_span"": 148, ""type"": ""Gene_or_gene_product""}, {""token"": ""renal carcinoma cell"", ""start_span"": 164, ""end_span"": 184, ""type"": ""Cell""}]"	test
Here we report that the chemotherapeutic drug doxorubicin, a DNA - damaging agent, activates a p53 - survivin signaling pathway inducing cell cycle arrest and apoptosis in childhood acute lymphoblastic leukemia ( ALL).	doxorubicin,46,57,Chemical	DNA,61,64,Cellular_component	p53,95,98,Gene_or_gene_product	survivin,101,109,Gene_or_gene_product	cell,137,141,Cell	acute lymphoblastic leukemia,182,210,Cancer	ALL,213,216,Cancer	"[{""token"": ""doxorubicin"", ""start_span"": 46, ""end_span"": 57, ""type"": ""Chemical""}, {""token"": ""DNA"", ""start_span"": 61, ""end_span"": 64, ""type"": ""Cellular_component""}, {""token"": ""p53"", ""start_span"": 95, ""end_span"": 98, ""type"": ""Gene_or_gene_product""}, {""token"": ""survivin"", ""start_span"": 101, ""end_span"": 109, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 137, ""end_span"": 141, ""type"": ""Cell""}, {""token"": ""acute lymphoblastic leukemia"", ""start_span"": 182, ""end_span"": 210, ""type"": ""Cancer""}, {""token"": ""ALL"", ""start_span"": 213, ""end_span"": 216, ""type"": ""Cancer""}]"	test
A vascular permeability enhancement ( VPE) assay was performed using guinea pigs to ascertain whether supernatant from cultures of Ve - and OMP - stimulated HGF enhance vascular permeability in vivo.	vascular,2,10,Multi	guinea pigs,69,80,Organism	supernatant,102,113,Organism_substance	Ve,131,133,Gene_or_gene_product	OMP,140,143,Gene_or_gene_product	HGF,157,160,Cell	vascular,169,177,Multi	"[{""token"": ""vascular"", ""start_span"": 2, ""end_span"": 10, ""type"": ""Multi""}, {""token"": ""guinea pigs"", ""start_span"": 69, ""end_span"": 80, ""type"": ""Organism""}, {""token"": ""supernatant"", ""start_span"": 102, ""end_span"": 113, ""type"": ""Organism_substance""}, {""token"": ""Ve"", ""start_span"": 131, ""end_span"": 133, ""type"": ""Gene_or_gene_product""}, {""token"": ""OMP"", ""start_span"": 140, ""end_span"": 143, ""type"": ""Gene_or_gene_product""}, {""token"": ""HGF"", ""start_span"": 157, ""end_span"": 160, ""type"": ""Cell""}, {""token"": ""vascular"", ""start_span"": 169, ""end_span"": 177, ""type"": ""Multi""}]"	test
BX471 ( R - N - [ 5 - chloro - 2 - [ 2 - [ 4 ( 4 - fluorophenyl) methyl] - 2 - methyl - 1 - piperazinyl] - 2 - oxoethoxy] phenyl] urea hydrochloric acid salt), a CCR1 antagonist, inhibits angiogenic properties of CCL16, whereas blocking of CCR8 or desensitizing CCR2, which are both well known receptors for CCL16, did not abolish endothelial activation.	BX471,0,5,Chemical	CCR1,162,166,Gene_or_gene_product	CCL16,213,218,Gene_or_gene_product	CCR8,240,244,Gene_or_gene_product	CCR2,262,266,Gene_or_gene_product	CCL16,308,313,Gene_or_gene_product	endothelial,331,342,Cell	"[{""token"": ""BX471"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Chemical""}, {""token"": ""CCR1"", ""start_span"": 162, ""end_span"": 166, ""type"": ""Gene_or_gene_product""}, {""token"": ""CCL16"", ""start_span"": 213, ""end_span"": 218, ""type"": ""Gene_or_gene_product""}, {""token"": ""CCR8"", ""start_span"": 240, ""end_span"": 244, ""type"": ""Gene_or_gene_product""}, {""token"": ""CCR2"", ""start_span"": 262, ""end_span"": 266, ""type"": ""Gene_or_gene_product""}, {""token"": ""CCL16"", ""start_span"": 308, ""end_span"": 313, ""type"": ""Gene_or_gene_product""}, {""token"": ""endothelial"", ""start_span"": 331, ""end_span"": 342, ""type"": ""Cell""}]"	test
Analysis of gene expression revealed increased expression of ANGPT1, ANGPT2, platelet - derived growth factor - B, placental growth factor, and VEGF mRNA in AdCA5 - injected eyes.	ANGPT1,61,67,Gene_or_gene_product	ANGPT2,69,75,Gene_or_gene_product	platelet - derived growth factor - B,77,113,Gene_or_gene_product	placental growth factor,115,138,Gene_or_gene_product	VEGF,144,148,Gene_or_gene_product	AdCA5,157,162,Organism	eyes,174,178,Organ	"[{""token"": ""ANGPT1"", ""start_span"": 61, ""end_span"": 67, ""type"": ""Gene_or_gene_product""}, {""token"": ""ANGPT2"", ""start_span"": 69, ""end_span"": 75, ""type"": ""Gene_or_gene_product""}, {""token"": ""platelet - derived growth factor - B"", ""start_span"": 77, ""end_span"": 113, ""type"": ""Gene_or_gene_product""}, {""token"": ""placental growth factor"", ""start_span"": 115, ""end_span"": 138, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 144, ""end_span"": 148, ""type"": ""Gene_or_gene_product""}, {""token"": ""AdCA5"", ""start_span"": 157, ""end_span"": 162, ""type"": ""Organism""}, {""token"": ""eyes"", ""start_span"": 174, ""end_span"": 178, ""type"": ""Organ""}]"	test
In conclusion, our study revealed that the overexpression of EphA2 protein in colorectal carcinoma tissue correlates closely with cancer progression and hematogenous and lymphogenous metastasis, suggesting that both EphA2 and E - cadherin may play an important role in tumor metastasis in colorectal cancer.	EphA2,61,66,Gene_or_gene_product	colorectal carcinoma tissue,78,105,Tissue	cancer,130,136,Cancer	EphA2,216,221,Gene_or_gene_product	E - cadherin,226,238,Gene_or_gene_product	tumor,269,274,Cancer	colorectal cancer,289,306,Cancer	"[{""token"": ""EphA2"", ""start_span"": 61, ""end_span"": 66, ""type"": ""Gene_or_gene_product""}, {""token"": ""colorectal carcinoma tissue"", ""start_span"": 78, ""end_span"": 105, ""type"": ""Tissue""}, {""token"": ""cancer"", ""start_span"": 130, ""end_span"": 136, ""type"": ""Cancer""}, {""token"": ""EphA2"", ""start_span"": 216, ""end_span"": 221, ""type"": ""Gene_or_gene_product""}, {""token"": ""E - cadherin"", ""start_span"": 226, ""end_span"": 238, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 269, ""end_span"": 274, ""type"": ""Cancer""}, {""token"": ""colorectal cancer"", ""start_span"": 289, ""end_span"": 306, ""type"": ""Cancer""}]"	test
Clusterin expression level depends on cell proliferation state, and we recently showed that its over - expression inhibited cell cycle progression of SV40 - immortalized human prostate epithelial cells PNT2 and PNT1a.	Clusterin,0,9,Gene_or_gene_product	cell,38,42,Cell	cell,124,128,Cell	SV40,150,154,Organism	human,170,175,Organism	prostate epithelial cells PNT2,176,206,Cell	PNT1a,211,216,Cell	"[{""token"": ""Clusterin"", ""start_span"": 0, ""end_span"": 9, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 38, ""end_span"": 42, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 124, ""end_span"": 128, ""type"": ""Cell""}, {""token"": ""SV40"", ""start_span"": 150, ""end_span"": 154, ""type"": ""Organism""}, {""token"": ""human"", ""start_span"": 170, ""end_span"": 175, ""type"": ""Organism""}, {""token"": ""prostate epithelial cells PNT2"", ""start_span"": 176, ""end_span"": 206, ""type"": ""Cell""}, {""token"": ""PNT1a"", ""start_span"": 211, ""end_span"": 216, ""type"": ""Cell""}]"	test
We quantified CYR61, CTGF, WISP - 1, and NOV mRNA expression levels in samples from sixty - six primary gliomas and five normal brain samples using quantitative real - time PCR assay.	CYR61,14,19,Gene_or_gene_product	CTGF,21,25,Gene_or_gene_product	WISP - 1,27,35,Gene_or_gene_product	NOV,41,44,Gene_or_gene_product	samples,71,78,Cancer	gliomas,104,111,Cancer	brain samples,128,141,Multi	"[{""token"": ""CYR61"", ""start_span"": 14, ""end_span"": 19, ""type"": ""Gene_or_gene_product""}, {""token"": ""CTGF"", ""start_span"": 21, ""end_span"": 25, ""type"": ""Gene_or_gene_product""}, {""token"": ""WISP - 1"", ""start_span"": 27, ""end_span"": 35, ""type"": ""Gene_or_gene_product""}, {""token"": ""NOV"", ""start_span"": 41, ""end_span"": 44, ""type"": ""Gene_or_gene_product""}, {""token"": ""samples"", ""start_span"": 71, ""end_span"": 78, ""type"": ""Cancer""}, {""token"": ""gliomas"", ""start_span"": 104, ""end_span"": 111, ""type"": ""Cancer""}, {""token"": ""brain samples"", ""start_span"": 128, ""end_span"": 141, ""type"": ""Multi""}]"	test
The aim of this study is to investigate ( 1) whether expression of COX - 2 and PPARgamma is associated with ovarian carcinogenesis and progression of ovarian tumours and ( 2) whether COX - 2 expression is controlled through ligand - mediated activation of PPARgamma in ovarian carcinoma cells.	COX - 2,67,74,Gene_or_gene_product	PPARgamma,79,88,Gene_or_gene_product	ovarian,108,115,Organ	ovarian tumours,150,165,Cancer	COX - 2,183,190,Gene_or_gene_product	PPARgamma,256,265,Gene_or_gene_product	ovarian carcinoma cells,269,292,Cell	"[{""token"": ""COX - 2"", ""start_span"": 67, ""end_span"": 74, ""type"": ""Gene_or_gene_product""}, {""token"": ""PPARgamma"", ""start_span"": 79, ""end_span"": 88, ""type"": ""Gene_or_gene_product""}, {""token"": ""ovarian"", ""start_span"": 108, ""end_span"": 115, ""type"": ""Organ""}, {""token"": ""ovarian tumours"", ""start_span"": 150, ""end_span"": 165, ""type"": ""Cancer""}, {""token"": ""COX - 2"", ""start_span"": 183, ""end_span"": 190, ""type"": ""Gene_or_gene_product""}, {""token"": ""PPARgamma"", ""start_span"": 256, ""end_span"": 265, ""type"": ""Gene_or_gene_product""}, {""token"": ""ovarian carcinoma cells"", ""start_span"": 269, ""end_span"": 292, ""type"": ""Cell""}]"	test
From these results, it was suggested that PPARgamma activation might suppress COX - 2 expression via the nuclear factor - kappaB pathway in the ovarian carcinoma cells and that low expression of PPARgamma and high expression of COX - 2 might be involved in carcinogenesis and progression of ovarian tumours.	PPARgamma,42,51,Gene_or_gene_product	COX - 2,78,85,Gene_or_gene_product	nuclear factor - kappaB,105,128,Gene_or_gene_product	ovarian carcinoma cells,144,167,Cell	PPARgamma,195,204,Gene_or_gene_product	COX - 2,228,235,Gene_or_gene_product	ovarian tumours,291,306,Cancer	"[{""token"": ""PPARgamma"", ""start_span"": 42, ""end_span"": 51, ""type"": ""Gene_or_gene_product""}, {""token"": ""COX - 2"", ""start_span"": 78, ""end_span"": 85, ""type"": ""Gene_or_gene_product""}, {""token"": ""nuclear factor - kappaB"", ""start_span"": 105, ""end_span"": 128, ""type"": ""Gene_or_gene_product""}, {""token"": ""ovarian carcinoma cells"", ""start_span"": 144, ""end_span"": 167, ""type"": ""Cell""}, {""token"": ""PPARgamma"", ""start_span"": 195, ""end_span"": 204, ""type"": ""Gene_or_gene_product""}, {""token"": ""COX - 2"", ""start_span"": 228, ""end_span"": 235, ""type"": ""Gene_or_gene_product""}, {""token"": ""ovarian tumours"", ""start_span"": 291, ""end_span"": 306, ""type"": ""Cancer""}]"	test
The Kaposi ' s sarcoma - associated herpesvirus ( KSHV) encodes a G protein - coupled receptor ( vGPCR) that has been implicated in the initiation of Kaposi ' s sarcoma, identifying vGPCR as an attractive target for preventing Kaposi ' s sarcoma.	Kaposi ' s sarcoma - associated herpesvirus,4,47,Organism	KSHV,50,54,Organism	G protein - coupled receptor,66,94,Gene_or_gene_product	vGPCR,97,102,Gene_or_gene_product	Kaposi ' s sarcoma,150,168,Cancer	vGPCR,182,187,Gene_or_gene_product	Kaposi ' s sarcoma,227,245,Cancer	"[{""token"": ""Kaposi ' s sarcoma - associated herpesvirus"", ""start_span"": 4, ""end_span"": 47, ""type"": ""Organism""}, {""token"": ""KSHV"", ""start_span"": 50, ""end_span"": 54, ""type"": ""Organism""}, {""token"": ""G protein - coupled receptor"", ""start_span"": 66, ""end_span"": 94, ""type"": ""Gene_or_gene_product""}, {""token"": ""vGPCR"", ""start_span"": 97, ""end_span"": 102, ""type"": ""Gene_or_gene_product""}, {""token"": ""Kaposi ' s sarcoma"", ""start_span"": 150, ""end_span"": 168, ""type"": ""Cancer""}, {""token"": ""vGPCR"", ""start_span"": 182, ""end_span"": 187, ""type"": ""Gene_or_gene_product""}, {""token"": ""Kaposi ' s sarcoma"", ""start_span"": 227, ""end_span"": 245, ""type"": ""Cancer""}]"	test
Recent reports suggest a participation of matrix metalloproteinases ( MMP) in tumour pericyte recruitment that is consistent with the effect of certain MMPs in the development of microvasculature in embryonic development and in in vitro models of vascular remodelling.	matrix metalloproteinases,42,67,Gene_or_gene_product	MMP,70,73,Gene_or_gene_product	tumour pericyte,78,93,Cell	MMPs,152,156,Gene_or_gene_product	microvasculature,179,195,Tissue	embryonic,199,208,Developing_anatomical_structure	vascular,247,255,Multi	"[{""token"": ""matrix metalloproteinases"", ""start_span"": 42, ""end_span"": 67, ""type"": ""Gene_or_gene_product""}, {""token"": ""MMP"", ""start_span"": 70, ""end_span"": 73, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumour pericyte"", ""start_span"": 78, ""end_span"": 93, ""type"": ""Cell""}, {""token"": ""MMPs"", ""start_span"": 152, ""end_span"": 156, ""type"": ""Gene_or_gene_product""}, {""token"": ""microvasculature"", ""start_span"": 179, ""end_span"": 195, ""type"": ""Tissue""}, {""token"": ""embryonic"", ""start_span"": 199, ""end_span"": 208, ""type"": ""Developing_anatomical_structure""}, {""token"": ""vascular"", ""start_span"": 247, ""end_span"": 255, ""type"": ""Multi""}]"	test
This was confirmed with chromatin immunoprecipitation experiments of the human c - Met promoter, as well as by the ability of adenovirally expressed Mitf to modulate endogenous c - Met protein levels in melanocytes.	chromatin,24,33,Cellular_component	human,73,78,Organism	c - Met,79,86,Gene_or_gene_product	adenovirally,126,138,Organism	Mitf,149,153,Gene_or_gene_product	c - Met,177,184,Gene_or_gene_product	melanocytes,203,214,Cell	"[{""token"": ""chromatin"", ""start_span"": 24, ""end_span"": 33, ""type"": ""Cellular_component""}, {""token"": ""human"", ""start_span"": 73, ""end_span"": 78, ""type"": ""Organism""}, {""token"": ""c - Met"", ""start_span"": 79, ""end_span"": 86, ""type"": ""Gene_or_gene_product""}, {""token"": ""adenovirally"", ""start_span"": 126, ""end_span"": 138, ""type"": ""Organism""}, {""token"": ""Mitf"", ""start_span"": 149, ""end_span"": 153, ""type"": ""Gene_or_gene_product""}, {""token"": ""c - Met"", ""start_span"": 177, ""end_span"": 184, ""type"": ""Gene_or_gene_product""}, {""token"": ""melanocytes"", ""start_span"": 203, ""end_span"": 214, ""type"": ""Cell""}]"	test
Finally, dominant - negative inhibition of Mitf resulted in profound resistance of melanocytes and melanoma cells to HGF - dependent matrix invasion, suggesting a physiologic role for this pathway in melanocytic development and melanoma.	Mitf,43,47,Gene_or_gene_product	melanocytes,83,94,Cell	melanoma cells,99,113,Cell	HGF,117,120,Gene_or_gene_product	matrix,133,139,Cellular_component	melanocytic,200,211,Cell	melanoma,228,236,Cancer	"[{""token"": ""Mitf"", ""start_span"": 43, ""end_span"": 47, ""type"": ""Gene_or_gene_product""}, {""token"": ""melanocytes"", ""start_span"": 83, ""end_span"": 94, ""type"": ""Cell""}, {""token"": ""melanoma cells"", ""start_span"": 99, ""end_span"": 113, ""type"": ""Cell""}, {""token"": ""HGF"", ""start_span"": 117, ""end_span"": 120, ""type"": ""Gene_or_gene_product""}, {""token"": ""matrix"", ""start_span"": 133, ""end_span"": 139, ""type"": ""Cellular_component""}, {""token"": ""melanocytic"", ""start_span"": 200, ""end_span"": 211, ""type"": ""Cell""}, {""token"": ""melanoma"", ""start_span"": 228, ""end_span"": 236, ""type"": ""Cancer""}]"	test
Targeted down - regulation of PIM - 2 by RNA interference ( RNAi) selectively abrogated survival of Ba / F3 cells transformed by various Fms - like tyrosine kinase 3 ( FLT3) - activating mutants [ internal tandem duplication ( ITD) and kinase domain] and attenuated growth of human cell lines containing FLT3 mutations.	PIM - 2,30,37,Gene_or_gene_product	Ba / F3 cells,100,113,Cell	Fms - like tyrosine kinase 3,137,165,Gene_or_gene_product	FLT3,168,172,Gene_or_gene_product	human,276,281,Organism	cell lines,282,292,Cell	FLT3,304,308,Gene_or_gene_product	"[{""token"": ""PIM - 2"", ""start_span"": 30, ""end_span"": 37, ""type"": ""Gene_or_gene_product""}, {""token"": ""Ba / F3 cells"", ""start_span"": 100, ""end_span"": 113, ""type"": ""Cell""}, {""token"": ""Fms - like tyrosine kinase 3"", ""start_span"": 137, ""end_span"": 165, ""type"": ""Gene_or_gene_product""}, {""token"": ""FLT3"", ""start_span"": 168, ""end_span"": 172, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 276, ""end_span"": 281, ""type"": ""Organism""}, {""token"": ""cell lines"", ""start_span"": 282, ""end_span"": 292, ""type"": ""Cell""}, {""token"": ""FLT3"", ""start_span"": 304, ""end_span"": 308, ""type"": ""Gene_or_gene_product""}]"	test
Endothelial cells grown at normal pH suffer no ill effects from this angiostatin - mediated inhibition of ATP synthase, whereas endothelial cells grown at low, tumor - like extracellular pH cannot maintain a normal intracellular pH and die.	Endothelial cells,0,17,Cell	angiostatin,69,80,Gene_or_gene_product	ATP synthase,106,118,Gene_or_gene_product	endothelial cells,128,145,Cell	tumor,160,165,Cancer	extracellular,173,186,Immaterial_anatomical_entity	intracellular,215,228,Immaterial_anatomical_entity	"[{""token"": ""Endothelial cells"", ""start_span"": 0, ""end_span"": 17, ""type"": ""Cell""}, {""token"": ""angiostatin"", ""start_span"": 69, ""end_span"": 80, ""type"": ""Gene_or_gene_product""}, {""token"": ""ATP synthase"", ""start_span"": 106, ""end_span"": 118, ""type"": ""Gene_or_gene_product""}, {""token"": ""endothelial cells"", ""start_span"": 128, ""end_span"": 145, ""type"": ""Cell""}, {""token"": ""tumor"", ""start_span"": 160, ""end_span"": 165, ""type"": ""Cancer""}, {""token"": ""extracellular"", ""start_span"": 173, ""end_span"": 186, ""type"": ""Immaterial_anatomical_entity""}, {""token"": ""intracellular"", ""start_span"": 215, ""end_span"": 228, ""type"": ""Immaterial_anatomical_entity""}]"	test
In the present study a DNA probe derived from cellular DNA sequences adjacent to the previously characterized HBV insert was used to analyze a set of 19 matched normal liver and HBV - positive hepatoma samples obtained from the same region of China, near Shanghai.	DNA,23,26,Cellular_component	cellular,46,54,Cell	DNA,55,58,Cellular_component	HBV,110,113,Organism	liver,168,173,Organ	HBV,178,181,Organism	hepatoma samples,193,209,Tissue	"[{""token"": ""DNA"", ""start_span"": 23, ""end_span"": 26, ""type"": ""Cellular_component""}, {""token"": ""cellular"", ""start_span"": 46, ""end_span"": 54, ""type"": ""Cell""}, {""token"": ""DNA"", ""start_span"": 55, ""end_span"": 58, ""type"": ""Cellular_component""}, {""token"": ""HBV"", ""start_span"": 110, ""end_span"": 113, ""type"": ""Organism""}, {""token"": ""liver"", ""start_span"": 168, ""end_span"": 173, ""type"": ""Organ""}, {""token"": ""HBV"", ""start_span"": 178, ""end_span"": 181, ""type"": ""Organism""}, {""token"": ""hepatoma samples"", ""start_span"": 193, ""end_span"": 209, ""type"": ""Tissue""}]"	test
Tumor - specific DNA changes were detected in two additional HCCs, suggesting that the small region of chromosome 17p defined by the flanking cell DNA probe is commonly altered in hepatomas.	Tumor,0,5,Cancer	DNA,17,20,Cellular_component	HCCs,61,65,Cancer	chromosome 17p,103,117,Cellular_component	cell,142,146,Cell	DNA,147,150,Cellular_component	hepatomas,180,189,Cancer	"[{""token"": ""Tumor"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Cancer""}, {""token"": ""DNA"", ""start_span"": 17, ""end_span"": 20, ""type"": ""Cellular_component""}, {""token"": ""HCCs"", ""start_span"": 61, ""end_span"": 65, ""type"": ""Cancer""}, {""token"": ""chromosome 17p"", ""start_span"": 103, ""end_span"": 117, ""type"": ""Cellular_component""}, {""token"": ""cell"", ""start_span"": 142, ""end_span"": 146, ""type"": ""Cell""}, {""token"": ""DNA"", ""start_span"": 147, ""end_span"": 150, ""type"": ""Cellular_component""}, {""token"": ""hepatomas"", ""start_span"": 180, ""end_span"": 189, ""type"": ""Cancer""}]"	test
This negative regulation is mediated by the cytoskeleton as the disruption of interactions between the PSMA cytoplasmic tail and the anchor protein filamin A decreases PSMA activity, integrin function, and PAK activation.	cytoskeleton,44,56,Cellular_component	PSMA,103,107,Gene_or_gene_product	cytoplasmic,108,119,Organism_substance	filamin A,148,157,Gene_or_gene_product	PSMA,168,172,Gene_or_gene_product	integrin,183,191,Gene_or_gene_product	PAK,206,209,Gene_or_gene_product	"[{""token"": ""cytoskeleton"", ""start_span"": 44, ""end_span"": 56, ""type"": ""Cellular_component""}, {""token"": ""PSMA"", ""start_span"": 103, ""end_span"": 107, ""type"": ""Gene_or_gene_product""}, {""token"": ""cytoplasmic"", ""start_span"": 108, ""end_span"": 119, ""type"": ""Organism_substance""}, {""token"": ""filamin A"", ""start_span"": 148, ""end_span"": 157, ""type"": ""Gene_or_gene_product""}, {""token"": ""PSMA"", ""start_span"": 168, ""end_span"": 172, ""type"": ""Gene_or_gene_product""}, {""token"": ""integrin"", ""start_span"": 183, ""end_span"": 191, ""type"": ""Gene_or_gene_product""}, {""token"": ""PAK"", ""start_span"": 206, ""end_span"": 209, ""type"": ""Gene_or_gene_product""}]"	test
In vivo animal models of tissue injury and in vitro data also implicate syndecans in processes necessary for wound healing, including fibroblast and endothelial proliferation, cell motility, angiogenesis, and extracellular matrix organization.	tissue,25,31,Tissue	syndecans,72,81,Gene_or_gene_product	wound,109,114,Pathological_formation	fibroblast,134,144,Cell	endothelial,149,160,Cell	cell,176,180,Cell	extracellular matrix,209,229,Cellular_component	"[{""token"": ""tissue"", ""start_span"": 25, ""end_span"": 31, ""type"": ""Tissue""}, {""token"": ""syndecans"", ""start_span"": 72, ""end_span"": 81, ""type"": ""Gene_or_gene_product""}, {""token"": ""wound"", ""start_span"": 109, ""end_span"": 114, ""type"": ""Pathological_formation""}, {""token"": ""fibroblast"", ""start_span"": 134, ""end_span"": 144, ""type"": ""Cell""}, {""token"": ""endothelial"", ""start_span"": 149, ""end_span"": 160, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 176, ""end_span"": 180, ""type"": ""Cell""}, {""token"": ""extracellular matrix"", ""start_span"": 209, ""end_span"": 229, ""type"": ""Cellular_component""}]"	test
In this work, we show that LPA stimulates invasion of primary ovarian cancer cells, but not ovarian epithelial or borderline ovarian tumor cells, although these benign cells indeed respond to LPA in cell migration.	LPA,27,30,Chemical	ovarian cancer cells,62,82,Cell	ovarian epithelial,92,110,Cell	borderline ovarian tumor cells,114,144,Cell	benign cells,161,173,Cell	LPA,192,195,Chemical	cell,199,203,Cell	"[{""token"": ""LPA"", ""start_span"": 27, ""end_span"": 30, ""type"": ""Chemical""}, {""token"": ""ovarian cancer cells"", ""start_span"": 62, ""end_span"": 82, ""type"": ""Cell""}, {""token"": ""ovarian epithelial"", ""start_span"": 92, ""end_span"": 110, ""type"": ""Cell""}, {""token"": ""borderline ovarian tumor cells"", ""start_span"": 114, ""end_span"": 144, ""type"": ""Cell""}, {""token"": ""benign cells"", ""start_span"": 161, ""end_span"": 173, ""type"": ""Cell""}, {""token"": ""LPA"", ""start_span"": 192, ""end_span"": 195, ""type"": ""Chemical""}, {""token"": ""cell"", ""start_span"": 199, ""end_span"": 203, ""type"": ""Cell""}]"	test
MATERIALS AND METHODS: Forty - two MRI exams were performed with intravascular contrast media in 21 rats: tumours were induced by subcutaneous injection of colon carcinoma cells in 7 rats and mammary adenocarcinoma cells in 14 rats.	intravascular,65,78,Immaterial_anatomical_entity	rats,100,104,Organism	tumours,106,113,Cancer	colon carcinoma cells,156,177,Cell	rats,183,187,Organism	mammary adenocarcinoma cells,192,220,Cell	rats,227,231,Organism	"[{""token"": ""intravascular"", ""start_span"": 65, ""end_span"": 78, ""type"": ""Immaterial_anatomical_entity""}, {""token"": ""rats"", ""start_span"": 100, ""end_span"": 104, ""type"": ""Organism""}, {""token"": ""tumours"", ""start_span"": 106, ""end_span"": 113, ""type"": ""Cancer""}, {""token"": ""colon carcinoma cells"", ""start_span"": 156, ""end_span"": 177, ""type"": ""Cell""}, {""token"": ""rats"", ""start_span"": 183, ""end_span"": 187, ""type"": ""Organism""}, {""token"": ""mammary adenocarcinoma cells"", ""start_span"": 192, ""end_span"": 220, ""type"": ""Cell""}, {""token"": ""rats"", ""start_span"": 227, ""end_span"": 231, ""type"": ""Organism""}]"	test
A panel of antibodies was used for immunohistochemistry: CD34 / Ki - 67, carbonic anhydrase IX, hypoxia - inducible factor - 1alpha ( HIF - 1alpha) and vascular endothelial growth factor ( VEGF).	CD34,57,61,Gene_or_gene_product	Ki - 67,64,71,Gene_or_gene_product	carbonic anhydrase IX,73,94,Gene_or_gene_product	hypoxia - inducible factor - 1alpha,96,131,Gene_or_gene_product	HIF - 1alpha,134,146,Gene_or_gene_product	vascular endothelial growth factor,152,186,Gene_or_gene_product	VEGF,189,193,Gene_or_gene_product	"[{""token"": ""CD34"", ""start_span"": 57, ""end_span"": 61, ""type"": ""Gene_or_gene_product""}, {""token"": ""Ki - 67"", ""start_span"": 64, ""end_span"": 71, ""type"": ""Gene_or_gene_product""}, {""token"": ""carbonic anhydrase IX"", ""start_span"": 73, ""end_span"": 94, ""type"": ""Gene_or_gene_product""}, {""token"": ""hypoxia - inducible factor - 1alpha"", ""start_span"": 96, ""end_span"": 131, ""type"": ""Gene_or_gene_product""}, {""token"": ""HIF - 1alpha"", ""start_span"": 134, ""end_span"": 146, ""type"": ""Gene_or_gene_product""}, {""token"": ""vascular endothelial growth factor"", ""start_span"": 152, ""end_span"": 186, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 189, ""end_span"": 193, ""type"": ""Gene_or_gene_product""}]"	test
In 1986, Dvorak went on to demonstrate that VPF was secreted by a variety of human tumor cell lines and proposed that VPF was in part responsible for the abnormal vasculature seen in human tumors.	VPF,44,47,Gene_or_gene_product	human,77,82,Organism	tumor cell lines,83,99,Cell	VPF,118,121,Gene_or_gene_product	vasculature,163,174,Multi	human,183,188,Organism	tumors,189,195,Cancer	"[{""token"": ""VPF"", ""start_span"": 44, ""end_span"": 47, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 77, ""end_span"": 82, ""type"": ""Organism""}, {""token"": ""tumor cell lines"", ""start_span"": 83, ""end_span"": 99, ""type"": ""Cell""}, {""token"": ""VPF"", ""start_span"": 118, ""end_span"": 121, ""type"": ""Gene_or_gene_product""}, {""token"": ""vasculature"", ""start_span"": 163, ""end_span"": 174, ""type"": ""Multi""}, {""token"": ""human"", ""start_span"": 183, ""end_span"": 188, ""type"": ""Organism""}, {""token"": ""tumors"", ""start_span"": 189, ""end_span"": 195, ""type"": ""Cancer""}]"	test
He noted that wounds, like tumors, secrete VPF, causing blood vessels to leak plasma fibrinogen, which stimulates blood vessel growth and provides a matrix on which they can spread.	wounds,14,20,Pathological_formation	tumors,27,33,Cancer	VPF,43,46,Gene_or_gene_product	blood vessels,56,69,Multi	plasma,78,84,Organism_substance	fibrinogen,85,95,Gene_or_gene_product	blood vessel,114,126,Multi	"[{""token"": ""wounds"", ""start_span"": 14, ""end_span"": 20, ""type"": ""Pathological_formation""}, {""token"": ""tumors"", ""start_span"": 27, ""end_span"": 33, ""type"": ""Cancer""}, {""token"": ""VPF"", ""start_span"": 43, ""end_span"": 46, ""type"": ""Gene_or_gene_product""}, {""token"": ""blood vessels"", ""start_span"": 56, ""end_span"": 69, ""type"": ""Multi""}, {""token"": ""plasma"", ""start_span"": 78, ""end_span"": 84, ""type"": ""Organism_substance""}, {""token"": ""fibrinogen"", ""start_span"": 85, ""end_span"": 95, ""type"": ""Gene_or_gene_product""}, {""token"": ""blood vessel"", ""start_span"": 114, ""end_span"": 126, ""type"": ""Multi""}]"	test
Unlike wounds, however, that turn off VPF production after healing, tumors did not turn off their VPF production and instead continued to make large amounts of VPF, allowing malignant cells to continue to induce new blood vessels and so to grow and spread.	wounds,7,13,Pathological_formation	VPF,38,41,Gene_or_gene_product	tumors,68,74,Cancer	VPF,98,101,Gene_or_gene_product	VPF,160,163,Gene_or_gene_product	malignant cells,174,189,Cell	blood vessels,216,229,Multi	"[{""token"": ""wounds"", ""start_span"": 7, ""end_span"": 13, ""type"": ""Pathological_formation""}, {""token"": ""VPF"", ""start_span"": 38, ""end_span"": 41, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumors"", ""start_span"": 68, ""end_span"": 74, ""type"": ""Cancer""}, {""token"": ""VPF"", ""start_span"": 98, ""end_span"": 101, ""type"": ""Gene_or_gene_product""}, {""token"": ""VPF"", ""start_span"": 160, ""end_span"": 163, ""type"": ""Gene_or_gene_product""}, {""token"": ""malignant cells"", ""start_span"": 174, ""end_span"": 189, ""type"": ""Cell""}, {""token"": ""blood vessels"", ""start_span"": 216, ""end_span"": 229, ""type"": ""Multi""}]"	test
In our study, MOG was shown to specifically inhibit the growth of human leukemia cell lines and primary acute myeloid leukemia ( AML) blasts via induction of apoptosis, with the evidence of mitochondrial DeltaPsim loss, reactive oxygen species production, caspases activation and nuclear fragmentation.	MOG,14,17,Chemical	human,66,71,Organism	leukemia cell lines,72,91,Cell	mitochondrial,190,203,Cellular_component	reactive oxygen species,220,243,Chemical	caspases,256,264,Gene_or_gene_product	nuclear,280,287,Cellular_component	"[{""token"": ""MOG"", ""start_span"": 14, ""end_span"": 17, ""type"": ""Chemical""}, {""token"": ""human"", ""start_span"": 66, ""end_span"": 71, ""type"": ""Organism""}, {""token"": ""leukemia cell lines"", ""start_span"": 72, ""end_span"": 91, ""type"": ""Cell""}, {""token"": ""mitochondrial"", ""start_span"": 190, ""end_span"": 203, ""type"": ""Cellular_component""}, {""token"": ""reactive oxygen species"", ""start_span"": 220, ""end_span"": 243, ""type"": ""Chemical""}, {""token"": ""caspases"", ""start_span"": 256, ""end_span"": 264, ""type"": ""Gene_or_gene_product""}, {""token"": ""nuclear"", ""start_span"": 280, ""end_span"": 287, ""type"": ""Cellular_component""}]"	test
Furthermore, it was showed that GSH depletion induced by MOG rendered some leukemia cell lines more sensitive to arsenic trioxide ( As2O3), doxorubicin or cisplatin.	GSH,32,35,Chemical	MOG,57,60,Chemical	some leukemia cell lines,70,94,Cell	arsenic trioxide,113,129,Chemical	As2O3,132,137,Chemical	doxorubicin,140,151,Chemical	cisplatin,155,164,Chemical	"[{""token"": ""GSH"", ""start_span"": 32, ""end_span"": 35, ""type"": ""Chemical""}, {""token"": ""MOG"", ""start_span"": 57, ""end_span"": 60, ""type"": ""Chemical""}, {""token"": ""some leukemia cell lines"", ""start_span"": 70, ""end_span"": 94, ""type"": ""Cell""}, {""token"": ""arsenic trioxide"", ""start_span"": 113, ""end_span"": 129, ""type"": ""Chemical""}, {""token"": ""As2O3"", ""start_span"": 132, ""end_span"": 137, ""type"": ""Chemical""}, {""token"": ""doxorubicin"", ""start_span"": 140, ""end_span"": 151, ""type"": ""Chemical""}, {""token"": ""cisplatin"", ""start_span"": 155, ""end_span"": 164, ""type"": ""Chemical""}]"	test
Surprisingly, analysis of K5CDK4 and K5CDK2 transgenic mouse embryos showed CDK4 and CDK2 expression not only in the expected tissues, but also in the adenohypophysis.	K5CDK4,26,32,Gene_or_gene_product	K5CDK2,37,43,Gene_or_gene_product	embryos,61,68,Developing_anatomical_structure	CDK4,76,80,Gene_or_gene_product	CDK2,85,89,Gene_or_gene_product	tissues,126,133,Tissue	adenohypophysis,151,166,Organ	"[{""token"": ""K5CDK4"", ""start_span"": 26, ""end_span"": 32, ""type"": ""Gene_or_gene_product""}, {""token"": ""K5CDK2"", ""start_span"": 37, ""end_span"": 43, ""type"": ""Gene_or_gene_product""}, {""token"": ""embryos"", ""start_span"": 61, ""end_span"": 68, ""type"": ""Developing_anatomical_structure""}, {""token"": ""CDK4"", ""start_span"": 76, ""end_span"": 80, ""type"": ""Gene_or_gene_product""}, {""token"": ""CDK2"", ""start_span"": 85, ""end_span"": 89, ""type"": ""Gene_or_gene_product""}, {""token"": ""tissues"", ""start_span"": 126, ""end_span"": 133, ""type"": ""Tissue""}, {""token"": ""adenohypophysis"", ""start_span"": 151, ""end_span"": 166, ""type"": ""Organ""}]"	test
DESIGN: Paraffin - embedded sections of 37 breast carcinomas were immunostained for survivin, bcl - 2, bcl - x, and bax.	Paraffin,8,16,Chemical	sections,28,36,Cancer	breast carcinomas,43,60,Cancer	survivin,84,92,Gene_or_gene_product	bcl - 2,94,101,Gene_or_gene_product	bcl - x,103,110,Gene_or_gene_product	bax,116,119,Gene_or_gene_product	"[{""token"": ""Paraffin"", ""start_span"": 8, ""end_span"": 16, ""type"": ""Chemical""}, {""token"": ""sections"", ""start_span"": 28, ""end_span"": 36, ""type"": ""Cancer""}, {""token"": ""breast carcinomas"", ""start_span"": 43, ""end_span"": 60, ""type"": ""Cancer""}, {""token"": ""survivin"", ""start_span"": 84, ""end_span"": 92, ""type"": ""Gene_or_gene_product""}, {""token"": ""bcl - 2"", ""start_span"": 94, ""end_span"": 101, ""type"": ""Gene_or_gene_product""}, {""token"": ""bcl - x"", ""start_span"": 103, ""end_span"": 110, ""type"": ""Gene_or_gene_product""}, {""token"": ""bax"", ""start_span"": 116, ""end_span"": 119, ""type"": ""Gene_or_gene_product""}]"	test
Transfection of SiHa cervical cancer cells with a plasmid expressing the TSP - 1 protein exhibited antiangiogenic activity in vitro and resulted in reduced tumor growth in severe combined immunodeficiency ( SCID) mice, which was accompanied by a decrease in tumor vascularization and lower expressions of alpha - SMA and desmin than those in the vector controls.	SiHa cervical cancer cells,16,42,Cell	TSP - 1,73,80,Gene_or_gene_product	tumor,156,161,Cancer	mice,213,217,Organism	tumor,258,263,Cancer	alpha - SMA,305,316,Gene_or_gene_product	desmin,321,327,Gene_or_gene_product	"[{""token"": ""SiHa cervical cancer cells"", ""start_span"": 16, ""end_span"": 42, ""type"": ""Cell""}, {""token"": ""TSP - 1"", ""start_span"": 73, ""end_span"": 80, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 156, ""end_span"": 161, ""type"": ""Cancer""}, {""token"": ""mice"", ""start_span"": 213, ""end_span"": 217, ""type"": ""Organism""}, {""token"": ""tumor"", ""start_span"": 258, ""end_span"": 263, ""type"": ""Cancer""}, {""token"": ""alpha - SMA"", ""start_span"": 305, ""end_span"": 316, ""type"": ""Gene_or_gene_product""}, {""token"": ""desmin"", ""start_span"": 321, ""end_span"": 327, ""type"": ""Gene_or_gene_product""}]"	test
Transforming growth factor - beta ( TGF - beta), a major factor in the activation of fibroblasts, increased alpha - SMA and desmin expression and the ability of cell migration and invasion in NIH3T3 cells.	Transforming growth factor - beta,0,33,Gene_or_gene_product	TGF - beta,36,46,Gene_or_gene_product	fibroblasts,85,96,Cell	alpha - SMA,108,119,Gene_or_gene_product	desmin,124,130,Gene_or_gene_product	cell,161,165,Cell	NIH3T3 cells,192,204,Cell	"[{""token"": ""Transforming growth factor - beta"", ""start_span"": 0, ""end_span"": 33, ""type"": ""Gene_or_gene_product""}, {""token"": ""TGF - beta"", ""start_span"": 36, ""end_span"": 46, ""type"": ""Gene_or_gene_product""}, {""token"": ""fibroblasts"", ""start_span"": 85, ""end_span"": 96, ""type"": ""Cell""}, {""token"": ""alpha - SMA"", ""start_span"": 108, ""end_span"": 119, ""type"": ""Gene_or_gene_product""}, {""token"": ""desmin"", ""start_span"": 124, ""end_span"": 130, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 161, ""end_span"": 165, ""type"": ""Cell""}, {""token"": ""NIH3T3 cells"", ""start_span"": 192, ""end_span"": 204, ""type"": ""Cell""}]"	test
Here, we show that a portion of laminin - 332, termed G45, which is proteolytically removed and absent in normal tissues, is prominently expressed in most human SCC tumors and plays an important role in human SCC tumorigenesis.	laminin - 332,32,45,Gene_or_gene_product	G45,54,57,Gene_or_gene_product	normal tissues,106,120,Tissue	human,155,160,Organism	SCC tumors,161,171,Cancer	human,203,208,Organism	SCC,209,212,Cancer	"[{""token"": ""laminin - 332"", ""start_span"": 32, ""end_span"": 45, ""type"": ""Gene_or_gene_product""}, {""token"": ""G45"", ""start_span"": 54, ""end_span"": 57, ""type"": ""Gene_or_gene_product""}, {""token"": ""normal tissues"", ""start_span"": 106, ""end_span"": 120, ""type"": ""Tissue""}, {""token"": ""human"", ""start_span"": 155, ""end_span"": 160, ""type"": ""Organism""}, {""token"": ""SCC tumors"", ""start_span"": 161, ""end_span"": 171, ""type"": ""Cancer""}, {""token"": ""human"", ""start_span"": 203, ""end_span"": 208, ""type"": ""Organism""}, {""token"": ""SCC"", ""start_span"": 209, ""end_span"": 212, ""type"": ""Cancer""}]"	test
After SCC transformation, the absence of G45 domain in DeltaG45 cells was associated with deficient extracellular signal - regulated kinase and phosphotidylinositol 3 - kinase ( PI3K) pathway activation, impaired invasion, deficient metalloproteinase activity, and absent tumorgenicity in vivo.	SCC,6,9,Cancer	G45,41,44,Gene_or_gene_product	DeltaG45,55,63,Gene_or_gene_product	extracellular signal - regulated kinase,100,139,Gene_or_gene_product	phosphotidylinositol 3 - kinase,144,175,Gene_or_gene_product	PI3K,178,182,Gene_or_gene_product	metalloproteinase,233,250,Gene_or_gene_product	"[{""token"": ""SCC"", ""start_span"": 6, ""end_span"": 9, ""type"": ""Cancer""}, {""token"": ""G45"", ""start_span"": 41, ""end_span"": 44, ""type"": ""Gene_or_gene_product""}, {""token"": ""DeltaG45"", ""start_span"": 55, ""end_span"": 63, ""type"": ""Gene_or_gene_product""}, {""token"": ""extracellular signal - regulated kinase"", ""start_span"": 100, ""end_span"": 139, ""type"": ""Gene_or_gene_product""}, {""token"": ""phosphotidylinositol 3 - kinase"", ""start_span"": 144, ""end_span"": 175, ""type"": ""Gene_or_gene_product""}, {""token"": ""PI3K"", ""start_span"": 178, ""end_span"": 182, ""type"": ""Gene_or_gene_product""}, {""token"": ""metalloproteinase"", ""start_span"": 233, ""end_span"": 250, ""type"": ""Gene_or_gene_product""}]"	test
The reference intervals for serum IL - 8 and urine IL - 8 corrected by creatinine ( Cr) were 15. 9 - 430. 3 pg / mL and 0. 0 - 28. 4 pg / mg Cr, respectively.	serum,28,33,Organism_substance	IL - 8,34,40,Gene_or_gene_product	urine,45,50,Organism_substance	IL - 8,51,57,Gene_or_gene_product	creatinine,71,81,Chemical	Cr,84,86,Chemical	Cr,141,143,Chemical	"[{""token"": ""serum"", ""start_span"": 28, ""end_span"": 33, ""type"": ""Organism_substance""}, {""token"": ""IL - 8"", ""start_span"": 34, ""end_span"": 40, ""type"": ""Gene_or_gene_product""}, {""token"": ""urine"", ""start_span"": 45, ""end_span"": 50, ""type"": ""Organism_substance""}, {""token"": ""IL - 8"", ""start_span"": 51, ""end_span"": 57, ""type"": ""Gene_or_gene_product""}, {""token"": ""creatinine"", ""start_span"": 71, ""end_span"": 81, ""type"": ""Chemical""}, {""token"": ""Cr"", ""start_span"": 84, ""end_span"": 86, ""type"": ""Chemical""}, {""token"": ""Cr"", ""start_span"": 141, ""end_span"": 143, ""type"": ""Chemical""}]"	test
During normal skin function, p53 in the keratinocyte is a transducer of the skin tanning signal and an essential component of what is effectively a keratinocyte - melanocyte signaling cycle that regulates skin pigmentation.	skin,14,18,Organ	p53,29,32,Gene_or_gene_product	keratinocyte,40,52,Cell	skin,76,80,Organ	keratinocyte,148,160,Cell	melanocyte,163,173,Cell	skin,205,209,Organ	"[{""token"": ""skin"", ""start_span"": 14, ""end_span"": 18, ""type"": ""Organ""}, {""token"": ""p53"", ""start_span"": 29, ""end_span"": 32, ""type"": ""Gene_or_gene_product""}, {""token"": ""keratinocyte"", ""start_span"": 40, ""end_span"": 52, ""type"": ""Cell""}, {""token"": ""skin"", ""start_span"": 76, ""end_span"": 80, ""type"": ""Organ""}, {""token"": ""keratinocyte"", ""start_span"": 148, ""end_span"": 160, ""type"": ""Cell""}, {""token"": ""melanocyte"", ""start_span"": 163, ""end_span"": 173, ""type"": ""Cell""}, {""token"": ""skin"", ""start_span"": 205, ""end_span"": 209, ""type"": ""Organ""}]"	test
Here, we investigate S727 phosphorylation of Stat3 and its subsequent effects in prostate cancer development, independent of Y705 phosphorylation, using mutated Stat3 in the human prostate cancer cell line LNCaP.	S727,21,25,Amino_acid	Stat3,45,50,Gene_or_gene_product	prostate cancer,81,96,Cancer	Y705,125,129,Amino_acid	Stat3,161,166,Gene_or_gene_product	human,174,179,Organism	prostate cancer cell line LNCaP,180,211,Cell	"[{""token"": ""S727"", ""start_span"": 21, ""end_span"": 25, ""type"": ""Amino_acid""}, {""token"": ""Stat3"", ""start_span"": 45, ""end_span"": 50, ""type"": ""Gene_or_gene_product""}, {""token"": ""prostate cancer"", ""start_span"": 81, ""end_span"": 96, ""type"": ""Cancer""}, {""token"": ""Y705"", ""start_span"": 125, ""end_span"": 129, ""type"": ""Amino_acid""}, {""token"": ""Stat3"", ""start_span"": 161, ""end_span"": 166, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 174, ""end_span"": 179, ""type"": ""Organism""}, {""token"": ""prostate cancer cell line LNCaP"", ""start_span"": 180, ""end_span"": 211, ""type"": ""Cell""}]"	test
The knockdown of robo4 abrogated the chemotactic response of endothelial cells to serum but enhanced a chemokinetic response to Slit2, while robo1 knockdown cells do not display chemotactic response to serum or VEGF.	robo4,17,22,Gene_or_gene_product	endothelial cells,61,78,Cell	serum,82,87,Organism_substance	Slit2,128,133,Gene_or_gene_product	robo1,141,146,Gene_or_gene_product	serum,202,207,Organism_substance	VEGF,211,215,Gene_or_gene_product	"[{""token"": ""robo4"", ""start_span"": 17, ""end_span"": 22, ""type"": ""Gene_or_gene_product""}, {""token"": ""endothelial cells"", ""start_span"": 61, ""end_span"": 78, ""type"": ""Cell""}, {""token"": ""serum"", ""start_span"": 82, ""end_span"": 87, ""type"": ""Organism_substance""}, {""token"": ""Slit2"", ""start_span"": 128, ""end_span"": 133, ""type"": ""Gene_or_gene_product""}, {""token"": ""robo1"", ""start_span"": 141, ""end_span"": 146, ""type"": ""Gene_or_gene_product""}, {""token"": ""serum"", ""start_span"": 202, ""end_span"": 207, ""type"": ""Organism_substance""}, {""token"": ""VEGF"", ""start_span"": 211, ""end_span"": 215, ""type"": ""Gene_or_gene_product""}]"	test
The aim of this study was to compare the effects of PRP and platelet - poor plasma ( PPP) on healing of critical - size bone defects. Bilateral full - thickness, critical - size bone defects were created in the parietal bones of 32 rabbits, which had been studied in 4 groups.	PRP,52,55,Organism_substance	platelet - poor plasma,60,82,Organism_substance	PPP,85,88,Organism_substance	bone,120,124,Organ	bone,178,182,Organ	parietal bones,211,225,Organ	rabbits,232,239,Organism	"[{""token"": ""PRP"", ""start_span"": 52, ""end_span"": 55, ""type"": ""Organism_substance""}, {""token"": ""platelet - poor plasma"", ""start_span"": 60, ""end_span"": 82, ""type"": ""Organism_substance""}, {""token"": ""PPP"", ""start_span"": 85, ""end_span"": 88, ""type"": ""Organism_substance""}, {""token"": ""bone"", ""start_span"": 120, ""end_span"": 124, ""type"": ""Organ""}, {""token"": ""bone"", ""start_span"": 178, ""end_span"": 182, ""type"": ""Organ""}, {""token"": ""parietal bones"", ""start_span"": 211, ""end_span"": 225, ""type"": ""Organ""}, {""token"": ""rabbits"", ""start_span"": 232, ""end_span"": 239, ""type"": ""Organism""}]"	test
Here, we established lymph node metastasis models by injecting overexpressing VEGF - D Lewis lung carcinoma cells into C57BL / 6 mice to explore the effect of honokiol on tumor - associated lymphangiogenesis and related lymph node metastasis.	lymph node,21,31,Multi	VEGF - D,78,86,Gene_or_gene_product	Lewis lung carcinoma cells,87,113,Cell	C57BL / 6 mice,119,133,Organism	honokiol,159,167,Chemical	tumor,171,176,Cancer	lymph node,220,230,Multi	"[{""token"": ""lymph node"", ""start_span"": 21, ""end_span"": 31, ""type"": ""Multi""}, {""token"": ""VEGF - D"", ""start_span"": 78, ""end_span"": 86, ""type"": ""Gene_or_gene_product""}, {""token"": ""Lewis lung carcinoma cells"", ""start_span"": 87, ""end_span"": 113, ""type"": ""Cell""}, {""token"": ""C57BL / 6 mice"", ""start_span"": 119, ""end_span"": 133, ""type"": ""Organism""}, {""token"": ""honokiol"", ""start_span"": 159, ""end_span"": 167, ""type"": ""Chemical""}, {""token"": ""tumor"", ""start_span"": 171, ""end_span"": 176, ""type"": ""Cancer""}, {""token"": ""lymph node"", ""start_span"": 220, ""end_span"": 230, ""type"": ""Multi""}]"	test
In in vitro study, honokiol inhibited VEGF - D - induced survival, proliferation and tube - formation of both human umbilical vein endothelial cells ( HUVECs) and lymphatic vascular endothelial cells ( HLECs).	honokiol,19,27,Chemical	VEGF - D,38,46,Gene_or_gene_product	tube -,85,91,Tissue	human umbilical vein endothelial cells,110,148,Cell	HUVECs,151,157,Cell	lymphatic vascular endothelial cells,163,199,Cell	HLECs,202,207,Cell	"[{""token"": ""honokiol"", ""start_span"": 19, ""end_span"": 27, ""type"": ""Chemical""}, {""token"": ""VEGF - D"", ""start_span"": 38, ""end_span"": 46, ""type"": ""Gene_or_gene_product""}, {""token"": ""tube -"", ""start_span"": 85, ""end_span"": 91, ""type"": ""Tissue""}, {""token"": ""human umbilical vein endothelial cells"", ""start_span"": 110, ""end_span"": 148, ""type"": ""Cell""}, {""token"": ""HUVECs"", ""start_span"": 151, ""end_span"": 157, ""type"": ""Cell""}, {""token"": ""lymphatic vascular endothelial cells"", ""start_span"": 163, ""end_span"": 199, ""type"": ""Cell""}, {""token"": ""HLECs"", ""start_span"": 202, ""end_span"": 207, ""type"": ""Cell""}]"	test
To verify that P18 acts in the same manner as PEDF, we used immunohistochemistry to measure PEDF targets, vascular endothelial growth factor receptor 2, and CD95 ligand expression in P18 - treated vasculature.	P18,15,18,Gene_or_gene_product	PEDF,46,50,Gene_or_gene_product	PEDF targets,92,104,Gene_or_gene_product	vascular endothelial growth factor receptor 2,106,151,Gene_or_gene_product	CD95 ligand,157,168,Gene_or_gene_product	P18,183,186,Gene_or_gene_product	vasculature,197,208,Multi	"[{""token"": ""P18"", ""start_span"": 15, ""end_span"": 18, ""type"": ""Gene_or_gene_product""}, {""token"": ""PEDF"", ""start_span"": 46, ""end_span"": 50, ""type"": ""Gene_or_gene_product""}, {""token"": ""PEDF targets"", ""start_span"": 92, ""end_span"": 104, ""type"": ""Gene_or_gene_product""}, {""token"": ""vascular endothelial growth factor receptor 2"", ""start_span"": 106, ""end_span"": 151, ""type"": ""Gene_or_gene_product""}, {""token"": ""CD95 ligand"", ""start_span"": 157, ""end_span"": 168, ""type"": ""Gene_or_gene_product""}, {""token"": ""P18"", ""start_span"": 183, ""end_span"": 186, ""type"": ""Gene_or_gene_product""}, {""token"": ""vasculature"", ""start_span"": 197, ""end_span"": 208, ""type"": ""Multi""}]"	test
In tumor studies, P18 was more effective in blocking the angiogenesis and growth of the prostate cancer than parental 34 - mer; in the renal cell carcinoma, P18 strongly decreased angiogenesis and halted the progression of established tumors.	tumor,3,8,Cancer	P18,18,21,Gene_or_gene_product	prostate cancer,88,103,Cancer	parental 34 - mer,109,126,Gene_or_gene_product	renal cell carcinoma,135,155,Cancer	P18,157,160,Gene_or_gene_product	tumors,235,241,Cancer	"[{""token"": ""tumor"", ""start_span"": 3, ""end_span"": 8, ""type"": ""Cancer""}, {""token"": ""P18"", ""start_span"": 18, ""end_span"": 21, ""type"": ""Gene_or_gene_product""}, {""token"": ""prostate cancer"", ""start_span"": 88, ""end_span"": 103, ""type"": ""Cancer""}, {""token"": ""parental 34 - mer"", ""start_span"": 109, ""end_span"": 126, ""type"": ""Gene_or_gene_product""}, {""token"": ""renal cell carcinoma"", ""start_span"": 135, ""end_span"": 155, ""type"": ""Cancer""}, {""token"": ""P18"", ""start_span"": 157, ""end_span"": 160, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumors"", ""start_span"": 235, ""end_span"": 241, ""type"": ""Cancer""}]"	test
These antivascular actions are due in part to direct effects on endothelial cells, and all MBDs ( both microtubule - stabilizing and microtubule - destabilizing) inhibit endothelial cell proliferation, migration, and tube formation in vitro, actions that are thought to correspond to therapeutic antiangiogenic actions.	antivascular,6,18,Multi	endothelial cells,64,81,Cell	MBDs,91,95,Chemical	microtubule,103,114,Cellular_component	microtubule,133,144,Cellular_component	endothelial cell,170,186,Cell	tube,217,221,Tissue	"[{""token"": ""antivascular"", ""start_span"": 6, ""end_span"": 18, ""type"": ""Multi""}, {""token"": ""endothelial cells"", ""start_span"": 64, ""end_span"": 81, ""type"": ""Cell""}, {""token"": ""MBDs"", ""start_span"": 91, ""end_span"": 95, ""type"": ""Chemical""}, {""token"": ""microtubule"", ""start_span"": 103, ""end_span"": 114, ""type"": ""Cellular_component""}, {""token"": ""microtubule"", ""start_span"": 133, ""end_span"": 144, ""type"": ""Cellular_component""}, {""token"": ""endothelial cell"", ""start_span"": 170, ""end_span"": 186, ""type"": ""Cell""}, {""token"": ""tube"", ""start_span"": 217, ""end_span"": 221, ""type"": ""Tissue""}]"	test
Perlecan was also found to stimulate endothelial cell proliferation in vitro over a period of 6 days in the presence of plasma proteins and fibroblastic growth factor 2 ( FGF - 2), however in the absence of FGF - 2 endothelial cell growth could not be maintained during this period.	Perlecan,0,8,Gene_or_gene_product	endothelial cell,37,53,Cell	plasma,120,126,Organism_substance	fibroblastic growth factor 2,140,168,Gene_or_gene_product	FGF - 2,171,178,Gene_or_gene_product	FGF - 2,207,214,Gene_or_gene_product	endothelial cell,215,231,Cell	"[{""token"": ""Perlecan"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Gene_or_gene_product""}, {""token"": ""endothelial cell"", ""start_span"": 37, ""end_span"": 53, ""type"": ""Cell""}, {""token"": ""plasma"", ""start_span"": 120, ""end_span"": 126, ""type"": ""Organism_substance""}, {""token"": ""fibroblastic growth factor 2"", ""start_span"": 140, ""end_span"": 168, ""type"": ""Gene_or_gene_product""}, {""token"": ""FGF - 2"", ""start_span"": 171, ""end_span"": 178, ""type"": ""Gene_or_gene_product""}, {""token"": ""FGF - 2"", ""start_span"": 207, ""end_span"": 214, ""type"": ""Gene_or_gene_product""}, {""token"": ""endothelial cell"", ""start_span"": 215, ""end_span"": 231, ""type"": ""Cell""}]"	test
Antiprogestin RU - 486 inhibits the induction of VEGF and TSP - 1 by progestins, suggesting that this effect of progestin is mediated by the progesterone receptor ( PR).	Antiprogestin RU - 486,0,22,Chemical	VEGF,49,53,Gene_or_gene_product	TSP - 1,58,65,Gene_or_gene_product	progestins,69,79,Chemical	progestin,112,121,Chemical	progesterone receptor,141,162,Gene_or_gene_product	PR,165,167,Gene_or_gene_product	"[{""token"": ""Antiprogestin RU - 486"", ""start_span"": 0, ""end_span"": 22, ""type"": ""Chemical""}, {""token"": ""VEGF"", ""start_span"": 49, ""end_span"": 53, ""type"": ""Gene_or_gene_product""}, {""token"": ""TSP - 1"", ""start_span"": 58, ""end_span"": 65, ""type"": ""Gene_or_gene_product""}, {""token"": ""progestins"", ""start_span"": 69, ""end_span"": 79, ""type"": ""Chemical""}, {""token"": ""progestin"", ""start_span"": 112, ""end_span"": 121, ""type"": ""Chemical""}, {""token"": ""progesterone receptor"", ""start_span"": 141, ""end_span"": 162, ""type"": ""Gene_or_gene_product""}, {""token"": ""PR"", ""start_span"": 165, ""end_span"": 167, ""type"": ""Gene_or_gene_product""}]"	test
Reduction of TCF activity in these cells attenuates their ability to form brain and bone metastases in mice, independently of effects on tumor growth in the lungs.	TCF,13,16,Gene_or_gene_product	cells,35,40,Cell	brain,74,79,Organ	bone,84,88,Organ	mice,103,107,Organism	tumor,137,142,Cancer	lungs,157,162,Organ	"[{""token"": ""TCF"", ""start_span"": 13, ""end_span"": 16, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 35, ""end_span"": 40, ""type"": ""Cell""}, {""token"": ""brain"", ""start_span"": 74, ""end_span"": 79, ""type"": ""Organ""}, {""token"": ""bone"", ""start_span"": 84, ""end_span"": 88, ""type"": ""Organ""}, {""token"": ""mice"", ""start_span"": 103, ""end_span"": 107, ""type"": ""Organism""}, {""token"": ""tumor"", ""start_span"": 137, ""end_span"": 142, ""type"": ""Cancer""}, {""token"": ""lungs"", ""start_span"": 157, ""end_span"": 162, ""type"": ""Organ""}]"	test
Thus, a distinct WNT / TCF signaling program through LEF1 and HOXB9 enhances the competence of lung adenocarcinoma cells to colonize the bones and the brain.	WNT,17,20,Gene_or_gene_product	TCF,23,26,Gene_or_gene_product	LEF1,53,57,Gene_or_gene_product	HOXB9,62,67,Gene_or_gene_product	lung adenocarcinoma cells,95,120,Cell	bones,137,142,Organ	brain,151,156,Organ	"[{""token"": ""WNT"", ""start_span"": 17, ""end_span"": 20, ""type"": ""Gene_or_gene_product""}, {""token"": ""TCF"", ""start_span"": 23, ""end_span"": 26, ""type"": ""Gene_or_gene_product""}, {""token"": ""LEF1"", ""start_span"": 53, ""end_span"": 57, ""type"": ""Gene_or_gene_product""}, {""token"": ""HOXB9"", ""start_span"": 62, ""end_span"": 67, ""type"": ""Gene_or_gene_product""}, {""token"": ""lung adenocarcinoma cells"", ""start_span"": 95, ""end_span"": 120, ""type"": ""Cell""}, {""token"": ""bones"", ""start_span"": 137, ""end_span"": 142, ""type"": ""Organ""}, {""token"": ""brain"", ""start_span"": 151, ""end_span"": 156, ""type"": ""Organ""}]"	test
Moreover, we demonstrate that this inflammation - driven netrin - 1 up - regulation is causal for colorectal cancer development as interference with netrin - 1 autocrine loop in a mouse model for ulcerative colitis - associated colorectal cancer, while showing no effect on inflammation, inhibits colorectal cancer progression.	netrin - 1,57,67,Gene_or_gene_product	colorectal cancer,98,115,Cancer	netrin - 1,149,159,Gene_or_gene_product	mouse,180,185,Organism	ulcerative,196,206,Pathological_formation	colorectal cancer,228,245,Cancer	colorectal cancer,297,314,Cancer	"[{""token"": ""netrin - 1"", ""start_span"": 57, ""end_span"": 67, ""type"": ""Gene_or_gene_product""}, {""token"": ""colorectal cancer"", ""start_span"": 98, ""end_span"": 115, ""type"": ""Cancer""}, {""token"": ""netrin - 1"", ""start_span"": 149, ""end_span"": 159, ""type"": ""Gene_or_gene_product""}, {""token"": ""mouse"", ""start_span"": 180, ""end_span"": 185, ""type"": ""Organism""}, {""token"": ""ulcerative"", ""start_span"": 196, ""end_span"": 206, ""type"": ""Pathological_formation""}, {""token"": ""colorectal cancer"", ""start_span"": 228, ""end_span"": 245, ""type"": ""Cancer""}, {""token"": ""colorectal cancer"", ""start_span"": 297, ""end_span"": 314, ""type"": ""Cancer""}]"	test
Gene expression data from bone marrow ( BM), liver, and spleen of mice exposed to a single dose ( 4 h) or seven daily doses of 2 - BE were used to develop a mechanistic model of hemangiosarcoma.	bone marrow,26,37,Multi	BM,40,42,Multi	liver,45,50,Organ	spleen,56,62,Organ	mice,66,70,Organism	2 - BE,127,133,Chemical	hemangiosarcoma,178,193,Cancer	"[{""token"": ""bone marrow"", ""start_span"": 26, ""end_span"": 37, ""type"": ""Multi""}, {""token"": ""BM"", ""start_span"": 40, ""end_span"": 42, ""type"": ""Multi""}, {""token"": ""liver"", ""start_span"": 45, ""end_span"": 50, ""type"": ""Organ""}, {""token"": ""spleen"", ""start_span"": 56, ""end_span"": 62, ""type"": ""Organ""}, {""token"": ""mice"", ""start_span"": 66, ""end_span"": 70, ""type"": ""Organism""}, {""token"": ""2 - BE"", ""start_span"": 127, ""end_span"": 133, ""type"": ""Chemical""}, {""token"": ""hemangiosarcoma"", ""start_span"": 178, ""end_span"": 193, ""type"": ""Cancer""}]"	test
In addition, the model supports local tissue hypoxia in the liver and spleen, coupled with increased erythropoeitin signaling and erythropoiesis in the spleen and BM, and suppression of mechanisms that contribute to genomic stability, events that could be contributing factors to hemangiosarcoma formation.	tissue,38,44,Tissue	liver,60,65,Organ	spleen,70,76,Organ	erythropoeitin,101,115,Gene_or_gene_product	spleen,152,158,Organ	BM,163,165,Multi	hemangiosarcoma,280,295,Cancer	"[{""token"": ""tissue"", ""start_span"": 38, ""end_span"": 44, ""type"": ""Tissue""}, {""token"": ""liver"", ""start_span"": 60, ""end_span"": 65, ""type"": ""Organ""}, {""token"": ""spleen"", ""start_span"": 70, ""end_span"": 76, ""type"": ""Organ""}, {""token"": ""erythropoeitin"", ""start_span"": 101, ""end_span"": 115, ""type"": ""Gene_or_gene_product""}, {""token"": ""spleen"", ""start_span"": 152, ""end_span"": 158, ""type"": ""Organ""}, {""token"": ""BM"", ""start_span"": 163, ""end_span"": 165, ""type"": ""Multi""}, {""token"": ""hemangiosarcoma"", ""start_span"": 280, ""end_span"": 295, ""type"": ""Cancer""}]"	test
ICAM - 3 enhances the migratory and invasive potential of human non - small cell lung cancer cells by inducing MMP - 2 and MMP - 9 via Akt and CREB.	ICAM - 3,0,8,Gene_or_gene_product	human,58,63,Organism	non - small cell lung cancer cells,64,98,Cell	MMP - 2,111,118,Gene_or_gene_product	MMP - 9,123,130,Gene_or_gene_product	Akt,135,138,Gene_or_gene_product	CREB,143,147,Gene_or_gene_product	"[{""token"": ""ICAM - 3"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 58, ""end_span"": 63, ""type"": ""Organism""}, {""token"": ""non - small cell lung cancer cells"", ""start_span"": 64, ""end_span"": 98, ""type"": ""Cell""}, {""token"": ""MMP - 2"", ""start_span"": 111, ""end_span"": 118, ""type"": ""Gene_or_gene_product""}, {""token"": ""MMP - 9"", ""start_span"": 123, ""end_span"": 130, ""type"": ""Gene_or_gene_product""}, {""token"": ""Akt"", ""start_span"": 135, ""end_span"": 138, ""type"": ""Gene_or_gene_product""}, {""token"": ""CREB"", ""start_span"": 143, ""end_span"": 147, ""type"": ""Gene_or_gene_product""}]"	test
Knocking down p24delta1 in insulinoma cell lines, which also resulted in the concomitant knock - down of other family members, impaired glucose - stimulated insulin secretion, decreased total cellular insulin content and reduced proinsulin biosynthesis.	p24delta1,14,23,Gene_or_gene_product	insulinoma cell lines,27,48,Cell	glucose,136,143,Chemical	insulin,157,164,Gene_or_gene_product	cellular,192,200,Cell	insulin,201,208,Gene_or_gene_product	proinsulin,229,239,Gene_or_gene_product	"[{""token"": ""p24delta1"", ""start_span"": 14, ""end_span"": 23, ""type"": ""Gene_or_gene_product""}, {""token"": ""insulinoma cell lines"", ""start_span"": 27, ""end_span"": 48, ""type"": ""Cell""}, {""token"": ""glucose"", ""start_span"": 136, ""end_span"": 143, ""type"": ""Chemical""}, {""token"": ""insulin"", ""start_span"": 157, ""end_span"": 164, ""type"": ""Gene_or_gene_product""}, {""token"": ""cellular"", ""start_span"": 192, ""end_span"": 200, ""type"": ""Cell""}, {""token"": ""insulin"", ""start_span"": 201, ""end_span"": 208, ""type"": ""Gene_or_gene_product""}, {""token"": ""proinsulin"", ""start_span"": 229, ""end_span"": 239, ""type"": ""Gene_or_gene_product""}]"	test
BACKGROUND: The aim of this study was to investigate not only the intratumoral and peritumoral lymphatic vessel density ( ILD and PLD) but also the expression of vascular endothelial growth factors ( VEGFs) and to test their correlation with regional lymph nodal metastases in papillary thyroid microcarcinoma ( PTMC).	intratumoral,66,78,Cancer	peritumoral lymphatic vessel,83,111,Multi	vascular endothelial growth factors,162,197,Gene_or_gene_product	VEGFs,200,205,Gene_or_gene_product	lymph nodal,251,262,Multi	papillary thyroid microcarcinoma,277,309,Cancer	PTMC,312,316,Cancer	"[{""token"": ""intratumoral"", ""start_span"": 66, ""end_span"": 78, ""type"": ""Cancer""}, {""token"": ""peritumoral lymphatic vessel"", ""start_span"": 83, ""end_span"": 111, ""type"": ""Multi""}, {""token"": ""vascular endothelial growth factors"", ""start_span"": 162, ""end_span"": 197, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGFs"", ""start_span"": 200, ""end_span"": 205, ""type"": ""Gene_or_gene_product""}, {""token"": ""lymph nodal"", ""start_span"": 251, ""end_span"": 262, ""type"": ""Multi""}, {""token"": ""papillary thyroid microcarcinoma"", ""start_span"": 277, ""end_span"": 309, ""type"": ""Cancer""}, {""token"": ""PTMC"", ""start_span"": 312, ""end_span"": 316, ""type"": ""Cancer""}]"	test
Multikinase inhibitor sorafenib inhibits proliferation and angiogenesis of tumors by suppressing the Raf / MEK / ERK signaling pathway and VEGF receptor tyrosine kinase.	sorafenib,22,31,Chemical	tumors,75,81,Cancer	Raf,101,104,Gene_or_gene_product	MEK,107,110,Gene_or_gene_product	ERK,113,116,Gene_or_gene_product	VEGF receptor,139,152,Gene_or_gene_product	tyrosine,153,161,Amino_acid	"[{""token"": ""sorafenib"", ""start_span"": 22, ""end_span"": 31, ""type"": ""Chemical""}, {""token"": ""tumors"", ""start_span"": 75, ""end_span"": 81, ""type"": ""Cancer""}, {""token"": ""Raf"", ""start_span"": 101, ""end_span"": 104, ""type"": ""Gene_or_gene_product""}, {""token"": ""MEK"", ""start_span"": 107, ""end_span"": 110, ""type"": ""Gene_or_gene_product""}, {""token"": ""ERK"", ""start_span"": 113, ""end_span"": 116, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF receptor"", ""start_span"": 139, ""end_span"": 152, ""type"": ""Gene_or_gene_product""}, {""token"": ""tyrosine"", ""start_span"": 153, ""end_span"": 161, ""type"": ""Amino_acid""}]"	test
Sorafenib treatment led to accumulation of autophagosomes as evidenced by conversion from LC3 - I to LC3 - II observed by immunoblot in Huh7, HLF and PLC / PRF / 5 cells.	Sorafenib,0,9,Chemical	autophagosomes,43,57,Cellular_component	LC3 - I,90,97,Gene_or_gene_product	LC3 - II,101,109,Gene_or_gene_product	Huh7,136,140,Cell	HLF,142,145,Cell	PLC / PRF / 5 cells,150,169,Cell	"[{""token"": ""Sorafenib"", ""start_span"": 0, ""end_span"": 9, ""type"": ""Chemical""}, {""token"": ""autophagosomes"", ""start_span"": 43, ""end_span"": 57, ""type"": ""Cellular_component""}, {""token"": ""LC3 - I"", ""start_span"": 90, ""end_span"": 97, ""type"": ""Gene_or_gene_product""}, {""token"": ""LC3 - II"", ""start_span"": 101, ""end_span"": 109, ""type"": ""Gene_or_gene_product""}, {""token"": ""Huh7"", ""start_span"": 136, ""end_span"": 140, ""type"": ""Cell""}, {""token"": ""HLF"", ""start_span"": 142, ""end_span"": 145, ""type"": ""Cell""}, {""token"": ""PLC / PRF / 5 cells"", ""start_span"": 150, ""end_span"": 169, ""type"": ""Cell""}]"	test
This induction was due to activation of autophagic flux, as there was further increase in LC3 - II expression upon treatment with lysosomal inhibitors, clear decline of the autophagy substrate p62, and an mRFP - GFP - LC3 fluorescence change in sorafenib - treated hepatoma cells.	LC3 - II,90,98,Gene_or_gene_product	p62,193,196,Gene_or_gene_product	mRFP,205,209,Gene_or_gene_product	GFP,212,215,Gene_or_gene_product	LC3,218,221,Gene_or_gene_product	sorafenib,245,254,Chemical	hepatoma cells,265,279,Cell	"[{""token"": ""LC3 - II"", ""start_span"": 90, ""end_span"": 98, ""type"": ""Gene_or_gene_product""}, {""token"": ""p62"", ""start_span"": 193, ""end_span"": 196, ""type"": ""Gene_or_gene_product""}, {""token"": ""mRFP"", ""start_span"": 205, ""end_span"": 209, ""type"": ""Gene_or_gene_product""}, {""token"": ""GFP"", ""start_span"": 212, ""end_span"": 215, ""type"": ""Gene_or_gene_product""}, {""token"": ""LC3"", ""start_span"": 218, ""end_span"": 221, ""type"": ""Gene_or_gene_product""}, {""token"": ""sorafenib"", ""start_span"": 245, ""end_span"": 254, ""type"": ""Chemical""}, {""token"": ""hepatoma cells"", ""start_span"": 265, ""end_span"": 279, ""type"": ""Cell""}]"	test
Relationship between of blood flow, glucose metabolism, protein synthesis, glucose and ATP content in experimentally - induced glioma ( RG1 2. 2) of rat brain.	blood,24,29,Organism_substance	glucose,36,43,Chemical	glucose,75,82,Chemical	ATP,87,90,Chemical	glioma,127,133,Cancer	rat,149,152,Organism	brain,153,158,Organ	"[{""token"": ""blood"", ""start_span"": 24, ""end_span"": 29, ""type"": ""Organism_substance""}, {""token"": ""glucose"", ""start_span"": 36, ""end_span"": 43, ""type"": ""Chemical""}, {""token"": ""glucose"", ""start_span"": 75, ""end_span"": 82, ""type"": ""Chemical""}, {""token"": ""ATP"", ""start_span"": 87, ""end_span"": 90, ""type"": ""Chemical""}, {""token"": ""glioma"", ""start_span"": 127, ""end_span"": 133, ""type"": ""Cancer""}, {""token"": ""rat"", ""start_span"": 149, ""end_span"": 152, ""type"": ""Organism""}, {""token"": ""brain"", ""start_span"": 153, ""end_span"": 158, ""type"": ""Organ""}]"	test
In experimental RG1 2. 2 glioma of rat brain, local blood flow, glucose utilization, protein synthesis, glucose and ATP content were measured by means of triple tracer autoradiography and bioluminescence technique, respectively, to determine hemodynamic and metabolic thresholds for local tumor energy failure.	rat,35,38,Organism	brain,39,44,Organ	blood,52,57,Organism_substance	glucose,64,71,Chemical	glucose,104,111,Chemical	ATP,116,119,Chemical	tumor,289,294,Cancer	"[{""token"": ""rat"", ""start_span"": 35, ""end_span"": 38, ""type"": ""Organism""}, {""token"": ""brain"", ""start_span"": 39, ""end_span"": 44, ""type"": ""Organ""}, {""token"": ""blood"", ""start_span"": 52, ""end_span"": 57, ""type"": ""Organism_substance""}, {""token"": ""glucose"", ""start_span"": 64, ""end_span"": 71, ""type"": ""Chemical""}, {""token"": ""glucose"", ""start_span"": 104, ""end_span"": 111, ""type"": ""Chemical""}, {""token"": ""ATP"", ""start_span"": 116, ""end_span"": 119, ""type"": ""Chemical""}, {""token"": ""tumor"", ""start_span"": 289, ""end_span"": 294, ""type"": ""Cancer""}]"	test
Because AR - ARD1 interaction facilitated the AR binding to its targeted promoters for gene transcription, we propose that ARD1 functions as a unique AR regulator and forms a positive feedback loop for AR - dependent prostate tumorigenesis.	AR,8,10,Gene_or_gene_product	ARD1,13,17,Gene_or_gene_product	AR,46,48,Gene_or_gene_product	ARD1,123,127,Gene_or_gene_product	AR,150,152,Gene_or_gene_product	AR,202,204,Gene_or_gene_product	prostate,217,225,Organ	"[{""token"": ""AR"", ""start_span"": 8, ""end_span"": 10, ""type"": ""Gene_or_gene_product""}, {""token"": ""ARD1"", ""start_span"": 13, ""end_span"": 17, ""type"": ""Gene_or_gene_product""}, {""token"": ""AR"", ""start_span"": 46, ""end_span"": 48, ""type"": ""Gene_or_gene_product""}, {""token"": ""ARD1"", ""start_span"": 123, ""end_span"": 127, ""type"": ""Gene_or_gene_product""}, {""token"": ""AR"", ""start_span"": 150, ""end_span"": 152, ""type"": ""Gene_or_gene_product""}, {""token"": ""AR"", ""start_span"": 202, ""end_span"": 204, ""type"": ""Gene_or_gene_product""}, {""token"": ""prostate"", ""start_span"": 217, ""end_span"": 225, ""type"": ""Organ""}]"	test
However, in Apc mutation - induced intestinal tumors, inactivation of Hes1 alone was sufficient for reducing tumor cell proliferation and inducing differentiation of tumor cells into all types of intestinal epithelial cells, but without affecting the homeostasis of normal crypts owing to genetic redundancy.	Apc,12,15,Gene_or_gene_product	intestinal tumors,35,52,Cancer	Hes1,70,74,Gene_or_gene_product	tumor cell,109,119,Cell	tumor cells,166,177,Cell	intestinal epithelial cells,196,223,Cell	crypts,273,279,Multi	"[{""token"": ""Apc"", ""start_span"": 12, ""end_span"": 15, ""type"": ""Gene_or_gene_product""}, {""token"": ""intestinal tumors"", ""start_span"": 35, ""end_span"": 52, ""type"": ""Cancer""}, {""token"": ""Hes1"", ""start_span"": 70, ""end_span"": 74, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor cell"", ""start_span"": 109, ""end_span"": 119, ""type"": ""Cell""}, {""token"": ""tumor cells"", ""start_span"": 166, ""end_span"": 177, ""type"": ""Cell""}, {""token"": ""intestinal epithelial cells"", ""start_span"": 196, ""end_span"": 223, ""type"": ""Cell""}, {""token"": ""crypts"", ""start_span"": 273, ""end_span"": 279, ""type"": ""Multi""}]"	test
Both B and T lymphocytes diversify their antigen receptors through RAG1 / 2 mediated recombination, but B cells undergo two additional processes - - somatic hypermutation ( SHM) and class - switch recombination ( CSR), both initiated by activation - induced cytidine deaminase ( AID).	B,0,1,Cell	T lymphocytes,11,24,Cell	RAG1,67,71,Gene_or_gene_product	2,74,75,Gene_or_gene_product	B cells,104,111,Cell	activation - induced cytidine deaminase,237,276,Gene_or_gene_product	AID,279,282,Gene_or_gene_product	"[{""token"": ""B"", ""start_span"": 0, ""end_span"": 1, ""type"": ""Cell""}, {""token"": ""T lymphocytes"", ""start_span"": 11, ""end_span"": 24, ""type"": ""Cell""}, {""token"": ""RAG1"", ""start_span"": 67, ""end_span"": 71, ""type"": ""Gene_or_gene_product""}, {""token"": ""2"", ""start_span"": 74, ""end_span"": 75, ""type"": ""Gene_or_gene_product""}, {""token"": ""B cells"", ""start_span"": 104, ""end_span"": 111, ""type"": ""Cell""}, {""token"": ""activation - induced cytidine deaminase"", ""start_span"": 237, ""end_span"": 276, ""type"": ""Gene_or_gene_product""}, {""token"": ""AID"", ""start_span"": 279, ""end_span"": 282, ""type"": ""Gene_or_gene_product""}]"	test
Transformation of BHK hamster fibroblasts by an env - strain of Rous sarcoma virus ( RSV) leads to the appearance at the cell surface of a virus - induced nonvirion antigen ( VCSA), specific for transformation, whose expression is controlled by the transforming src gene.	BHK hamster fibroblasts,18,41,Cell	Rous sarcoma virus,64,82,Organism	RSV,85,88,Organism	cell surface,121,133,Cellular_component	virus - induced nonvirion antigen,139,172,Gene_or_gene_product	VCSA,175,179,Gene_or_gene_product	src,262,265,Gene_or_gene_product	"[{""token"": ""BHK hamster fibroblasts"", ""start_span"": 18, ""end_span"": 41, ""type"": ""Cell""}, {""token"": ""Rous sarcoma virus"", ""start_span"": 64, ""end_span"": 82, ""type"": ""Organism""}, {""token"": ""RSV"", ""start_span"": 85, ""end_span"": 88, ""type"": ""Organism""}, {""token"": ""cell surface"", ""start_span"": 121, ""end_span"": 133, ""type"": ""Cellular_component""}, {""token"": ""virus - induced nonvirion antigen"", ""start_span"": 139, ""end_span"": 172, ""type"": ""Gene_or_gene_product""}, {""token"": ""VCSA"", ""start_span"": 175, ""end_span"": 179, ""type"": ""Gene_or_gene_product""}, {""token"": ""src"", ""start_span"": 262, ""end_span"": 265, ""type"": ""Gene_or_gene_product""}]"	test
This observation indicates that VCSA expression at the cell surface is likely to be the result of the interaction between the viral src gene product pp60src with host cell gene ( s) or gene product ( s), rather than the simple expression of this molecule at the cell surface.	VCSA,32,36,Gene_or_gene_product	cell surface,55,67,Cellular_component	viral,126,131,Organism	src,132,135,Gene_or_gene_product	pp60src,149,156,Gene_or_gene_product	cell,167,171,Cell	cell surface,262,274,Cellular_component	"[{""token"": ""VCSA"", ""start_span"": 32, ""end_span"": 36, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell surface"", ""start_span"": 55, ""end_span"": 67, ""type"": ""Cellular_component""}, {""token"": ""viral"", ""start_span"": 126, ""end_span"": 131, ""type"": ""Organism""}, {""token"": ""src"", ""start_span"": 132, ""end_span"": 135, ""type"": ""Gene_or_gene_product""}, {""token"": ""pp60src"", ""start_span"": 149, ""end_span"": 156, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 167, ""end_span"": 171, ""type"": ""Cell""}, {""token"": ""cell surface"", ""start_span"": 262, ""end_span"": 274, ""type"": ""Cellular_component""}]"	test
Treatment of murine pulmonary capillary endothelial cells with HAH - cortisol at 10 ( - 5) M ( with respect to cortisol) suppressed their DNA synthesis by 50% and inhibited their migration into wounded areas of confluent monolayers.	murine,13,19,Organism	pulmonary capillary endothelial cells,20,57,Cell	HAH - cortisol,63,77,Chemical	cortisol,111,119,Chemical	DNA,138,141,Cellular_component	wounded areas,194,207,Pathological_formation	monolayers,221,231,Cell	"[{""token"": ""murine"", ""start_span"": 13, ""end_span"": 19, ""type"": ""Organism""}, {""token"": ""pulmonary capillary endothelial cells"", ""start_span"": 20, ""end_span"": 57, ""type"": ""Cell""}, {""token"": ""HAH - cortisol"", ""start_span"": 63, ""end_span"": 77, ""type"": ""Chemical""}, {""token"": ""cortisol"", ""start_span"": 111, ""end_span"": 119, ""type"": ""Chemical""}, {""token"": ""DNA"", ""start_span"": 138, ""end_span"": 141, ""type"": ""Cellular_component""}, {""token"": ""wounded areas"", ""start_span"": 194, ""end_span"": 207, ""type"": ""Pathological_formation""}, {""token"": ""monolayers"", ""start_span"": 221, ""end_span"": 231, ""type"": ""Cell""}]"	test
Human K562 cells, which express PHGPX, but not GPX, were also more sensitive to t - BuOOH in the Se - deficient ( K. Se ( -)) than Se - satisfied ( K. Se ( +)) condition.	Human,0,5,Organism	K562 cells,6,16,Cell	PHGPX,32,37,Gene_or_gene_product	GPX,47,50,Gene_or_gene_product	t - BuOOH,80,89,Chemical	Se,97,99,Chemical	Se,117,119,Chemical	"[{""token"": ""Human"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Organism""}, {""token"": ""K562 cells"", ""start_span"": 6, ""end_span"": 16, ""type"": ""Cell""}, {""token"": ""PHGPX"", ""start_span"": 32, ""end_span"": 37, ""type"": ""Gene_or_gene_product""}, {""token"": ""GPX"", ""start_span"": 47, ""end_span"": 50, ""type"": ""Gene_or_gene_product""}, {""token"": ""t - BuOOH"", ""start_span"": 80, ""end_span"": 89, ""type"": ""Chemical""}, {""token"": ""Se"", ""start_span"": 97, ""end_span"": 99, ""type"": ""Chemical""}, {""token"": ""Se"", ""start_span"": 117, ""end_span"": 119, ""type"": ""Chemical""}]"	test
Appearance of tumorous phenotypes in goldfish erythrophores transfected with ras, src, and myc oncogenes and spontaneous differentiation of the transformants in vitro.	tumorous,14,22,Cancer	goldfish,37,45,Organism	erythrophores,46,59,Cell	ras,77,80,Gene_or_gene_product	src,82,85,Gene_or_gene_product	myc,91,94,Gene_or_gene_product	transformants,144,157,Cell	"[{""token"": ""tumorous"", ""start_span"": 14, ""end_span"": 22, ""type"": ""Cancer""}, {""token"": ""goldfish"", ""start_span"": 37, ""end_span"": 45, ""type"": ""Organism""}, {""token"": ""erythrophores"", ""start_span"": 46, ""end_span"": 59, ""type"": ""Cell""}, {""token"": ""ras"", ""start_span"": 77, ""end_span"": 80, ""type"": ""Gene_or_gene_product""}, {""token"": ""src"", ""start_span"": 82, ""end_span"": 85, ""type"": ""Gene_or_gene_product""}, {""token"": ""myc"", ""start_span"": 91, ""end_span"": 94, ""type"": ""Gene_or_gene_product""}, {""token"": ""transformants"", ""start_span"": 144, ""end_span"": 157, ""type"": ""Cell""}]"	test
Patterns of X - chromosome inactivation, mutations in the K - ras gene, mutations or allelic loss of the p53 gene, or human papillomavirus detection were identical in both endometrial and ovarian lesions in three of the cases suggesting that those three cases represented single primary tumors with metastases.	X - chromosome,12,26,Cellular_component	K - ras,58,65,Gene_or_gene_product	p53,105,108,Gene_or_gene_product	human papillomavirus,118,138,Organism	endometrial,172,183,Pathological_formation	ovarian lesions,188,203,Pathological_formation	primary tumors,279,293,Cancer	"[{""token"": ""X - chromosome"", ""start_span"": 12, ""end_span"": 26, ""type"": ""Cellular_component""}, {""token"": ""K - ras"", ""start_span"": 58, ""end_span"": 65, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 105, ""end_span"": 108, ""type"": ""Gene_or_gene_product""}, {""token"": ""human papillomavirus"", ""start_span"": 118, ""end_span"": 138, ""type"": ""Organism""}, {""token"": ""endometrial"", ""start_span"": 172, ""end_span"": 183, ""type"": ""Pathological_formation""}, {""token"": ""ovarian lesions"", ""start_span"": 188, ""end_span"": 203, ""type"": ""Pathological_formation""}, {""token"": ""primary tumors"", ""start_span"": 279, ""end_span"": 293, ""type"": ""Cancer""}]"	test
The high - oncogenic - risk HPV types associated with invasive cervical cancer produce two oncoproteins, designated E6 and E7, which interact with endogenous cell cycle regulatory proteins, including p53 and Rb.	HPV,28,31,Organism	cervical cancer,63,78,Cancer	E6,116,118,Gene_or_gene_product	E7,123,125,Gene_or_gene_product	cell,158,162,Cell	p53,200,203,Gene_or_gene_product	Rb,208,210,Gene_or_gene_product	"[{""token"": ""HPV"", ""start_span"": 28, ""end_span"": 31, ""type"": ""Organism""}, {""token"": ""cervical cancer"", ""start_span"": 63, ""end_span"": 78, ""type"": ""Cancer""}, {""token"": ""E6"", ""start_span"": 116, ""end_span"": 118, ""type"": ""Gene_or_gene_product""}, {""token"": ""E7"", ""start_span"": 123, ""end_span"": 125, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 158, ""end_span"": 162, ""type"": ""Cell""}, {""token"": ""p53"", ""start_span"": 200, ""end_span"": 203, ""type"": ""Gene_or_gene_product""}, {""token"": ""Rb"", ""start_span"": 208, ""end_span"": 210, ""type"": ""Gene_or_gene_product""}]"	test
Treatment of NIH 3T3 cells with the PKC inhibitor staurosporine, the tyrosine kinase inhibitor herbimycin A, and the AA metabolism inhibitor quinacrine induces apoptotic cell death.	NIH 3T3 cells,13,26,Cell	PKC,36,39,Gene_or_gene_product	staurosporine,50,63,Chemical	herbimycin A,95,107,Chemical	AA,117,119,Chemical	quinacrine,141,151,Chemical	cell,170,174,Cell	"[{""token"": ""NIH 3T3 cells"", ""start_span"": 13, ""end_span"": 26, ""type"": ""Cell""}, {""token"": ""PKC"", ""start_span"": 36, ""end_span"": 39, ""type"": ""Gene_or_gene_product""}, {""token"": ""staurosporine"", ""start_span"": 50, ""end_span"": 63, ""type"": ""Chemical""}, {""token"": ""herbimycin A"", ""start_span"": 95, ""end_span"": 107, ""type"": ""Chemical""}, {""token"": ""AA"", ""start_span"": 117, ""end_span"": 119, ""type"": ""Chemical""}, {""token"": ""quinacrine"", ""start_span"": 141, ""end_span"": 151, ""type"": ""Chemical""}, {""token"": ""cell"", ""start_span"": 170, ""end_span"": 174, ""type"": ""Cell""}]"	test
The present studies examine whether lymphocyte stimulation via cells engineered to secrete GM - CSF or IL - 2 decreases hepatic tumor growth, and whether stimulation of both macrophages and lymphocytes is more effective than either individually.	lymphocyte,36,46,Cell	cells,63,68,Cell	GM - CSF,91,99,Gene_or_gene_product	IL - 2,103,109,Gene_or_gene_product	hepatic tumor,120,133,Cancer	macrophages,174,185,Cell	lymphocytes,190,201,Cell	"[{""token"": ""lymphocyte"", ""start_span"": 36, ""end_span"": 46, ""type"": ""Cell""}, {""token"": ""cells"", ""start_span"": 63, ""end_span"": 68, ""type"": ""Cell""}, {""token"": ""GM - CSF"", ""start_span"": 91, ""end_span"": 99, ""type"": ""Gene_or_gene_product""}, {""token"": ""IL - 2"", ""start_span"": 103, ""end_span"": 109, ""type"": ""Gene_or_gene_product""}, {""token"": ""hepatic tumor"", ""start_span"": 120, ""end_span"": 133, ""type"": ""Cancer""}, {""token"": ""macrophages"", ""start_span"": 174, ""end_span"": 185, ""type"": ""Cell""}, {""token"": ""lymphocytes"", ""start_span"": 190, ""end_span"": 201, ""type"": ""Cell""}]"	test
Upon initiation of angiogenesis with basic fibroblast growth factor ( bFGF) on the chick chorioallantoic membrane ( CAM), endothelial cell mitogen - activated protein ( MAP) kinase ( ERK) activity was detected as early as 5 min yet was sustained for at least 20 h.	basic fibroblast growth factor,37,67,Gene_or_gene_product	bFGF,70,74,Gene_or_gene_product	chick,83,88,Organism	chorioallantoic membrane,89,113,Multi	CAM,116,119,Multi	endothelial cell,122,138,Cell	ERK,183,186,Gene_or_gene_product	"[{""token"": ""basic fibroblast growth factor"", ""start_span"": 37, ""end_span"": 67, ""type"": ""Gene_or_gene_product""}, {""token"": ""bFGF"", ""start_span"": 70, ""end_span"": 74, ""type"": ""Gene_or_gene_product""}, {""token"": ""chick"", ""start_span"": 83, ""end_span"": 88, ""type"": ""Organism""}, {""token"": ""chorioallantoic membrane"", ""start_span"": 89, ""end_span"": 113, ""type"": ""Multi""}, {""token"": ""CAM"", ""start_span"": 116, ""end_span"": 119, ""type"": ""Multi""}, {""token"": ""endothelial cell"", ""start_span"": 122, ""end_span"": 138, ""type"": ""Cell""}, {""token"": ""ERK"", ""start_span"": 183, ""end_span"": 186, ""type"": ""Gene_or_gene_product""}]"	test
Inhibition of MAP kinase kinase ( MEK) during this sustained alphavbeta3 - dependent ERK signal blocked the formation of new blood vessels while not influencing preexisting blood vessels on the CAM.	MAP kinase kinase,14,31,Gene_or_gene_product	MEK,34,37,Gene_or_gene_product	alphavbeta3,61,72,Gene_or_gene_product	ERK,85,88,Gene_or_gene_product	blood vessels,125,138,Multi	blood vessels,173,186,Multi	CAM,194,197,Multi	"[{""token"": ""MAP kinase kinase"", ""start_span"": 14, ""end_span"": 31, ""type"": ""Gene_or_gene_product""}, {""token"": ""MEK"", ""start_span"": 34, ""end_span"": 37, ""type"": ""Gene_or_gene_product""}, {""token"": ""alphavbeta3"", ""start_span"": 61, ""end_span"": 72, ""type"": ""Gene_or_gene_product""}, {""token"": ""ERK"", ""start_span"": 85, ""end_span"": 88, ""type"": ""Gene_or_gene_product""}, {""token"": ""blood vessels"", ""start_span"": 125, ""end_span"": 138, ""type"": ""Multi""}, {""token"": ""blood vessels"", ""start_span"": 173, ""end_span"": 186, ""type"": ""Multi""}, {""token"": ""CAM"", ""start_span"": 194, ""end_span"": 197, ""type"": ""Multi""}]"	test
